
<html lang="en"     class="pb-page"  data-request-id="40837a9f-2c2f-41c0-b97e-fc576f44774b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm400218y;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules" /></meta><meta name="dc.Creator" content="Camilla  Hofström" /></meta><meta name="dc.Creator" content="Mohamed  Altai" /></meta><meta name="dc.Creator" content="Hadis  Honarvar" /></meta><meta name="dc.Creator" content="Joanna  Strand" /></meta><meta name="dc.Creator" content="Jennie  Malmberg" /></meta><meta name="dc.Creator" content="Seyed Jalal  Hosseinimehr" /></meta><meta name="dc.Creator" content="Anna  Orlova" /></meta><meta name="dc.Creator" content="Torbjörn  Gräslund" /></meta><meta name="dc.Creator" content="Vladimir  Tolmachev" /></meta><meta name="dc.Description" content="Engineered affibody molecules can be used for high contrast in vivo molecular imaging. Extending a recombinantly produced HER2 binding affibody molecule with a hexa-histidine tag allows for conveni..." /></meta><meta name="Description" content="Engineered affibody molecules can be used for high contrast in vivo molecular imaging. Extending a recombinantly produced HER2 binding affibody molecule with a hexa-histidine tag allows for conveni..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 14, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400218y" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400218y" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400218y" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400218y" /></link>
        
    
    

<title>HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400218y" /></meta><meta property="og:title" content="HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0003.jpeg" /></meta><meta property="og:description" content="Engineered affibody molecules can be used for high contrast in vivo molecular imaging. Extending a recombinantly produced HER2 binding affibody molecule with a hexa-histidine tag allows for convenient purification by immobilized metal-ion affinity chromatography and labeling with [99mTc(CO)3]+ but increases radioactivity uptake in the liver. To investigate the impact of charge, lipophilicity, and position on biodistribution, 10 variants of a histidine-based tag was attached to a HER2 binding affibody molecule. The biochemical properties and the HER2 binding affinity appeared to be similar for all variants. In vivo, positive charge promoted liver uptake. For N-terminally placed tags, lipophilicity promoted liver uptake and decreased kidney uptake. Kidney uptake was higher for C-terminally placed tags compared to their N-terminal counterparts. The variant with the amino acid composition HEHEHE placed in the N-terminus gave the lowest nonspecific uptake." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400218y"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400218y">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400218y&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400218y&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400218y&amp;href=/doi/10.1021/jm400218y" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 4966-4974</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm400209h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400262a" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Camilla++Hofstr%C3%B6m">Camilla Hofström</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed++Altai">Mohamed Altai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hadis++Honarvar">Hadis Honarvar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joanna++Strand">Joanna Strand</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennie++Malmberg">Jennie Malmberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seyed+Jalal++Hosseinimehr">Seyed Jalal Hosseinimehr</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Orlova">Anna Orlova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Torbj%C3%B6rn++Gr%C3%A4slund">Torbjörn Gräslund</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir++Tolmachev">Vladimir Tolmachev</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran</span></div><div class="corresp-info"><strong>*</strong>Phone: +46-8-5537 8332. E-mail: <a href="/cdn-cgi/l/email-protection#bfcbd0cdddd5d0cdd1ffddd6d0cbdadcd791d4cbd791ccda"><span class="__cf_email__" data-cfemail="b9cdd6cbdbd3d6cbd7f9dbd0d6cddcdad197d2cdd197cadc">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400218y&amp;href=/doi/10.1021%2Fjm400218y" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 4966–4974</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 21, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 February 2013</li><li><span class="item_label"><b>Published</b> online</span>14 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400218y" title="DOI URL">https://doi.org/10.1021/jm400218y</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4966%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCamilla%2BHofstr%25C3%25B6m%252C%2BMohamed%2BAltai%252C%2BHadis%2BHonarvar%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D12%26contentID%3Djm400218y%26title%3DHAHAHA%252C%2BHEHEHE%252C%2BHIHIHI%252C%2Bor%2BHKHKHK%253A%2BInfluence%2Bof%2BPosition%2Band%2BComposition%2Bof%2BHistidine%2BContaining%2BTags%2Bon%2BBiodistribution%2Bof%2B%255B99mTc%2528CO%25293%255D%252B-Labeled%2BAffibody%2BMolecules%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4974%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400218y"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1082</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400218y" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Camilla&quot;,&quot;last_name&quot;:&quot;Hofström&quot;},{&quot;first_name&quot;:&quot;Mohamed&quot;,&quot;last_name&quot;:&quot;Altai&quot;},{&quot;first_name&quot;:&quot;Hadis&quot;,&quot;last_name&quot;:&quot;Honarvar&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;Strand&quot;},{&quot;first_name&quot;:&quot;Jennie&quot;,&quot;last_name&quot;:&quot;Malmberg&quot;},{&quot;first_name&quot;:&quot;Seyed&quot;,&quot;last_name&quot;:&quot;Jalal Hosseinimehr&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Orlova&quot;},{&quot;first_name&quot;:&quot;Torbjörn&quot;,&quot;last_name&quot;:&quot;Gräslund&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;Tolmachev&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4966-4974&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400218y&quot;},&quot;abstract&quot;:&quot;Engineered affibody molecules can be used for high contrast in vivo molecular imaging. Extending a recombinantly produced HER2 binding affibody molecule with a hexa-histidine tag allows for convenient purification by immobilized metal-ion affinity chromatography and labeling with [99mTc(CO)3]+ but increases radioactivity uptake in the liver. To investigate the impact of charge, lipophilicity, and position on biodistribution, 10 variants of a histidine-based tag was attached to a HER2 binding affibody molecule. The biochemical properties and the HER2 binding affinity appeared to be similar for all variants. In vivo, positive charge promoted liver uptake. For N-terminally placed tags, lipophilicity promoted liver uptake and decreased kidney uptake. Kidney uptake was higher for C-terminally placed tags compared to their N-terminal counterparts. The variant with the amino acid composition HEHEHE placed in the N-terminus gave the lowest nonspecific uptake.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400218y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400218y" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400218y&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400218y" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400218y&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400218y" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400218y&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400218y&amp;href=/doi/10.1021/jm400218y" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400218y" /></input><a href="/doi/pdf/10.1021/jm400218y" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (949 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400218y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400218y%26sid%3Dliteratum%253Aachs%26pmid%3D23692562%26genre%3Darticle%26aulast%3DHofstr%25C3%25B6m%26date%3D2013%26atitle%3DHAHAHA%252C%2BHEHEHE%252C%2BHIHIHI%252C%2Bor%2BHKHKHK%253A%2BInfluence%2Bof%2BPosition%2Band%2BComposition%2Bof%2BHistidine%2BContaining%2BTags%2Bon%2BBiodistribution%2Bof%2B%255B99mTc%2528CO%25293%255D%252B-Labeled%2BAffibody%2BMolecules%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D12%26spage%3D4966%26epage%3D4974%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291334" title="Biodistribution">Biodistribution</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jmcmar.2013.56.issue-12/production/jmcmar.2013.56.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Engineered affibody molecules can be used for high contrast in vivo molecular imaging. Extending a recombinantly produced HER2 binding affibody molecule with a hexa-histidine tag allows for convenient purification by immobilized metal-ion affinity chromatography and labeling with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> but increases radioactivity uptake in the liver. To investigate the impact of charge, lipophilicity, and position on biodistribution, 10 variants of a histidine-based tag was attached to a HER2 binding affibody molecule. The biochemical properties and the HER2 binding affinity appeared to be similar for all variants. In vivo, positive charge promoted liver uptake. For N-terminally placed tags, lipophilicity promoted liver uptake and decreased kidney uptake. Kidney uptake was higher for C-terminally placed tags compared to their N-terminal counterparts. The variant with the amino acid composition HEHEHE placed in the N-terminus gave the lowest nonspecific uptake.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A promising approach to treat disseminated cancer is a specific delivery of cytotoxic agents to the tumor cells, i.e., targeting therapy. Targeting can be achieved by attachment of the cytotoxic agent to an affinity probe that specifically recognizes tumor-associated phenotypic abnormalities. Often, the molecular targets on the tumor cells are transmembrane receptor tyrosine kinases (RTKs) regulating proliferation, differentiation, apoptosis, motility, and angiogenesis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Abnormal expression of a RTK (e.g., overexpression or expression of mutated forms) is often predictive for response to the targeting therapy. The use of radionuclide molecular imaging for detection of abnormal expression of a RTK therefore has the potential to improve patient stratification for successful targeting therapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Affibody molecules are a novel class of affinity proteins that have been generated to target a number of different proteins with low nanomolar or even subnanomolar affinities.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> They are derived from a modified version of the triple-helical B-domain of staphylococcal protein A. To generate affibody molecules interacting with a desired target, phage display selection from a combinatorial library followed by affinity maturation is typically performed. The library consists of variants of the modified version of the B-domain where 13 surface-exposed amino acids in helix 1 and 2 (near the N-terminus) have been combinatorially varied.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Affibody molecules with subnanomolar affinity to several RTKs, such as HER2,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> EGFR,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> HER3,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> PDGFRβ,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and IGF-1R,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> have been identified. When used for radionuclide molecular imaging, the small size of the affibody molecule (approx. 7 kDa) leads to rapid extravasation and tissue penetration and also to rapid clearance of nonbound tracer molecules from blood and nonspecific compartments. In combination with high affinity, this creates the preconditions for high-contrast imaging of RTKs in vivo. Indeed, preclinical studies have shown the high potential of radiolabeled affibody molecules as imaging agents.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Two clinical studies also confirmed the potential of affibody-based imaging agents for visualization of HER2-expressing metastases in patients with disseminated breast cancer.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">Biodistribution and targeting properties of radiolabeled affinity probes relies on several factors including probe size, target affinity and specificity, labeling stability, lipophilicity, and charge.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Understanding how these factors affect biodistribution is important to minimize unspecific uptake and processing of the probe. Sensitivity of imaging depends on many parameters including absolute tumor uptake and contrast, where contrast in turn is affected by the tumor-to-normal tissue ratios. Thus, minimization of the uptake of an imaging probe in normal tissues is as important as maximizing its uptake in tumors. Previous studies have demonstrated that the properties of the radionuclide in combination with a chelator or linker for attachment to the targeting protein can substantially influence radioactivity uptake.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p"><sup>99m</sup>Tc (<i>T</i><sub>1/2</sub> = 6 h, <i>E</i>γ =140.5 keV) is a commonly used radionuclide for molecular imaging applications due to its photon energy (nearly ideal for SPECT imaging), low cost, excellent availability, and low absorbed dose burden to the patient. Also, recent developments of SPECT/CT hybrid instruments now allow for unprecedented imaging quality using <sup>99m</sup>Tc.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Several different peptide-based radionuclide chelators for conjugation of <sup>99m</sup>Tc to affibody molecules have been investigated.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14-17)</a> The use of peptide-based chelators provides an opportunity for their direct incorporation in the peptide sequence of the targeting protein by genetic engineering, thus excluding an additional conjugation step. One of the peptide-based chelators that has been used to conjugate <sup>99m</sup>Tc to affibody molecules is the hexa-histidine tag (H<sub>6</sub>-tag), which allows facile labeling with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The H<sub>6</sub>-tag may also be used for convenient purification of the affibody molecule by immobilized metal-ion affinity chromatography (IMAC) after recombinant production. However, the H<sub>6</sub>-tag altered the biodistribution of the probe with an increase of radioactivity uptake in the liver compared to the same construct lacking a H<sub>6</sub>-tag and labeled by other methods.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Unspecific radioactivity uptake in the liver is problematic because the liver is a common metastatic site of many types of cancer. From other studies, it was found that substitution of only a few amino acids in the chelating part of an affibody molecule can dramatically alter its biodistribution.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> This prompted the search for alterations to the placement and composition of the H<sub>6</sub>-tag that would lead to decreased uptake of radioactivity in the liver.</div><div class="NLM_p">The proposed structure of the [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-tag complex suggests that the peptide motif H-X-H is responsible for chelation of technetium, i.e., every second histidine is involved in the chelation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It implies that labeling of modified histidine-based tags with the format: H-X-H-X-H-X, where X is a variable amino acid, would be allowed. To explore this hypothesis we previously devised and attached a HEHEHE-tag ((HE)<sub>3</sub>-tag) to the HER2-binding affibody molecule Z<sub>HER2:342</sub> and found that it allowed purification by IMAC and stable and efficient labeling with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A comparative biodistribution of Z<sub>HER2:342</sub> extended with either a H<sub>6</sub>-tag or the (HE)<sub>3</sub>-tag showed dramatic differences, where the liver uptake was decreased 10-fold for the (HE)<sub>3</sub>-tag containing probe. In the same study, repositioning of the H<sub>6</sub>-tag from the N- to C-terminus was found to decrease liver uptake by 2-fold. It has to be noted that although that study has demonstrated that position and composition of a histidine tag strongly influences the biodistribution of affibody molecules, the choice of creating the variant with a N-terminal (HE)<sub>3</sub>-tag was based mainly on intuition. The influence of charge and lipophilicity of the side chains in histidine containing peptide-based chelators on biodistribution have not previously been investigated.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed structure of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled histidine-containing tags and calculated biochemical properties of the free peptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this study, the goal was to examine the behavior of an affibody molecule, extended with a tag with the amino acid sequence H-X-H-X-H-X, by systematically varying charge, lipophilicity, and position of the tag. The amino acid X was histidine, glutamic acid, lysine, alanine, or isoleucine (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Lysine was selected because it is as hydrophilic as glutamic acid, but has an opposite charge at physiological conditions. The use of alanine and isoleucine allowed for elucidation of the effect of increased lipophilicity. On the basis of the calculated differences in net charge and lipophilicity of the tags (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), it was expected that they would lead to differences in the biodistribution of the probe. The position of the tags was varied by placement in the N- or C-terminus. The variants were labeled with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> and the chelate stability and biodistribution of the labeled probes was investigated.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Production, Purification, and Characterization of the Affibody Molecules</h3><div class="NLM_p">The affibody molecule Z<sub>HER2:342</sub>, extended with different (HX)<sub>3</sub>-tags, was produced in <i>Escherichia coli</i> and purified by IMAC followed by reverse-phase HPLC (RP-HPLC) as previously described.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Eluted fractions after the RP-HPLC-step contained essentially a single protein of expected molecular weight when analyzed by SDS-PAGE (data not shown). The purified proteins were stable at mg/mL concentrations in phosphate buffered saline (PBS), except for (HI)<sub>3</sub>-Z<sub>HER2:342</sub>, which precipitated at concentrations higher than 2 mg/mL. The biochemical properties of the variants were investigated and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Their molecular masses were determined by LC-MS and the obtained values correlated well (within the accuracy of the method) with their corresponding theoretical molecular masses. The constructs were analyzed by RP-HPLC (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and the purity ranged from 95% to more than 99% (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The secondary structure content of the variants was determined by circular dichroism spectroscopy and was found to be similar for all variants. The melting temperatures were determined and ranged from 63 to 65 °C (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The variants displayed similar secondary structure at 20 °C before and after heating to 90 °C, indicating that they refolded after thermal denaturation, except for (HI)<sub>3</sub>-Z<sub>HER2:342</sub>, which precipitated at around 80 °C. Its melting temperature could therefore not be determined but its thermal unfolding curve was similar to the other variants until it precipitated.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Characterization of Affibody Molecules</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="​" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">calcd Mw (Da)</th><th class="colsep0 rowsep0" align="center" char=".">found Mw (Da)</th><th class="colsep0 rowsep0" align="center" char="​">melting temperature (°C)</th><th class="colsep0 rowsep0" align="center" char=".">RP-HPLC retention (min)</th><th class="colsep0 rowsep0" align="center" char=".">purity (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>6</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char=".">7859</td><td class="colsep0 rowsep0" align="char" char=".">7860</td><td class="colsep0 rowsep0" align="char" char="​">64</td><td class="colsep0 rowsep0" align="char" char=".">18.49</td><td class="colsep0 rowsep0" align="char" char=".">95.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HE)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char=".">7835</td><td class="colsep0 rowsep0" align="char" char=".">7836</td><td class="colsep0 rowsep0" align="char" char="​">65</td><td class="colsep0 rowsep0" align="char" char=".">18.54</td><td class="colsep0 rowsep0" align="char" char=".">98.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HA)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char=".">7661</td><td class="colsep0 rowsep0" align="char" char=".">7662</td><td class="colsep0 rowsep0" align="char" char="​">64</td><td class="colsep0 rowsep0" align="char" char=".">18.56</td><td class="colsep0 rowsep0" align="char" char=".">99.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HK)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char=".">7833</td><td class="colsep0 rowsep0" align="char" char=".">7833</td><td class="colsep0 rowsep0" align="char" char="​">63</td><td class="colsep0 rowsep0" align="char" char=".">18.43</td><td class="colsep0 rowsep0" align="char" char=".">99.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HI)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char=".">7787</td><td class="colsep0 rowsep0" align="char" char=".">7788</td><td class="colsep0 rowsep0" align="char" char="​">ND<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">19.06</td><td class="colsep0 rowsep0" align="char" char=".">99.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-H<sub>6</sub></td><td class="colsep0 rowsep0" align="char" char=".">7872</td><td class="colsep0 rowsep0" align="char" char=".">7873</td><td class="colsep0 rowsep0" align="char" char="​">63</td><td class="colsep0 rowsep0" align="char" char=".">18.17</td><td class="colsep0 rowsep0" align="char" char=".">99.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HE)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">7848</td><td class="colsep0 rowsep0" align="char" char=".">7849</td><td class="colsep0 rowsep0" align="char" char="​">63</td><td class="colsep0 rowsep0" align="char" char=".">18.28</td><td class="colsep0 rowsep0" align="char" char=".">98.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HA)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">7674</td><td class="colsep0 rowsep0" align="char" char=".">7675</td><td class="colsep0 rowsep0" align="char" char="​">63</td><td class="colsep0 rowsep0" align="char" char=".">18.34</td><td class="colsep0 rowsep0" align="char" char=".">99.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HK)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">7846</td><td class="colsep0 rowsep0" align="char" char=".">7846</td><td class="colsep0 rowsep0" align="char" char="​">64</td><td class="colsep0 rowsep0" align="char" char=".">18.16</td><td class="colsep0 rowsep0" align="char" char=".">99.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HI)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">7800</td><td class="colsep0 rowsep0" align="char" char=".">7801</td><td class="colsep0 rowsep0" align="char" char="​">63</td><td class="colsep0 rowsep0" align="char" char=".">18.87</td><td class="colsep0 rowsep0" align="char" char=".">99.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">ND = not determined.</p></div></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Analytical RP-HPLC analysis of the (HX)<sub>3</sub>-Z<sub>HER2:342</sub> variants. The <i>x</i>-axis corresponds to retention time after injection, and the <i>y</i>-axis corresponds to the absorbance measured at 220 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Analysis of the Binding Kinetics</h3><div class="NLM_p">Real-time biosensor analysis was performed to investigate if the composition and position of the (HX)<sub>3</sub>-tags influenced the kinetic constants of the Z<sub>HER2:342</sub>-interaction with HER2. The equilibrium dissociation constant, <i>K</i><sub>D</sub>, was found to be similar for all variants ranging between 26 and 88 pM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These affinities are somewhat weaker than the previously determined <i>K</i><sub>D</sub> value of 22 pM for interaction between Z<sub>HER2:342</sub> and HER2.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Measured Kinetic Constants of the Interaction between the Affibody Molecules and HER2</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="×" /></col><col align="char" char="×" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="×"><i>k</i><sub>a</sub>(M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="×"><i>k</i><sub>d</sub>(s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>D</sub> (pM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">H<sub>6</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="×">2.2 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">1.7 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HE)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="×">2.2 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">1.9 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HA)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="×">6.1 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">1.6 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HK)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="×">5.6 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">2.9 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(HI)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="×">5.0 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">2.5 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-H<sub>6</sub></td><td class="colsep0 rowsep0" align="char" char="×">6.9 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">2.4 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HE)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="×">6.6 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">3.8 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HA)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="×">6.4 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">3.7 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HK)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="×">8.2 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">3.3 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Z<sub>HER2:342</sub>-(HI)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="×">8.1 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="char" char="×">3.6 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Radiolabeling with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup></h3><div class="NLM_p">Site-specific labeling of the constructs with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> was performed according to methods developed earlier<a onclick="showRef(event, 'ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref20">(14, 20)</a> with a radiochemical yield ranging from 50 to 84%. After labeling, a simple purification step was performed to remove unconjugated [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> using disposable NAP-5 size-exclusion columns, resulting in a radiochemical purity of 97–99% for all constructs.</div><div class="NLM_p">To evaluate the stability of the radiolabel, the constructs were subjected to a histidine challenge where they were incubated with 5000-fold molar excess of histidine for 4 h (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The results show an appreciably higher stability of conjugates having the (HX)<sub>3</sub>-tag in the N-terminus compared to the variants with the same tag in the C-terminus. The same pattern was also observed in the control experiments, where PBS without histidine was used. The retained radioactivity for all conjugates with N-terminal tags was higher than 97%. The nature of the nonhistidine side chain also appeared to influence the stability. The positively charged HKHKHK-tag offered the most stable conjugate at both C- or N-terminal positioning compared to the other variants, whereas the least stable label was found for the negatively charged HEHEHE-tag for both positions.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Stability of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">protein-associated radioactivity (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">after histidine challenge</th><th class="colsep0 rowsep0" align="center" char="±">control (PBS)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">93.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">97.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HE)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">75.8 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">86.6 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HK)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">99.15 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">99.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HK)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">93.3 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">95.1 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">98.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">99.2 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HA)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">83.4 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">91.8 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">94.6 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">98.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-H<sub>6</sub></td><td class="colsep0 rowsep0" align="char" char="±">92.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">96.8 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">95.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">97.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HI)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">87.3 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">95.8 ± 0.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">The challenge was performed by incubation with 5000-fold molar excess of histidine at 37 °C during 4 h. Control samples were kept at room temperature during the same time. The experiment was performed in duplicates. The data are presented as an average of the two experiments with maximum error.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Binding Specificity of Radiolabeled Affibody Molecules to HER2-Expressing Cells in Vitro</h3><div class="NLM_p">To investigate the binding of the radiolabeled constructs to HER2 expressing cells, SKOV-3 cells were incubated with the constructs with or without preincubation with nonradiolabeled Z<sub>HER2:342</sub>. The results are displayed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and indicate that binding of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-(HA)<sub>3</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HK)<sub>3</sub>-Z<sub>HER2:342</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>- Z<sub>HER2:342-</sub>(HK)<sub>3</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-(HI)<sub>3</sub>, and [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HE)<sub>3</sub> was receptor mediated because saturation of the receptors by preincubation with nonlabeled Z<sub>HER2:342</sub> significantly decreased binding. For [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub>, an unusualy high level of unspecific binding was detected even though it also decreased upon presaturation of the receptors. Previously, a similar study on [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>HER2:342</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-H<sub>6</sub>, and [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-Z<sub>HER2:342</sub> was performed, where the results also indicated that cell binding was receptor mediated because it could be decreased by receptor presaturation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Specificity of Binding of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled Affibody Molecules to HER2-Expressing SKOV-3 Cells in Vitro<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">cell-bound radioactivity (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">nonblocked</th><th class="colsep0 rowsep0" align="center" char="±">blocked</th><th class="colsep0 rowsep0" align="center"><i>p</i>-value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">21 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">0.78 ± 0.06</td><td class="colsep0 rowsep0" align="left"><5 × 10<sup>–5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HA)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">27 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.56 ± 0.04</td><td class="colsep0 rowsep0" align="left"><5 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HK)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">14.8 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.5</td><td class="colsep0 rowsep0" align="left"><5 × 10<sup>–5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HK)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">28 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.1</td><td class="colsep0 rowsep0" align="left"><5 × 10<sup>–5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub></td><td class="colsep0 rowsep0" align="char" char="±">12.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">0.0002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HI)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">35 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.04</td><td class="colsep0 rowsep0" align="left"><5 × 10<sup>–6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342-</sub>(HE)<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">30 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.1</td><td class="colsep0 rowsep0" align="left"><5 × 10<sup>–6</sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Cells were incubated with 1 nM of radiolabeled conjugates for 1 h at 37 °C. For presaturation of HER2, a 500-fold molar excess of nonradioactive affibody molecules was added. Data are presented as mean values of percent added radioactivity that is cell-bound from three cell dishes and standard deviations.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Studies</h3><div class="NLM_p">To determine the radioactivity uptake in different organs in vivo, the radiolabeled constructs were injected into female NMRI mice. Data concerning biodistribution, 4 and 24 h pi, are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. For all 10 constructs, the biodistribution pattern was typical for affibody molecules, where clearance via glomeruli was rather fast, followed by renal reabsorption, except for [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub> and [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HK)<sub>3</sub>-Z<sub>HER2:342</sub>). The ratio of radioactivity uptake at 4 and 24 h pi in liver and kidneys was in the range of 1.5–2 for all conjugates, indicating a moderately residualizing character of all constructs. The obtained biodistribution of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>HER2:342</sub>, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-H<sub>6</sub>, and [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-Z<sub>HER2:342</sub> were in agreement with a previously published data for these constructs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biodistribution of [<sup>99m</sup>Tc(CO)3]<sup>+</sup>-Labeled Affibody Molecules in Female NMRI Mice, 4 and 24 h after Intravenous Injection<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">His<sub>6</sub>-Z<sub>HER2:342</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Z<sub>HER2:342</sub>-His<sub>6</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">0.42 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.347 ± 0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">10.5 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="±">6.3 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">5 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">1.22 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">109 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">56 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">128 ± 19</td><td class="colsep0 rowsep0" align="char" char="±">98 ± 13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.17 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.23 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">0.17 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">0.56 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.38 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GI tract<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">8 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carcass<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">7 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.7</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">(HE)<sub>3</sub>-Z<sub>HER2:342</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Z<sub>HER2:342</sub>-(HE)<sub>3</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">0.83 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">0.80 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">3.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.14 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.50 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">129 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">57 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">117 ± 10</td><td class="colsep0 rowsep0" align="char" char="±">61 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.42 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.53 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GI tract<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">5 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carcass<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">11.7 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">5.3 ± 0.3</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">(HK)<sub>3</sub>-Z<sub>HER2:342</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Z<sub>HER2:342</sub>-(HK)<sub>3</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">23 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">12 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">9 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">36 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">27 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">84 ± 14</td><td class="colsep0 rowsep0" align="char" char="±">53 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.15 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">0.09 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.38 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.19 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.92 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GI tract<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">7.4 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carcass<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">11 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">6 ± 1</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">(HA)<sub>3</sub>-Z<sub>HER2:342</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Z<sub>HER2:342</sub>-(HA)<sub>3</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">0.40 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">0.13 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.50 ± 0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.316 ± 0.009</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">4.2 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">4.1 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">78 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">51 ± 9</td><td class="colsep0 rowsep0" align="char" char="±">116 ± 16</td><td class="colsep0 rowsep0" align="char" char="±">63 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.10 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.06 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">0.54 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.20 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.27 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GI tract<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">16 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">2.2 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carcass<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">1.88 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">9.9 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 0.6</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">(HI)<sub>3</sub>-Z<sub>HER2:342</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Z<sub>HER2:342</sub>-(HI)<sub>3</sub></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th><th class="colsep0 rowsep0" align="center" char="±">4 h</th><th class="colsep0 rowsep0" align="center" char="±">24 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.43 ± 0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="char" char="±">7.3 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">2.1 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="char" char="±">32 ± 4</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">6.4 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="char" char="±">38 ± 9</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="char" char="±">9 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">6 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">106 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">56 ± 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="char" char="±">0.19 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.11 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">0.30 ± 0.06</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bone</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.39 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.46 ± 0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GI tract<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">4.3 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">3 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">6 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">carcass<a class="ref internalNav" href="#t5fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">5.7 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">9 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">4.8 ± 1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">The measured radioactivity of different organs is expressed as % ID/g and presented as an average value from four animals ± standard deviation.</p></div><div class="footnote" id="t5fn1"><sup>b</sup><p class="last">Data for GI tract with content and carcass are presented as % of injected radioactivity per whole sample.</p></div></div></div><div class="NLM_p">Overall, the analysis demonstrated a profound influence of the composition and position of the (HX)<sub>3</sub>-tag on the observed biodistribution. Most obvious was the influence on uptake in liver and spleen and the level of hepatobiliary excretion (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). From Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, it is apparent that positioning of the tags was crucial. For C-terminal placement, the radioactivity uptake in liver was significantly higher for [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-(HK)<sub>3</sub> than for the other four constructs (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). However, the difference between the other variants was small. For N-terminal placement, the composition had a much more pronounced effect on biodistribution (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Incorporation of the lipophilic isoleucine in the tag shifted the excretion pathway from renal to hepatobiliary and provoked a high uptake in spleen. Hydrophilic histidine and intermediate lipophilic alanine had elevated liver uptake, 10.5 ± 0.7 and 4.2 ± 0.8% ID/g at 4 h pi, respectively. Although hepatic uptake per gram of tissue was lower for [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub>, more radioactivity was excreted through bile into GI-tract. The sum of radioactivity (% ID per whole organ) in liver plus GI-tract did not differ significantly between [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub> (20.9 ± 4.5% ID) and [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-Z<sub>HER2:342</sub> (22.1 ± 2.9% ID).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Influence of position and composition of the (HX)<sub>3</sub>-tag on uptake of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules in liver, spleen, and gastrointestinal tract at 4 h after injection. (A) (HX)<sub>3</sub>-tags placed in the N-terminus. (B). (HX)<sub>3</sub>-tags placed in the C-terminus. The radioactivity of different organs is expressed as % ID/g and presented as an average value from four animals ± standard deviation. * Data for intestines with content are presented as % of injected radioactivity per whole sample.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The conjugate with the hydrophilic glutamate ([<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>HER2:342</sub>) had the lowest uptake in liver and lowest sum of hepatic uptake and hepatobiliary excretion. Surprisingly, [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HK)<sub>3</sub>-Z<sub>HER2:342</sub> had high uptake in both liver and spleen, although lysine is considered to be as hydrophilic as glutamate (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><div class="NLM_p">The influence of position and composition of the (HX)<sub>3</sub>-tags on radioactive concentration in blood as well as in lung and muscle was very distinct (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). The concentration of radioactivity in blood was lower for conjugates with N-terminal placement of the tag compared to conjugates with C-terminal placement. The pattern was similar for lungs (except for [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub>) and muscle. There was a good correlation between concentration of radioactivity in blood at 4 h pi and release of radioactivity during the histidine challenge (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Influence of position and composition of the (HX)<sub>3</sub>-tags on radiactivity concentration of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules in blood, lung, and muscle at 4 pi. The concentration of radioactivity in different organs is expressed as % ID/g and presented as an average value from four animals ± standard deviation. (B) Correlation between release of radioactivity from [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules during histidine challenge and radioactivity concentration in blood at 4 h pi.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The use of a built-in tag in a recombinantly expressed affinity protein for both purification and labeling with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> is convenient. However, tagging the HER2 binding affibody molecule Z<sub>HER2:342</sub> with the commonly used N-terminal hexa-histidine tag (H<sub>6</sub>-tag) was found to be associated with high liver uptake.<a onclick="showRef(event, 'ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref20">(14, 20)</a> Furthermore, it was previously shown that the presence of a H<sub>6</sub>-tag in the N-terminus is associated with a substantially elevated liver uptake when nuclides, other than <sup>99m</sup>Tc, were attached to the C-terminus.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> A previous study demonstrated that the liver uptake of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules could be substantially reduced by replacing every second histidine in the tag by the hydrophilic glutamate, resulting in the HEHEHE-tag or by repositioning the H<sub>6</sub>-tag to the C-terminus.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> At the same time, the tumor uptake was not influenced by the composition of histidine-containing tag (no significant difference between tested conjugates).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This translates into a much higher tumor-to-liver ratio, which could potentially enable imaging of liver metastases in clinics in the future.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Furthermore, a similar effect (i.e., high tumor-to-liver ratio) as a result of the composition of an N-terminally placed histidine-containing tag was observed for other kinds of residualizing labels placed in the C-terminus, such as <sup>111</sup>In attached to the affibody molecule using the DOTA chelator or <sup>99m</sup>Tc═O attached via a cysteine-containing peptide-based chelator.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A reduction of liver uptake was also observed for an IGF-1R binding affibody molecule conjugated with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> using an N-terminal HEHEHE-tag compared to the same construct with a H<sub>6</sub>-tag.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Still, it was impossible to determine all major factors that influence liver uptake. In other studies, positive correlation between lipophilicity and hepatic uptake were observed for different targeting proteins and peptides.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Thus, a combination of the lipophilic [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> and deprotonated histidines might be an explanation for the increase. However, the liver uptake of affibody molecules with a N-terminal hexa-histidine tag is high even in the absence of the [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-label.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23-25)</a> Another contributing factor might be the charge of the tag. Studies on biodistribution of affibody molecules labeled with <sup>99m</sup>Tc═O using peptide-based chelators demonstrated that the presence of a lysine in the chelator causes high liver uptake for both N-terminal<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and C-terminal<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> positioning of the label. In fact,high liver uptake of both <sup>99m</sup>Tc-(HK)<sub>3</sub>-Z<sub>HER2:342</sub> and <sup>99m</sup>Tc-Z<sub>HER2:342</sub>-(HK)<sub>3</sub>, which was observed in this study, suggests that a positive charge in the histidine-containing tag plays a substantial role. However, the influence of lipophilicity was also obvious. For the N-terminally placed and lipophilic (HI)<sub>3</sub>-tag, liver uptake and hepatobiliary excretion was higher than for the hydrophilic (HE)<sub>3</sub>-tag. For [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub> and [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-Z<sub>HER2:342</sub>, the sum of liver uptake and hepatobiliary excretion was the same, but <sup>99m</sup>Tc-H<sub>6</sub>-Z<sub>HER2:342</sub> had higher hepatic retention in contrast to [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HA)<sub>3</sub>-Z<sub>HER2:342</sub>, which had a higher hepatobiliary excretion. This suggests that the hepatocytes handled these constructs or their radiocatabolites differently. Together, these data indicate that the hepatic uptake of affibody molecules occurs by two different pathways. One is promoted by positive charge and the other by lipophilicity. Uptake in the kidneys of the variants with an N-terminal (HX)<sub>3</sub>-tag was inversely correlated with the uptake in the liver which indicates that renal excretion, which is otherwise typical for the Z<sub>HER2:342</sub> affibody molecule, was suppressed by hepatic uptake. An important conclusion from this study is that an increase in hydrophilicity of the (HX)<sub>3</sub>-tags improves the biodistribution of the affibody molecules, but lysine, and possibly other positively charged amino acids, appears to be undesirable in the chelator of <sup>99m</sup>Tc.</div><div class="NLM_p">An interesting observation is the influence of positioning of the tags on biodistribution. The effect of the composition of the tag can be observed also for C-terminal placement, but it was much less pronounced than for N-terminal positioning (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This is in agreement with the earlier observations that modification of the C-terminus of affibody molecules has smaller impact on hepatic uptake and hepatobiliary excretion.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It is also concordant with the idea that not only overall lipophilicity but also local concentration of surface-exposed lipophilic amino acids (”lipophilic patches”) might be a contributing factor for elevated liver uptake.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> It should be noted that the N-terminus is located close to the target-binding site containing a number of surface-exposed hydrophobic amino acids. In a previous study, it was demonstrated that the composition of the binding site can influence the biodistribution pattern of affibody molecules affecting their blood clearance rate and liver uptake.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> It is therefore not surprising that N-terminally placed lipophilic histidine containing tags gives rise to higher liver uptake than the same tags in the C-terminus and is possibly a consequence of their closeness to the lipophilic amino acids in the binding site.</div><div class="NLM_p">An important finding of this study is that the blood concentration and uptake in lung and muscle was lower for affibody molecules having (HX)<sub>3</sub>-tags in the N-terminus with the exception of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HI)<sub>3</sub>-Z<sub>HER2:342</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). The lipophilicity of the conjugates might cause an elevated stickiness to blood plasma proteins increasing its retention in blood, but there was no correlation between blood concentration and the hydrophobicity of the tags. Instead, there was a strong correlation between loss of activity from conjugates during the histidine challenge and radioactivity concentration in the blood (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). There was a report that surrounding amino acids influence the stability of histidine-based tags,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and it is likely that the same effect was observed also in this study. Weakly bound [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> can transchelate to blood proteins, which would slow down the clearance of radioactivity. The higher uptake in lung and muscle could then be a consequence of the higher blood concentration of radioactivity. An important practical implication is that the use of C-terminal tags is unfavorable for affibody molecules intended for labeling with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>.</div><div class="NLM_p">Radionuclide molecular imaging might be a powerful tool to help in personalizing cancer treatment. Particularly, imaging of membranous expression of molecular targets, such as RTKs, is a promising approach. An important factor for successful imaging is a high sensitivity, which depends on high contrast between the targeted structures and surrounding tissue. The use of small (4–10 kDa) scaffold proteins as imaging agents provides a combination of rapid in vivo kinetics and high affinity that creates a precondition for high contrast in vivo imaging.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Our studies also suggest that selection of labeling chemistry (radionuclide, chelator/linker, labeling, and purification conditions) is as critical for successful imaging as selection of the affinity protein.</div><div class="NLM_p last">In conclusion, the current study demonstrates that the glutamate-containing (HX)<sub>3</sub>-tag, located in the N-terminus, is the preferable choice for purification and labeling of affibody molecules with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>. The use of this tag can simplify development of affibody molecules for radionuclide molecular imaging of a variety of molecular targets. It will hopefully aid in the development of other scaffold proteins as well.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General</h3><div class="NLM_p">The purity of each peptide was analyzed by RP-HPLC on a Reprosil Gold 300 C18 column (4.6 mm × 250 mm, 3 μm particle size (Dr Maisch, Ammerbuch, Germany)) using a gradient of 20–50% B (A, 0.1% trifluoroacetic acid (TFA) in H<sub>2</sub>O; B, 0.1% TFA in acetonitrile) over 20 min using a flow rate of 1 mL/min. From each recorded chromatogram, the integrated peak area corresponding to the affibody molecule at 220 nm was divided by to the area of all peaks using Chemstation software (Agilent Technology) to measure the purity. The purity was found to be >95% for all peptides. IsoLink kits were kindly provided by Covidien (Mansfield, MA, USA). Buffers were prepared using common methods from chemicals supplied by Merck (Darmstadt, Germany). High-quality Milli-Q water (resistance higher than 18 MΩ/cm) was used for preparing solutions. <sup>99m</sup>Tc was obtained as pertechnetate from an Ultra-TechneKow generator (Covidien) by elution with sterile 0.9% NaCl. NAP-5 size exclusion columns were from GE Healthcare (Uppsala, Sweden). Phosphate buffered saline (PBS, 0.1 M), pH 7.5, was prepared using common methods. Cells used during in vitro experiments were detached using a trypsin–EDTA solution (0.25% trypsin, 0.02% EDTA in buffer, Biochrom AG, Berlin, Germany). For in vivo experiments, Ketalar (50 mg/mL, Pfizer, NY, USA), Rompun (20 mg/mL, Bayer, Leverkusen,Germany), and heparin (5000 IE/mL, Leo Pharma, Copenhagen, Danmark) were used. Data on cellular uptake and biodistribution were assessed by an unpaired, two-tailed <i>t</i>-test using GraphPad Prism (version 4.00 for Windows GraphPad Software, San Diego, CA, USA) in order to determine any significant differences (<i>p</i> < 0.05). Radioactivity was measured using an automated gamma-counter with a 3-in. NaI(Tl) detector (1480 WIZARD, Wallac Oy, Turku, Finland). The distribution of radioactivity along thin layer chromatography strips and SDS-PAGE gels was measured on a Cyclone storage phosphor system and analyzed using the OptiQuant image analysis software (PerkinElmer, Waltham, MA, USA).</div><div class="NLM_p last">The net charges of the tags at pH = 7.0 were calculated at <a href="http://www.innovagen.se/custom-peptide-synthesis/peptide-property-calculator/peptide-property-calculator.asp" class="extLink">http://www.innovagen.se/custom-peptide-synthesis/peptide-property-calculator/peptide-property-calculator.asp</a> as described.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The grand averages of hydrophathy (GRAVY-score) of the tags at pH = 7.0 were calculated at <a href="http://web.expasy.org/protparam/" class="extLink">http://web.expasy.org/protparam/</a> using the methods described by Kyte et al.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Production of Affibody Molecules</h3><div class="NLM_p">The gene coding for the affibody molecule Z<sub>HER2:342</sub> was PCR amplified using DNA primers carrying overhang-extensions encoding the different (HX)<sub>3</sub>-tags, HHHHHH, HEHEHE, HAHAHA, HKHKHK, or HIHIHI. The resulting DNA fragments were cut with <i>Hin</i>dIII (New England Biolabs, Ipswitch, MA, USA) and <i>Nde</i>I (New England Biolabs) followed by ligation using T4 DNA ligase (New England Biolabs) into the protein expression vector pET21a(+) (Novagen, Darmstadt, Germany). Correct DNA sequences were verified by DNA sequencing.</div><div class="NLM_p">The different Z<sub>HER2:342</sub> variants were produced in <i>Escherichia coli</i> strain BL21(DE3) after inducing protein expression by adding isopropyl-β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (IPTG) to a final concentration of 1.0 mM. After 4 h of production (37 °C, 125 rpm), cells were harvested by centrifugation (2200<i>g</i>, 10 min, 4 °C) and resuspended in wash buffer (50 mM H<sub>2</sub>PO<sub>4</sub>, 300 mM NaCl, pH 7.5). Cells were disrupted by sonication and cell debris was removed by centrifugation (35000<i>g</i>, 20 min, 4 °C). Finally, the clarified cell lysate was filtered through a 0.45 μm filter (Merck Millipore, Billerica, MA, USA) before being applied onto a Talon metal affinity resin (BD Bioscience, San Jose, CA, USA), except for (HI)<sub>3</sub>-Z<sub>HER2:342</sub>, which was applied to a Ni<sup>2+</sup>-chelating sepharose resin (GE Healthcare). After extensive washing, the affibody variants were eluted using elution buffer (50 mM NaAc, 300 mM NaCl, pH 5.0).</div><div class="NLM_p last">The affibody constructs were further purified by reverse-phase high performance liquid chromatography (RP-HPLC) on an Agilent 1200 instrument (Agilent Technology, Santa Clara, CA, USA) using a Reprosil Gold 300 C18 column (10 mm × 250 mm, 5 μm particle size, Dr. Maisch). Elution was carried out by applying a gradient of 20–50% B (A, 0.1% TFA in H<sub>2</sub>O; B, 0.1% TFA in acetonitrile) over 20 min using a flow rate of 2.5 mL/min.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Characterization of Affibody Molecules</h3><div class="NLM_p">The molecular masses of the Z<sub>HER2:342</sub> constructs were determined on a 6520 Accurate-Mass Q-TOF LC-MS instrument (Agilent Technologies), using Agilent <i>MassHunter</i> software (Agilent Technologies) to interpret the isotopic and charge state information. Variable temperature measurements (VTM) were performed on a JASCO J-810 spectropolarimeter instrument (JASCO, Tokyo, Japan), where 60 μM of each affibody molecule, diluted in PBS, was subjected to a temperature gradient increasing 5 °C/min from 20 to 90 °C while measuring the signal at 221 nm. To investigate the impact on secondary structure as a consequence of heat treatment, circular dichroism spectra from 250 to 195 nm were recorded at 20 °C before and after heating to 90 °C.</div><div class="NLM_p last">To determine if the (HX)<sub>3</sub>-tags’ composition and location influenced the binding affinity of Z<sub>HER2:342</sub> to HER2, real-time biosensor analysis on a BIAcore3000 instrument (GE Healthcare) was performed. First, 800 RU of the extracellular domain of HER2 fused to the Fc region of human IgG (R&D systems, Minneapolis, MN, USA) was immobilized on a flow-cell surface of a CM5 chip (GE Healthcare) by amine coupling according to the manufacturer’s recommendation. As a reference, another flow-cell surface was activated and deactivated without any immobilization. A 3-fold dilution series comprised of three different concentrations ranging between 10 and 1.1 nM was prepared for each (HX)<sub>3</sub>-Z<sub>HER2:342</sub> variant. Samples were injected over the flow-cell using a flow rate of 50 μL/min with 5 min association and 20 min dissociation before regenerating the flow-cell surfaces with 20 μL of 20 mM HCl. All concentrations were run in duplicates. The association constant (<i>k</i><sub>a</sub>), the dissociation constant (<i>k</i><sub>d</sub>), and the equilibrium dissociation constant (<i>K</i><sub>D</sub>) were retrieved using the BIAcore evaluation software <i>BIAeval</i> by applying a global curve fit and assuming a one-to-one interaction model.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Labeling of Affibody Molecules with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup></h3><div class="NLM_p">Labeling of affibody molecules with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> was performed as described earlier.<a onclick="showRef(event, 'ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref20">(14, 20)</a> Briefly, 500 μL (350 MBq-2 GBq) of <sup>99m</sup>TcO<sub>4</sub><sup>–</sup>-containing generator eluate were added to a vial with the IsoLink kit. The mixture was incubated at 100 °C for 20 min. Thereafter, 40 μL of mixture was transferred to a tube containing 50 μg (∼6.8 nmol) of affibody molecule in 40 μL of PBS, followed by incubation at 50 °C. The labeling yield after incubation for 60 min was monitored by ITLC. Then 1 μL samples were taken for analysis of the labeling yield using 150–771 DARK GREEN strips eluted with PBS. When the ITLC strips were eluted with PBS, pertechnetate, as well as carbonyl and histidine complexes of <sup>99m</sup>Tc, migrated with the eluent front (<i>R</i><sub>f</sub> = 1.0), while affibody molecules do not move under these conditions (<i>R</i><sub>f</sub> = 0.0).The experiments were performed in quadruplicates. In addition, blank experiments were performed where the affibody molecules were omitted. The labeled affibody molecules were purified using NAP-5 desalting columns (GE Healthcare), pre-equilibrated and eluted with PBS. The purity of each preparation was evaluated using thin layer chromatography.</div><div class="NLM_p last">To evaluate the stability of the <sup>99m</sup>Tc-label, a histidine challenge of the conjugates was performed.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Samples of each labeled conjugate were incubated at 37 °C with 5000-fold excess of histidine for 4 h. Control samples were incubated at 20 °C in PBS. Thereafter, the samples were analyzed using ITLC as described above.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Binding Specificity of Radiolabeled Affibody Molecules to HER2-Expressing Cells in Vitro</h3><div class="NLM_p last">The specificity of binding of the radiolabeled affibody molecules to HER2-expressing cells in vitro was evaluated as previously described.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The SKOV-3 ovarian carcinoma cell line (American Type Tissue Culture Collection (ATCC) via LGC Promochem, Borås, Sweden) was used for the test. Labeled conjugates were added to cell dishes in concentrations of 1 nM. To one set of dishes, nonlabeled Z<sub>HER2:342</sub> at a concentration of 0.5 μM was added 30 min before the labeled conjugate to saturate receptors on cells. The total volume of solutions was 1 mL, and the experiment was done in triplicate. Cells were incubated for 1 h at 37 °C, after which the medium was collected. The cells were washed once with cold serum-free medium, followed by detachment with 0.5 mL of trypsin-EDTA. The cells were subsequently resuspended in 0.5 mL of complete medium and collected. The radioactivity of the incubation medium, and the cells was measured and the percent of cell-bound radioactivity was determined for each set of samples.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Studies</h3><div class="NLM_p">All animal experiments were planned and performed in accordance with the national legislation on laboratory animals’ protection and were approved by the Local Ethics Committee for Animal Research.</div><div class="NLM_p last">Female NMRI mice (18 weeks old, weight 24–29 g) were used in the biodistribution studies. The biodistribution of each conjugate was determined at 4 or 24 h after injection. A group of four mice was used for each data point. The animals were intravenously injected with 70 kBq (for measurement at 4 h pi) or 640 kBq (for measurement at 24 h pi) of radiolabeled conjugate diluted in 100 μL of PBS. In each case, the injected protein dose was adjusted with nonlabeled affibody molecule to 1 μg (0.12 nmol) per mouse. The mice were euthanized at 4 or 24 h after injection by an intraperitoneal injection of Ketalar Rompun solution (20 μL of solution per gram body weight: Ketalar, 10 mg/mL; Rompun, 1 mg/mL) followed by heart puncture with a 1 mL syringe rinsed with heparin (5000 IE/mL). Blood and organ samples: lung, liver, spleen, kidneys, muscle, bone, intestines (with content), and the remaining carcass were collected and weighed and their radioactivity was measured. The organ uptake values are expressed as percent of injected dose per gram of tissue (% ID/g), except for the intestines and the remaining carcass, where values are expressed as % ID per whole sample.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm400218y" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Torbjörn Gräslund</span> - <span class="hlFld-Affiliation affiliation">Division of Protein Technology,
School of Biotechnology, KTH Royal Institute of Technology, Stockholm,
Sweden</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4e3a213c2c24213c200e2c27213a2b2d2660253a26603d2b"><span class="__cf_email__" data-cfemail="92e6fde0f0f8fde0fcd2f0fbfde6f7f1fabcf9e6fabce1f7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Camilla Hofström</span> - <span class="hlFld-Affiliation affiliation">Division of Protein Technology,
School of Biotechnology, KTH Royal Institute of Technology, Stockholm,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed Altai</span> - <span class="hlFld-Affiliation affiliation">Division of Biomedical
Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hadis Honarvar</span> - <span class="hlFld-Affiliation affiliation">Division of Biomedical
Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna Strand</span> - <span class="hlFld-Affiliation affiliation">Division of Biomedical
Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala,
Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennie Malmberg</span> - <span class="hlFld-Affiliation affiliation">Preclinical PET Platform,
Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seyed Jalal Hosseinimehr</span> - <span class="hlFld-Affiliation affiliation">Division of Biomedical
Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala,
Sweden</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Radiopharmacy,
Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari,
Iran</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Orlova</span> - <span class="hlFld-Affiliation affiliation">Preclinical PET Platform,
Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir Tolmachev</span> - <span class="hlFld-Affiliation affiliation">Division of Biomedical
Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala,
Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d199e3121-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was financially supported by grants from Swedish Cancer Society (Cancerfonden), Swedish Research Council (Vetenskapsrådet). We express our gratitude to Covidien for providing IsoLink kits.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> Abbreviations Used</h2><tr><td class="NLM_term">GRAVY</td><td class="NLM_def"><p class="first last">grand average of hydropathy</p></td></tr><tr><td class="NLM_term">H<sub>6</sub></td><td class="NLM_def"><p class="first last">hexa-histidine</p></td></tr><tr><td class="NLM_term">IMAC</td><td class="NLM_def"><p class="first last">immobilized metal-ion affinity chromatography</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl-β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">RP-HPLC</td><td class="NLM_def"><p class="first last">reverse-phase high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sharma, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, T.</span><span> </span><span class="NLM_article-title">Receptor tyrosine kinase inhibitors as potent weapons in war against cancers</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2174%2F138161209787582219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19275641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=758-776&author=P.+S.+Sharmaauthor=R.+Sharmaauthor=T.+Tyagi&title=Receptor+tyrosine+kinase+inhibitors+as+potent+weapons+in+war+against+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinase inhibitors as potent weapons in war against cancers</span></div><div class="casAuthors">Sharma, P. Sapra; Sharma, R.; Tyagi, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">758-776</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor Tyrosine Kinases class I (RTK class I, EGF receptor family) constitute a family of transmembrane proteins involved in various aspects of cell growth and survival and have been implicated in the initiation and progression of several types of human malignancies.  Activation of EGFR may be because of overexpression, mutations resulting in constitutive activation, or autocrine expression of ligand.  In contrast, activation of HER2 occurs mainly by overexpression, which leads to spontaneous homodimerization and activation of downstream signaling events in a ligand-independent manner.  EGFR and HER2 have now been validated as a clin. relevant target, and several different types of agents inhibiting these receptors are currently in development.  The EGFR inhibitors Erlotinib, Gefitinib, and Cetuximab have undergone extensive clin. testing and have established clin. activity in non small cell lung cancer (NSCLS) and other types of solid tumors.  Several of the other erbB inhibitors are also undergoing advanced clin. testing, either alone or in combination with other agents.  This review reports various inhibitors, natural, small mols. and monoclonal antibodies, along with their reported activities for various members of erbB family.  It will highlight the potential for the development of novel anti-cancer mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4DFJZs8wJd7Vg90H21EOLACvtfcHk0lgKBTitTU1tjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSnsrY%253D&md5=792b79efb1a5276505912df047108451</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161209787582219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787582219%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DP.%2BS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DT.%26atitle%3DReceptor%2520tyrosine%2520kinase%2520inhibitors%2520as%2520potent%2520weapons%2520in%2520war%2520against%2520cancers%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D758%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone-Elander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Current approaches to the use of radiolabeled tyrosine kinase-targeting drugs for patient stratification and treatment response monitoring: prospects and pitfalls</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1016%2FS1470-2045%2810%2970088-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20667780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ertLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=992-1000&author=V.+Tolmachevauthor=S.+Stone-Elanderauthor=A.+Orlova&title=Current+approaches+to+the+use+of+radiolabeled+tyrosine+kinase-targeting+drugs+for+patient+stratification+and+treatment+response+monitoring%3A+prospects+and+pitfalls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls</span></div><div class="casAuthors">Tolmachev, Vladimir; Stone-Elander, Sharon; Orlova, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">992-1000</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Transmembrane receptor tyrosine kinases (RTKs) are overexpressed in many malignancies.  RTK signalling triggers cell proliferation, suppression of apoptosis, increased motility, and recruitment of neovasculature.  Overexpressed RTKs are the mol. targets for an increasing no. of anticancer drugs.  Monoclonal antibodies block the ligands or their binding sites and prevent receptor dimerization, thereby hindering RTK signalling.  The antibody-dependent cellular cytotoxicity can boost the therapeutic effect.  Small-mol. tyrosine kinase inhibitors (TKIs) hamper downstream RTK signalling by targeting the intracellular kinase domain.  These drugs have significantly increased survival in several patient groups.  Improved patient stratification and therapy monitoring might further enhance the efficacy of anti-RTK therapy.  Radionuclide-based mol. imaging can provide methods for localizing and estg. the expression of RTKs.  It can potentially identify patients who have tumors that overexpress RTK and would, therefore, most likely benefit from a targeted treatment.  Monitoring changes in RTK expression during therapy could help avoid overtreatment and undertreatment.  Radionuclide-based methods are less invasive and less sensitive to expression heterogeneity than more conventional sampling methods.  The biochem. information is also obtained in an anatomical context.  The development of radiolabeled anti-RTK drugs and their analogs is the subject of intensive preclin. and translational research.  In this review, we present current approaches to developing imaging probes for in-vivo RTK visualization and discuss their advantages and disadvantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6aQHJNbdTIrVg90H21EOLACvtfcHk0lgKBTitTU1tjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ertLjI&md5=3f89bb6d613f9681a75bd8f7d09b577c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2810%2970088-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252810%252970088-7%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DStone-Elander%26aufirst%3DS.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DCurrent%2520approaches%2520to%2520the%2520use%2520of%2520radiolabeled%2520tyrosine%2520kinase-targeting%2520drugs%2520for%2520patient%2520stratification%2520and%2520treatment%2520response%2520monitoring%253A%2520prospects%2520and%2520pitfalls%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D992%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Löfblom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frejd, F. Y.</span><span> </span><span class="NLM_article-title">Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">2670</span><span class="NLM_x">–</span> <span class="NLM_lpage">2680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=2670-2680&author=J.+L%C3%B6fblomauthor=J.+Feldwischauthor=V.+Tolmachevauthor=J.+Carlssonauthor=S.+St%C3%A5hlauthor=F.+Y.+Frejd&title=Affibody+molecules%3A+engineered+proteins+for+therapeutic%2C+diagnostic+and+biotechnological+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6fblom%26aufirst%3DJ.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DFrejd%26aufirst%3DF.%2BY.%26atitle%3DAffibody%2520molecules%253A%2520engineered%2520proteins%2520for%2520therapeutic%252C%2520diagnostic%2520and%2520biotechnological%2520applications%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D2670%26epage%3D2680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höiden-Guthenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, F. Y.</span><span> </span><span class="NLM_article-title">Tumor imaging using a picomolar affinity HER2 binding affibody molecule</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4339-4348&author=A.+Orlovaauthor=M.+Magnussonauthor=T.+L.+Erikssonauthor=M.+Nilssonauthor=B.+Larssonauthor=I.+H%C3%B6iden-Guthenbergauthor=C.+Widstr%C3%B6mauthor=J.+Carlssonauthor=V.+Tolmachevauthor=S.+St%C3%A5hlauthor=F.+Y.+Nilsson&title=Tumor+imaging+using+a+picomolar+affinity+HER2+binding+affibody+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DMagnusson%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DT.%2BL.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DB.%26aulast%3DH%25C3%25B6iden-Guthenberg%26aufirst%3DI.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DF.%2BY.%26atitle%3DTumor%2520imaging%2520using%2520a%2520picomolar%2520affinity%2520HER2%2520binding%2520affibody%2520molecule%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4339%26epage%3D4348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Imaging of EGFR expression in murine xenografts using site-specifically labeled anti-EGFR <sup>111</sup>In-DOTA-Z<sub>EGFR:2377</sub> affibody molecule: aspect of the injected tracer amount</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs00259-009-1283-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19838701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A280%3ADC%252BC3c7gs1Ckug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=613-622&author=V.+Tolmachevauthor=D.+Rosikauthor=H.+W%C3%A5llbergauthor=A.+Sj%C3%B6bergauthor=M.+Sandstr%C3%B6mauthor=M.+Hanssonauthor=A.+Wennborgauthor=A.+Orlova&title=Imaging+of+EGFR+expression+in+murine+xenografts+using+site-specifically+labeled+anti-EGFR+111In-DOTA-ZEGFR%3A2377+affibody+molecule%3A+aspect+of+the+injected+tracer+amount"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount</span></div><div class="casAuthors">Tolmachev Vladimir; Rosik Daniel; Wallberg Helena; Sjoberg Anna; Sandstrom Mattias; Hansson Monika; Wennborg Anders; Orlova Anna</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Overexpression of epidermal growth factor receptor (EGFR) is a prognostic and predictive biomarker in a number of malignant tumours.  Radionuclide molecular imaging of EGFR expression in cancer could influence patient management.  However, EGFR expression in normal tissues might complicate in vivo imaging.  The aim of this study was to evaluate if optimization of the injected protein dose might improve imaging of EGFR expression in tumours using a novel EGFR-targeting protein, the DOTA-Z(EGFR:2377) Affibody molecule.  METHODS:  An anti-EGFR Affibody molecule, Z(EGFR:2377), was labelled with (111)In via the DOTA chelator site-specifically conjugated to a C-terminal cysteine.  The affinity of DOTA-Z(EGFR:2377) for murine and human EGFR was measured by surface plasmon resonance.  The cellular processing of (111)In-DOTA-Z(EGFR:2377) was evaluated in vitro.  The biodistribution of radiolabelled Affibody molecules injected in a broad range of injected Affibody protein doses was evaluated in mice bearing EGFR-expressing A431 xenografts.  RESULTS:  Site-specific coupling of DOTA provided a uniform conjugate possessing equal affinity for human and murine EGFR.  The internalization of (111)In-DOTA-Z(EGFR:2377) by A431 cells was slow.  In vivo, the conjugate accumulated specifically in xenografts and in EGFR-expressing tissues.  The curve representing the dependence of tumour uptake on the injected Affibody protein dose was bell-shaped.  The highest specific radioactivity (lowest injected protein dose) provided a suboptimal tumour-to-blood ratio.  The results of the biodistribution study were confirmed by gamma-camera imaging.  CONCLUSION:  The (111)In-DOTA-Z(EGFR:2377) Affibody molecule is a promising tracer for radionuclide molecular imaging of EGFR expression in malignant tumours.  Careful optimization of protein dose is required for high-contrast imaging of EGFR expression in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8Py3uNN3EoIqdXsLcGTEUfW6udTcc2eZaTGigTUzXK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7gs1Ckug%253D%253D&md5=1598caa865162de28b30667d495eb103</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00259-009-1283-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-009-1283-x%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DM.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DImaging%2520of%2520EGFR%2520expression%2520in%2520murine%2520xenografts%2520using%2520site-specifically%2520labeled%2520anti-EGFR%2520111In-DOTA-ZEGFR%253A2377%2520affibody%2520molecule%253A%2520aspect%2520of%2520the%2520injected%2520tracer%2520amount%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2010%26volume%3D37%26spage%3D613%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kronqvist, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göstring, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunneriusson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höiden-Guthenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frejd, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löfblom, J.</span><span> </span><span class="NLM_article-title">Combining phage and staphylococcal surface display for generation of ErbB3-specific affibody molecules</span> <span class="citation_source-journal">Protein Eng., Des. Sel.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1093%2Fprotein%2Fgzq118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=21177282" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=385-396&author=N.+Kronqvistauthor=M.+Malmauthor=L.+G%C3%B6stringauthor=E.+Gunneriussonauthor=M.+Nilssonauthor=I.+H%C3%B6iden-Guthenbergauthor=L.+Geddaauthor=F.+Y.+Frejdauthor=S.+St%C3%A5hlauthor=J.+L%C3%B6fblom&title=Combining+phage+and+staphylococcal+surface+display+for+generation+of+ErbB3-specific+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzq118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzq118%26sid%3Dliteratum%253Aachs%26aulast%3DKronqvist%26aufirst%3DN.%26aulast%3DMalm%26aufirst%3DM.%26aulast%3DG%25C3%25B6string%26aufirst%3DL.%26aulast%3DGunneriusson%26aufirst%3DE.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DH%25C3%25B6iden-Guthenberg%26aufirst%3DI.%26aulast%3DGedda%26aufirst%3DL.%26aulast%3DFrejd%26aufirst%3DF.%2BY.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DL%25C3%25B6fblom%26aufirst%3DJ.%26atitle%3DCombining%2520phage%2520and%2520staphylococcal%2520surface%2520display%2520for%2520generation%2520of%2520ErbB3-specific%2520affibody%2520molecules%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2010%26volume%3D24%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lindborg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höiden-Guthenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunneriusson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hage, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herne, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frejd, F. Y.</span><span> </span><span class="NLM_article-title">Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor beta in vivo</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1016%2Fj.jmb.2011.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=21277312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFWqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=298-315&author=M.+Lindborgauthor=E.+Cortezauthor=I.+H%C3%B6iden-Guthenbergauthor=E.+Gunneriussonauthor=E.+von+Hageauthor=F.+Syudauthor=M.+Morrisonauthor=L.+Abrahms%C3%A9nauthor=N.+Herneauthor=K.+Pietrasauthor=F.+Y.+Frejd&title=Engineered+high-affinity+affibody+molecules+targeting+platelet-derived+growth+factor+receptor+beta+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Engineered High-Affinity Affibody Molecules Targeting Platelet-Derived Growth Factor Receptor β In Vivo</span></div><div class="casAuthors">Lindborg, M.; Cortez, E.; Hoeiden-Guthenberg, I.; Gunneriusson, E.; von Hage, E.; Syud, F.; Morrison, M.; Abrahmsen, L.; Herne, N.; Pietras, K.; Frejd, F. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-315</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Platelet-derived growth factor receptor (PDGFR) β is a marker of stromal pericytes and fibroblasts and represents an interesting target for both diagnosis and therapy of solid tumors.  A receptor-specific imaging agent would be a useful tool for further understanding the prognostic role of this receptor in vivo.  Affibody mols. constitute a class of very small binding proteins that are highly suited for in vivo imaging applications and that can be selected to specifically recognize a desired target protein.  Here we describe the isolation of PDGFRβ-specific Affibody mols. with subnanomolar affinity.  First-generation Affibody mols. were generated from a large naive library using phage display selection.  Subsequently, sequences from binders having a desired selectivity profile and competing with the natural ligand for binding were used in the design of an affinity maturation library, which was created using a single partially randomized oligonucleotide.  From this second-generation library, Affibody mols. with a 10-fold improvement in affinity (K d = 0.4-0.5 nM) for human PDGFRβ and a 4-fold improvement in affinity (K d = 6-7 nM) for murine PDGFRβ were isolated and characterized.  Complete reversible folding after heating to 90 °C, as demonstrated by CD anal., supports tolerance to labeling conditions for mol. imaging.  The binders were highly specific, as verified by dot blot showing staining reactivity only with human and murine PDGFRβ, but not with human PDGFRα, or a panel of control proteins including 16 abundant human serum proteins.  The final binder recognized the native conformation of PDGFRβ expressed in murine NIH-3T3 fibroblasts and human AU565 cells, and inhibited ligand-induced receptor phosphorylation in PDGFRβ-transfected porcine aortic endothelial cells.  The PDGFRβ-specific Affibody mol. also accumulated around tumoral blood vessels in a model of spontaneous insulinoma, confirming a potential for in vivo targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0zHAlJQGtlLVg90H21EOLACvtfcHk0ljjo1Q9cGqbhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFWqsbs%253D&md5=0d3f996fc70a3fe5373c5233a8203570</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DLindborg%26aufirst%3DM.%26aulast%3DCortez%26aufirst%3DE.%26aulast%3DH%25C3%25B6iden-Guthenberg%26aufirst%3DI.%26aulast%3DGunneriusson%26aufirst%3DE.%26aulast%3Dvon%2BHage%26aufirst%3DE.%26aulast%3DSyud%26aufirst%3DF.%26aulast%3DMorrison%26aufirst%3DM.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DHerne%26aufirst%3DN.%26aulast%3DPietras%26aufirst%3DK.%26aulast%3DFrejd%26aufirst%3DF.%2BY.%26atitle%3DEngineered%2520high-affinity%2520affibody%2520molecules%2520targeting%2520platelet-derived%2520growth%2520factor%2520receptor%2520beta%2520in%2520vivo%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D407%26spage%3D298%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Imaging of insulin-like growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule <sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub></span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=90-97&author=V.+Tolmachevauthor=J.+Malmbergauthor=C.+Hofstr%C3%B6mauthor=L.+Abrahms%C3%A9nauthor=T.+Bergmanauthor=A.+Sj%C3%B6bergauthor=M.+Sandstr%C3%B6mauthor=T.+Gr%C3%A4slundauthor=A.+Orlova&title=Imaging+of+insulin-like+growth+factor+type+1+receptor+in+prostate+cancer+xenografts+using+the+affibody+molecule+111In-DOTA-ZIGF1R%3A4551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DMalmberg%26aufirst%3DJ.%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DBergman%26aufirst%3DT.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DImaging%2520of%2520insulin-like%2520growth%2520factor%2520type%25201%2520receptor%2520in%2520prostate%2520cancer%2520xenografts%2520using%2520the%2520affibody%2520molecule%2520111In-DOTA-ZIGF1R%253A4551%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D90%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Radionuclide molecular imaging using affibody molecules</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2174%2F138920110792246609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20497119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CmsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=581-589&author=S.+Ahlgrenauthor=V.+Tolmachev&title=Radionuclide+molecular+imaging+using+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Radionuclide molecular imaging using affibody molecules</span></div><div class="casAuthors">Ahlgren, Sara; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The current way to increase efficacy of cancer therapy is the use of mol. recognition of aberrantly expressed gene products for selective treatment.  However, only a fraction of the patients have tumors with a particular mol. target.  Radionuclide imaging of mol. targets might help to stratify patient for cancer treatment.  Affibody mols. are scaffold proteins, which can be selected for high affinity recognition of proteinaceous mol. targets.  The capacity to re-fold under physiol. conditions allows labeling of Affibody mols. in a broad range of pH and temps. with preserved binding properties.  Peptide synthesis or introduction of a unique cysteine enables site-specific labeling of Affibody mols., resulting in uniform conjugates with well-defined pharmacol. characteristics.  The small size (7 kDa) of Affibody mols. provides rapid extravasation, rapid tumor penetration, and rapid clearance of unbound tracer from healthy organs and tissues.  In combination with sub-nanomolar affinity, this results in high contrast in vivo imaging a few hours after injection.  Excellent targeting has been demonstrated in pre-clin. studies with HER2-targeting Affibody mols. labeled with 99mTc and 111In for single photon computed tomog. (SPECT), and 18F, 64Cu, 124I and 68Ga for positron emission tomog. (PET).  Pilot clin. data confirm the high potential of Affibody mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMCx5xwZc2J7Vg90H21EOLACvtfcHk0ljjo1Q9cGqbhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CmsrjI&md5=f5f1d1fd75658e31aa5d3af6a03f9c62</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F138920110792246609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920110792246609%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DRadionuclide%2520molecular%2520imaging%2520using%2520affibody%2520molecules%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2010%26volume%3D11%26spage%3D581%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Baum, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuchardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span> </span><span class="NLM_article-title">Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic <sup>111</sup>In- or <sup>68</sup>Ga-labeled affibody molecules</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2967%2Fjnumed.109.073239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20484419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A280%3ADC%252BC3czmt1WnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=892-897&author=R.+P.+Baumauthor=V.+Prasadauthor=D.+M%C3%BCllerauthor=C.+Schuchardtauthor=A.+Orlovaauthor=A.+Wennborgauthor=V.+Tolmachevauthor=J.+Feldwisch&title=Molecular+imaging+of+HER2-expressing+malignant+tumors+in+breast+cancer+patients+using+synthetic+111In-+or+68Ga-labeled+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules</span></div><div class="casAuthors">Baum Richard P; Prasad Vikas; Muller Dirk; Schuchardt Christiane; Orlova Anna; Wennborg Anders; Tolmachev Vladimir; Feldwisch Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  The clinical utility of a human epidermal growth factor receptor 2 (HER2)-targeting Affibody molecule for detection and characterization of HER2-positive lesions was investigated in patients with recurrent metastatic breast cancer.  METHODS:  Three patients received (111)In- or (68)Ga-labeled DOTA(0)-Z(HER2:342-pep2) (ABY-002). gamma-Camera, SPECT, or PET/CT images were compared with earlier (18)F-FDG PET/CT results.  RESULTS:  Administration of radiolabeled ABY-002 was well tolerated.  Blood kinetics of radiolabeled ABY-002 showed a first half-life of 4-14 min, second half-life of 1-4 h, and third half-life of 12-18 h.  Radiolabeled ABY-002 detected 9 of 11 (18)F-FDG-positive metastases as early as 2-3 h after injection.  CONCLUSION:  Molecular imaging using (111)In- or (68)Ga-labeled ABY-002 has the potential to localize metastatic lesions in vivo, adds qualitative information not available today by conventional imaging techniques, and may allow the HER2 status to be determined for metastases not amenable to biopsy.  To our knowledge, this is the first report on clinical imaging data obtained with a non-immunoglobulin-based scaffold protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxq6EVK_8-BFvAgqb2vdc5fW6udTcc2eYEiU6KPuP6urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmt1WnsA%253D%253D&md5=4f67732329c856be99195fdd1c71ca05</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.109.073239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.109.073239%26sid%3Dliteratum%253Aachs%26aulast%3DBaum%26aufirst%3DR.%2BP.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%26aulast%3DSchuchardt%26aufirst%3DC.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DFeldwisch%26aufirst%3DJ.%26atitle%3DMolecular%2520imaging%2520of%2520HER2-expressing%2520malignant%2520tumors%2520in%2520breast%2520cancer%2520patients%2520using%2520synthetic%2520111In-%2520or%252068Ga-labeled%2520affibody%2520molecules%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D892%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sandberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garske, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sörensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindman, H.</span><span> </span><span class="NLM_article-title">First clinical observations of HER2 specific [<sup>111</sup>In]ABY-025 metastatic detection capability in females with metastatic breast cancer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl1</span><span class="NLM_x">) </span> <span class="NLM_fpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=220&issue=Suppl1&author=D.+Sandbergauthor=A.+Wennborgauthor=F.+Feldwischauthor=V.+Tolmachevauthor=J.+Carlssonauthor=U.+Garskeauthor=J.+S%C3%B6rensenauthor=H.+Lindman&title=First+clinical+observations+of+HER2+specific+%5B111In%5DABY-025+metastatic+detection+capability+in+females+with+metastatic+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DD.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DFeldwisch%26aufirst%3DF.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DGarske%26aufirst%3DU.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DJ.%26aulast%3DLindman%26aufirst%3DH.%26atitle%3DFirst%2520clinical%2520observations%2520of%2520HER2%2520specific%2520%255B111In%255DABY-025%2520metastatic%2520detection%2520capability%2520in%2520females%2520with%2520metastatic%2520breast%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26issue%3DSuppl1%26spage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Influence of labeling methods on biodistribution and imaging properties of radiolabelled peptides for visualization of molecular therapeutic targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2636</span><span class="NLM_x">–</span> <span class="NLM_lpage">2655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2174%2F092986710791859397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20491631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2636-2655&author=V.+Tolmachevauthor=A.+Orlova&title=Influence+of+labeling+methods+on+biodistribution+and+imaging+properties+of+radiolabelled+peptides+for+visualization+of+molecular+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets</span></div><div class="casAuthors">Tolmachev, V.; Orlova, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2636-2655</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Progress in genomics and proteomics provides clin. oncol. with new anti-cancer drugs, which target selectively aberrantly expressed membrane proteins and assocd. signaling pathways in malignant cells.  Mol. targeting also enables specific delivery of cytotoxic substances to tumors sparing healthy tissues.  Improved selectivity of the treatment reduces side effects and widens the therapeutic window.  However, only a part of the patients might benefit from such treatment due to inter- and intrapatient heterogeneity of therapeutic target expression.  This makes it necessary to identify patients, who may benefit from targeting therapy.  Radiolabeled peptides can provide selective and sensitive detection of mol. therapeutic targets in both primary tumors and metastases in a single non-invasive procedure, making personalized treatment possible.  The choice of detection method (single photon emission tomog. or positron emission tomog.), radionuclide for labeling and labeling chem. can appreciably influence the imaging property of a tracer.  The labeling method might affect the binding affinity, the cellular processing and retention of a radionuclide, the biodistribution of a targeting peptide, and excretion pathways of a non-bound tracer and radiocatabolites.  This influences the sensitivity and specificity of the imaging.  This influence is exemplified by three classes of tumor-targeting peptides: somatostatin analogs, bombesin analogs and Affibody mols.  The review suggests approaches for selection of an optimal labeling chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5k8-43_isN7Vg90H21EOLACvtfcHk0lhFJ3fsjHAfQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nE&md5=da62e94476aef0b9ac9fae5cfc8c3d69</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986710791859397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859397%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DInfluence%2520of%2520labeling%2520methods%2520on%2520biodistribution%2520and%2520imaging%2520properties%2520of%2520radiolabelled%2520peptides%2520for%2520visualization%2520of%2520molecular%2520therapeutic%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2636%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Núñez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erwin, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madewell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macapinlac, H. A.</span><span> </span><span class="NLM_article-title">Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs11307-009-0266-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=110-138&author=R.+N%C3%BA%C3%B1ezauthor=W.+D.+Erwinauthor=R.+E.+Wendtauthor=A.+Stachowiakauthor=M.+Marauthor=D.+Stevensauthor=J.+E.+Madewellauthor=H.+W.+Yeungauthor=H.+A.+Macapinlac&title=Acquisition+parameters+for+oncologic+imaging+with+a+new+SPECT%2Fmultislice+CT+scanner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs11307-009-0266-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-009-0266-4%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DR.%26aulast%3DErwin%26aufirst%3DW.%2BD.%26aulast%3DWendt%26aufirst%3DR.%2BE.%26aulast%3DStachowiak%26aufirst%3DA.%26aulast%3DMar%26aufirst%3DM.%26aulast%3DStevens%26aufirst%3DD.%26aulast%3DMadewell%26aufirst%3DJ.%2BE.%26aulast%3DYeung%26aufirst%3DH.%2BW.%26aulast%3DMacapinlac%26aufirst%3DH.%2BA.%26atitle%3DAcquisition%2520parameters%2520for%2520oncologic%2520imaging%2520with%2520a%2520new%2520SPECT%252Fmultislice%2520CT%2520scanner%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2010%26volume%3D2%26spage%3D110%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=512-519&author=A.+Orlovaauthor=F.+Y.+Nilssonauthor=M.+Wikmanauthor=C.+Widstr%C3%B6mauthor=S.+St%C3%A5hlauthor=J.+Carlssonauthor=V.+Tolmachev&title=Comparative+in+vivo+evaluation+of+technetium+and+iodine+labels+on+an+anti-HER2+affibody+for+single-photon+imaging+of+HER2+expression+in+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DF.%2BY.%26aulast%3DWikman%26aufirst%3DM.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DComparative%2520in%2520vivo%2520evaluation%2520of%2520technetium%2520and%2520iodine%2520labels%2520on%2520an%2520anti-HER2%2520affibody%2520for%2520single-photon%2520imaging%2520of%2520HER2%2520expression%2520in%2520tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26spage%3D512%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tran, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of a HER2-specific affibody molecule for molecular imaging</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1873</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs00259-009-1176-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19504093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSlu7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=1864-1873&author=T.+A.+Tranauthor=D.+Rosikauthor=L.+Abrahms%C3%A9nauthor=M.+Sandstr%C3%B6mauthor=A.+Sj%C3%B6bergauthor=H.+W%C3%A5llbergauthor=S.+Ahlgrenauthor=A.+Orlovaauthor=V.+Tolmachev&title=Design%2C+synthesis+and+biological+evaluation+of+a+HER2-specific+affibody+molecule+for+molecular+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging</span></div><div class="casAuthors">Tran, Thuy A.; Rosik, Daniel; Abrahmsen, Lars; Sandstroem, Mattias; Sjoeberg, Anna; Wallberg, Helena; Ahlgren, Sara; Orlova, Anna; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1864-1873</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose. The purpose of this study was to design and evaluate a novel platform for labeling of Affibody mols., enabling both recombinant and synthetic prodn. and site-specific labeling with 99mTc or trivalent radiometals.  Methods. The HER2-specific Affibody mol. PEP05352 was made by peptide synthesis.  The chelator sequence SECG (serine-glutamic acid-cysteine-glycine) was anchored on the C-terminal to allow 99mTc labeling.  The cysteine can alternatively serve as a conjugation site of the chelator DOTA for indium labeling.  The resulting 99mTc- and 111In-labeled Affibody mols. were evaluated both in vitro and in vivo.  Results. Both conjugates retained their capacity to bind to HER2 receptors in vitro and in vivo.  The tumor to blood ratio in LS174T xenografts was 30 at 4 h post-injection for both conjugates.  Biodistribution data showed that the 99mTc-labeled Affibody mol. had a fourfold lower kidney accumulation compared with the 111In-labeled Affibody mol. while the accumulation in other organs was similar.  Gamma camera imaging of the conjugates could clearly visualize the tumors 4 h after injection.  Conclusion. Incorporation of the C-terminal SECG sequence in Affibody mols. provides a general multifunctional platform for site-specific labeling with different nuclides (technetium, indium, gallium, cobalt or yttrium) and for a flexible prodn. (chem. synthesis or recombinant).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzFLblUMuT1bVg90H21EOLACvtfcHk0lhqhdxORUHn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSlu7zJ&md5=1e422a4037468bb6fe505a6afdec92bb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00259-009-1176-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-009-1176-z%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BA.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520HER2-specific%2520affibody%2520molecule%2520for%2520molecular%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2009%26volume%3D36%26spage%3D1864%26epage%3D1873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Molecular design and optimization of <sup>99m</sup>Tc-labeled recombinant affibody molecules improves their biodistribution and imaging properties</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=461-469&author=H.+W%C3%A5llbergauthor=A.+Orlovaauthor=M.+Altaiauthor=S.+J.+Hosseinimehrauthor=C.+Widstr%C3%B6mauthor=J.+Malmbergauthor=S.+St%C3%A5hlauthor=V.+Tolmachev&title=Molecular+design+and+optimization+of+99mTc-labeled+recombinant+affibody+molecules+improves+their+biodistribution+and+imaging+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DAltai%26aufirst%3DM.%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DMalmberg%26aufirst%3DJ.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DMolecular%2520design%2520and%2520optimization%2520of%252099mTc-labeled%2520recombinant%2520affibody%2520molecules%2520improves%2520their%2520biodistribution%2520and%2520imaging%2520properties%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D461%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Altai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosestedt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span> </span><span class="NLM_article-title">Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of <sup>99m</sup>Tc-labeled recombinant affibody molecules</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1975-1985&author=M.+Altaiauthor=H.+W%C3%A5llbergauthor=A.+Orlovaauthor=M.+Rosestedtauthor=S.+J.+Hosseinimehrauthor=V.+Tolmachevauthor=S.+St%C3%A5hl&title=Order+of+amino+acids+in+C-terminal+cysteine-containing+peptide-based+chelators+influences+cellular+processing+and+biodistribution+of+99mTc-labeled+recombinant+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltai%26aufirst%3DM.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DRosestedt%26aufirst%3DM.%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26atitle%3DOrder%2520of%2520amino%2520acids%2520in%2520C-terminal%2520cysteine-containing%2520peptide-based%2520chelators%2520influences%2520cellular%2520processing%2520and%2520biodistribution%2520of%252099mTc-labeled%2520recombinant%2520affibody%2520molecules%26jtitle%3DAmino%2520Acids%26date%3D2012%26volume%3D42%26spage%3D1975%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Waibel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willuda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stichelberger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abram, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plücthun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1038%2F12890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=10471933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADyaK1MXlslOmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=897-901&author=R.+Waibelauthor=R.+Albertoauthor=J.+Willudaauthor=R.+Finnernauthor=R.+Schibliauthor=A.+Stichelbergerauthor=A.+Egliauthor=U.+Abramauthor=J.+P.+Machauthor=A.+Pl%C3%BCcthunauthor=P.+A.+Schubiger&title=Stable+one-step+technetium-99m+labeling+of+His-tagged+recombinant+proteins+with+a+novel+Tc%28I%29-carbonyl+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex</span></div><div class="casAuthors">Waibel, Robert; Alberto, Roger; Willuda, Jorg; Finnern, Ricarda; Schibli, Roger; Stichelberger, Albert; Egli, Andre; Abram, Ulrich; Mach, Jean-Pierre; Pluckthun, Andreas; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">897-901</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We have developed a technetium labeling technol. based on a new organometallic chem., which involves simple mixing of the novel reagent, a 99mTc(I)-carbonyl compd., with a His-tagged recombinant protein.  This method obviates the labeling of unpaired engineered cysteines, which frequently create problems in large-scale expression and storage of disulfide-contg. proteins.  In this study, we labeled antibody single-chain Fv fragments to high specific activities (90 mCi/mg), and the label was very stable to serum and all other challenges tested.  The pharmacokinetic characteristics were indistinguishable from iodinated scFv fragments, and thus scFV fragments labeled by the new method will be suitable for biodistribution studies.  This novel labeling method should be applicable not only to diagnostic imaging with 99mTc, but also to radioimmunotherapy approaches with 186/188Re, and its use can be easily extended to almost any recombinant protein or synthetic peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtsBx_xGvq-bVg90H21EOLACvtfcHk0lhDtmxdQxQjTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslOmtLs%253D&md5=40e325f0dfd4bfab5d5cc4da00e4a6e0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F12890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12890%26sid%3Dliteratum%253Aachs%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAlberto%26aufirst%3DR.%26aulast%3DWilluda%26aufirst%3DJ.%26aulast%3DFinnern%26aufirst%3DR.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DStichelberger%26aufirst%3DA.%26aulast%3DEgli%26aufirst%3DA.%26aulast%3DAbram%26aufirst%3DU.%26aulast%3DMach%26aufirst%3DJ.%2BP.%26aulast%3DPl%25C3%25BCcthun%26aufirst%3DA.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DStable%2520one-step%2520technetium-99m%2520labeling%2520of%2520His-tagged%2520recombinant%2520proteins%2520with%2520a%2520novel%2520Tc%2528I%2529-carbonyl%2520complex%26jtitle%3DNature%2520Biotechnol.%26date%3D1999%26volume%3D17%26spage%3D897%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Novak-Hofer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waibel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Radiometal labeling of antibodies and antibody fragments for imaging and therapy</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=14970515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Kksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2004&pages=481-494&author=I.+Novak-Hoferauthor=R.+Waibelauthor=K.+Zimmermannauthor=R.+Schibliauthor=J.+Gr%C3%BCnbergauthor=K.+A.+Chesterauthor=A.+Murrayauthor=B.+K.+Loauthor=A.+C.+Perkinsauthor=P.+A.+Schubiger&title=Radiometal+labeling+of+antibodies+and+antibody+fragments+for+imaging+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Radiometal labeling of antibodies and antibody fragments for imaging and therapy</span></div><div class="casAuthors">Novak-Hofer, Ilse; Waibel, Robert; Zimmermann, Kurt; Schibli, Roger; Gruenberg, Juergen; Chester, Kerry A.; Murray, Andrea; Lo, Benny K. C.; Perkins, Alan C.; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">Antibody Engineering</span>),
    <span class="NLM_cas:pages">481-494</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Monoclonal antibodies are highly selective agents for delivering radiation to tumors for in vivo imaging and for therapy.  The labeling of antibodies with 3 metallic nuclides is described, which include 67Cu for both imaging and therapy, 99mTc for imaging, and 188/186Re for therapy.  The protocols also include methods for the evaluation of the radiochem. purity and immunoreactivity of 67Cu-labeled antibodies.  In addn., protocols for labeling the His-tagged single chain Fv MFE-23, an anti-CEA-antibody fragment, with 99mTc-tricarbonyl and with the 188Re nuclide are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkV0ioZ_jyTLVg90H21EOLACvtfcHk0lhDtmxdQxQjTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Kksg%253D%253D&md5=78f08c9038593179a3e86d621dd4f688</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovak-Hofer%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DGr%25C3%25BCnberg%26aufirst%3DJ.%26aulast%3DChester%26aufirst%3DK.%2BA.%26aulast%3DMurray%26aufirst%3DA.%26aulast%3DLo%26aufirst%3DB.%2BK.%26aulast%3DPerkins%26aufirst%3DA.%2BC.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DRadiometal%2520labeling%2520of%2520antibodies%2520and%2520antibody%2520fragments%2520for%2520imaging%2520and%2520therapy%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2004%26volume%3D248%26spage%3D481%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span> </span><span class="NLM_article-title">HEHEHE-tagged affibody molecules may be purified by IMAC, are conveniently labeled with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> and show improved biodistribution</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc1002357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlalurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2013-2022&author=V.+Tolmachevauthor=C.+Hofstr%C3%B6mauthor=J.+Malmbergauthor=S.+Ahlgrenauthor=S.+J.+Hosseinimehrauthor=M.+Sandstr%C3%B6mauthor=L.+Abrahms%C3%A9nauthor=A.+Orlovaauthor=T.+Gr%C3%A4slund&title=HEHEHE-tagged+affibody+molecules+may+be+purified+by+IMAC%2C+are+conveniently+labeled+with+%5B99mTc%28CO%293%5D%2B+and+show+improved+biodistribution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation</span></div><div class="casAuthors">Tolmachev, Vladimir; Hofstrom, Camilla; Malmberg, Jennie; Ahlgren, Sara; Hosseinimehr, Seyed Jalal; Sandstrom, Mattias; Abrahmsen, Lars; Orlova, Anna; Graeslund, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-2022</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Affibody mols. are a class of small (ca. 7 kDa) robust scaffold proteins suitable for radionuclide mol. imaging of therapeutic targets in vivo.  A hexahistidine tag at the N-terminus streamlines development of new imaging probes by enabling facile purifn. using immobilized metal ion affinity chromatog. (IMAC), as well as convenient [99mTc(CO)3]+-labeling.  However, previous studies in mice have demonstrated that Affibody mols. labeled by this method yield higher liver accumulation of radioactivity, compared to the same tracer lacking the hexahistidine tag and labeled by an alternative method.  Two variants of the HER2-binding Affibody mol. ZHER2:342 were made in an attempt to create a tagged tracer that could be purified by immobilized metal affinity chromatog., yet would not result in anomalous hepatic radioactivity accumulation following labeling with [99mTc(CO)3]+.  In one construct, the hexahistidine tag was moved to the C-terminus.  In the other construct, every second histidine residue in the hexahistidine tag was replaced by the more hydrophilic glutamate, resulting in a HEHEHE-tag.  Both variants, denoted ZHER2:342-H6 and (HE)3-ZHER2:342, resp., could be efficiently purified using IMAC and stably labeled with [99mTc(CO)3]+ and were subsequently compared with the parental H6-ZHER2:342 having an N-terminal hexahistidine tag.  All three variants were demonstrated to specifically bind to HER2-expressing cells in vitro.  The hepatic accumulation of radioactivity in a murine model was 2-fold lower with [99mTc(CO)3]+-ZHER2:342-H6 compared to [99mTc(CO)3]+-H6-ZHER2:342, and more than 10-fold lower with [99mTc(CO)3]+-(HE)3-ZHER2:342.  These differences translated into appreciably superior tumor-to-liver ratio for [99mTc(CO)3]+-(HE)3-ZHER2:342 compared to the alternative conjugates.  This information might be useful for development of other scaffold-based mol. imaging probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5PQtrJnBobVg90H21EOLACvtfcHk0ljQYe4rhF8ywg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlalurrP&md5=80bdf638f387fe164822be26bc475c04</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbc1002357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc1002357%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DMalmberg%26aufirst%3DJ.%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26atitle%3DHEHEHE-tagged%2520affibody%2520molecules%2520may%2520be%2520purified%2520by%2520IMAC%252C%2520are%2520conveniently%2520labeled%2520with%2520%255B99mTc%2528CO%25293%255D%252B%2520and%2520show%2520improved%2520biodistribution%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D2013%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hopp, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. R.</span><span> </span><span class="NLM_article-title">Prediction of protein antigenic determinants from amino acid sequence</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">3824</span><span class="NLM_x">–</span> <span class="NLM_lpage">3828</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1982&pages=3824-3828&author=T.+P.+Hoppauthor=K.+R.+Woods&title=Prediction+of+protein+antigenic+determinants+from+amino+acid+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHopp%26aufirst%3DT.%2BP.%26aulast%3DWoods%26aufirst%3DK.%2BR.%26atitle%3DPrediction%2520of%2520protein%2520antigenic%2520determinants%2520from%2520amino%2520acid%2520sequence%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1982%26volume%3D78%26spage%3D3824%26epage%3D3828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kyte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doolittle, R. F.</span><span> </span><span class="NLM_article-title">A simple method for displaying the hydropathic character of a protein</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1016%2F0022-2836%2882%2990515-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=7108955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADyaL38Xks1yjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=1982&pages=105-132&author=J.+Kyteauthor=R.+F.+Doolittle&title=A+simple+method+for+displaying+the+hydropathic+character+of+a+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for displaying the hydropathic character of a protein</span></div><div class="casAuthors">Kyte, Jack; Doolittle, Russell F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-32</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A computer program that progressively evaluates the hydrophilicity and hydrophobicity of a protein along its amino acid sequence was devised.  A hydropathy scale takes into consideration the hydrophilic and hydrophobic properties of each of the 20 amino acid side chains.  Correlation was demonstrated between the plotted values and known structures detd. by crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPRHRl8WYl97Vg90H21EOLACvtfcHk0liNYFgloEumHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xks1yjtro%253D&md5=ee67eb115939dfe56b2b2cae2c32dbd3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2882%2990515-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252882%252990515-0%26sid%3Dliteratum%253Aachs%26aulast%3DKyte%26aufirst%3DJ.%26aulast%3DDoolittle%26aufirst%3DR.%2BF.%26atitle%3DA%2520simple%2520method%2520for%2520displaying%2520the%2520hydropathic%2520character%2520of%2520a%2520protein%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1982%26volume%3D157%26spage%3D105%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baastrup, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fant, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc700307y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntV2g" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=235-243&author=S.+Ahlgrenauthor=A.+Orlovaauthor=D.+Rosikauthor=M.+Sandstr%C3%B6mauthor=A.+Sj%C3%B6bergauthor=B.+Baastrupauthor=O.+Widmarkauthor=G.+Fantauthor=J.+Feldwischauthor=V.+Tolmachev&title=Evaluation+of+maleimide+derivative+of+DOTA+for+site-specific+labeling+of+recombinant+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules</span></div><div class="casAuthors">Ahlgren, Sara; Orlova, Anna; Rosik, Daniel; Sandstroem, Mattias; Sjoeberg, Anna; Baastrup, Barbro; Widmark, Olof; Fant, Gunilla; Feldwisch, Joachim; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-243</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Affibody mols. are a new class of small (7 kDa) scaffold affinity proteins, which demonstrate promising properties as agents for in vivo radionuclide targeting.  The Affibody scaffold is cysteine-free and therefore independent of disulfide bonds.  Thus, a single thiol group can be engineered into the protein by introduction of one cysteine.  Coupling of thiol-reactive bifunctional chelators can enable site-specific labeling of recombinantly produced Affibody mols.  In this study, the use of 1,4,7,10-tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide (MMA-DOTA) for 111In-labeling of anti-HER2 Affibody mols. His6-ZHER2:342-Cys and ZHER2:2395-Cys has been evaluated.  The introduction of a cysteine residue did not affect the affinity of the proteins, which was 29 pM for His6-ZHER2:342-Cys and 27 pM for ZHER2:2395-Cys, comparable with 22 pM for the parental ZHER2:342.  MMA-DOTA was conjugated to DTT-reduced Affibody mols. with a coupling efficiency of 93% using a 1:1 molar ratio of chelator to protein.  The conjugates were labeled with 111In to a specific radioactivity of up to 7 GBq/mmol, with preserved binding for the target HER2.  In vivo, the non-His-tagged variant 111In-[MMA-DOTA-Cys61]-ZHER2:2395-Cys demonstrated appreciably lower liver uptake than its His-tag-contg. counterpart.  In mice bearing HER2-expressing LS174T xenografts, 111In-[MMA-DOTA-Cys61]-ZHER2:2395-Cys showed specific and rapid tumor localization, and rapid clearance from blood and nonspecific compartments, leading to a tumor-to-blood-ratio of 18 ± 8 already 1 h p.i.  Four hours p.i., the tumor-to-blood ratio was 138 ± 8.  Xenografts were clearly visualized already 1 h p.i.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd4OnqYTv9HbVg90H21EOLACvtfcHk0liNYFgloEumHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntV2g&md5=38967dbf371fa3e9e7766ace799a0137</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbc700307y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700307y%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DBaastrup%26aufirst%3DB.%26aulast%3DWidmark%26aufirst%3DO.%26aulast%3DFant%26aufirst%3DG.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DEvaluation%2520of%2520maleimide%2520derivative%2520of%2520DOTA%2520for%2520site-specific%2520labeling%2520of%2520recombinant%2520affibody%2520molecules%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjertman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndorff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinkelborg, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyr, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Targeting of HER2-expressing tumors with a site-specifically <sup>99m</sup>Tc-labeled recombinant affibody molecule, Z<sub>HER2:2395</sub>, with C-terminally engineered cysteine</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2967%2Fjnumed.108.056929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19372467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtV2hsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=781-789&author=S.+Ahlgrenauthor=H.+W%C3%A5llbergauthor=T.+A.+Tranauthor=C.+Widstr%C3%B6mauthor=M.+Hjertmanauthor=L.+Abrahms%C3%A9nauthor=D.+Berndorffauthor=L.+M.+Dinkelborgauthor=J.+E.+Cyrauthor=J.+Feldwischauthor=A.+Orlovaauthor=V.+Tolmachev&title=Targeting+of+HER2-expressing+tumors+with+a+site-specifically+99mTc-labeled+recombinant+affibody+molecule%2C+ZHER2%3A2395%2C+with+C-terminally+engineered+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine</span></div><div class="casAuthors">Ahlgren, Sara; Waallberg, Helena; Tran, Thuy A.; Widstroem, Charles; Hjertman, Magnus; Abrahmsen, Lars; Berndorff, Dietmar; Dinkelborg, Ludger M.; Cyr, John E.; Feldwisch, Joachim; Orlova, Anna; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The detection of human epidermal growth factor receptor type 2 (HER2) expression in malignant tumors provides important information influencing patient management.  Redionuclide in vivo imaging of HER2 may permit the detection of HER2 in both primary tumors and metastases by a single noninvasive procedure.  Small (7 kDa) high-affinity anti-HER2 Affibody mols. may be suitable tracers for SPECT visualization of HER2-expressing tumors.  The use of generator-produced 99mTc as a label would facilitate the prompt translation of anti-HER2 Affibody mols. into use in clinics.  Methods: A C-terminal cysteine was introduced into the Affibody mol. ZHER2:342 to enable site-specific labeling with 99mTc.  Two recombinant variants, His6-ZHER2:342-Cys (dissocn. const. [KD], 29 pM) and ZHER2:2395-Cys, lacking a His tag (KD, 27 pM), were labeled with 99mTc in yields exceeding 90%.  The binding specificity and the cellular processing of Affibody mols. were studied in vitro.  Biodistribution and γ-camera imaging studies were performed in mice bearing HER2-expressing xenografts.  Results: 99mTc-His6-ZHER2:342-Cys was capable of targeting HER2-expressing SKOV-3 xenografts in SCID mice, but the liver radioactivity up-take was high.  A series of comparative biodistribution expts. indicated that the presence of the His tag caused elevated accumulation in the liver.  99mTc-ZHER2:2395-Cys, not contg. a His tag, showed low uptake in the liver and high and specific uptake in HER2-expressing xenografts.  Four hours after injection, the radioactivity uptake values (percentage of injected activity per g of tissue [%IA/g]) were 6.9 ± 2.5 (mean ± SD) %IA/g in LS174T xenografts (moderate level of HER2 expression) and 15 ± 3 %IA/g in SKOV-3 xenografts (high level of HER2 expression).  The corresponding tumor-to-blood ratios were 88 ± 24 and 121 ± 24, resp.  Both LS174T and SKOV-3 xenografts were clearly visualized with a clin. γ-camera 1 h after injection of 99mTc-ZHER2:2395-Cys.  Conclusion: The Affibody mol. 99mTc-ZHER2:2395-Cys is a promising tracer for SPECT visualization of HER2-expressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorXZQm1LQ8YbVg90H21EOLACvtfcHk0liMSEniIGsIPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtV2hsrw%253D&md5=f9d6f7c050b96835736797cd8cfe5e05</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.056929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.056929%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DTran%26aufirst%3DT.%2BA.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DHjertman%26aufirst%3DM.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DBerndorff%26aufirst%3DD.%26aulast%3DDinkelborg%26aufirst%3DL.%2BM.%26aulast%3DCyr%26aufirst%3DJ.%2BE.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DTargeting%2520of%2520HER2-expressing%2520tumors%2520with%2520a%2520site-specifically%252099mTc-labeled%2520recombinant%2520affibody%2520molecule%252C%2520ZHER2%253A2395%252C%2520with%2520C-terminally%2520engineered%2520cysteine%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D781%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangsell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Use of a HEHEHE purification tag instead of a hexa-histidine tag improves biodistribution of affibody molecules site-specifically labeled with <sup>(99m)</sup>Tc, <sup>(111)</sup>In, and <sup>(125)</sup>I</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3817</span><span class="NLM_x">–</span> <span class="NLM_lpage">3826</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200065e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3817-3826&author=C.+Hofstr%C3%B6mauthor=A.+Orlovaauthor=M.+Altaiauthor=F.+Wangsellauthor=T.+Gr%C3%A4slundauthor=V.+Tolmachev&title=Use+of+a+HEHEHE+purification+tag+instead+of+a+hexa-histidine+tag+improves+biodistribution+of+affibody+molecules+site-specifically+labeled+with+%2899m%29Tc%2C+%28111%29In%2C+and+%28125%29I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm200065e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200065e%26sid%3Dliteratum%253Aachs%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DAltai%26aufirst%3DM.%26aulast%3DWangsell%26aufirst%3DF.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DUse%2520of%2520a%2520HEHEHE%2520purification%2520tag%2520instead%2520of%2520a%2520hexa-histidine%2520tag%2520improves%2520biodistribution%2520of%2520affibody%2520molecules%2520site-specifically%2520labeled%2520with%2520%252899m%2529Tc%252C%2520%2528111%2529In%252C%2520and%2520%2528125%2529I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3817%26epage%3D3826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasteh, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>IGF1R:4551</sub>, a new affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs00259-012-2284-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=23179942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=439-449&author=A.+Orlovaauthor=C.+Hofstr%C3%B6mauthor=J.+Strandauthor=Z.+Varastehauthor=M.+Sandstr%C3%B6mauthor=K.+Anderssonauthor=V.+Tolmachevauthor=T.+Gr%C3%A4slund&title=%5B99mTc%28CO%293%5D%2B-%28HE%293-ZIGF1R%3A4551%2C+a+new+affibody+conjugate+for+visualization+of+insulin-like+growth+factor-1+receptor+expression+in+malignant+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours</span></div><div class="casAuthors">Orlova, Anna; Hofstroem, Camilla; Strand, Joanna; Varasteh, Zohreh; Sandstrom, Mattias; Andersson, Karl; Tolmachev, Vladimir; Graeslund, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">439-449</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose Radionuclide imaging of insulin-like growth factor type 1 receptor (IGF-1R) expression in tumors might be used for selection of patients who would benefit from IGF-1R-targeted therapy.  We have previously shown the feasibility of IGF-1R imaging using the Affibody mol. 111In-DOTA-His6-ZIGF1R:4551.  The use of 99mTc instead of 111In should improve sensitivity and resoln. of imaging, and reduce the dose burden to patients.  We hypothesized that inclusion of a HEHEHE tag instead of a His6 tag in ZIGF1R:4551 would permit its convenient purifn. using IMAC, enable labeling with [99mTc(CO)3]+, and improve its biodistribution.  Methods ZIGF1R:4551 was expressed with a HEHEHE tag in the N terminus.  The resulting (HE)3-ZIGF1R:4551 construct was labeled with [99mTc(CO)3]+.  Targeting of IGF-1R-expressing cells using [99mTc(CO)3]+-(HE)3-ZIGF1R:4551 was evaluated in vitro and in vivo.  Results (HE)3-ZIGF1R:4551 was stably labeled with 99mTc with preserved specific binding to IGF-1R-expressing DU-145 prostate cancer cells in vitro.  In mice, [99mTc(CO)3]+-(HE)3-ZIGF1R:4551 accumulated in IGF-1R-expressing organs (pancreas, stomach, lung and salivary gland). [99mTc(CO)3]+-(HE)3-ZIGF1R:4551 demonstrated 3.6-fold lower accumulation in the liver and spleen than 111In-DOTA-ZIGF1R:4551.  In NMRI nu/nu mice with DU-145 prostate cancer xenografts, the tumor uptake was 1.32 ± 0.11 %ID/g and the tumor-to-blood ratio was 4.4 ± 0.3 at 8 h after injection.  The xenografts were visualized using a gamma camera 6 h after injection.  Conclusion 99mTc(CO)3]+-(HE)3-ZIGF1R:4551 is a promising candidate for visualization of IGF-1R expression in malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbX-7pDUPZRrVg90H21EOLACvtfcHk0liMSEniIGsIPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhurs%253D&md5=b3564a0e6253d030f0338c8c403f19b0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2284-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2284-8%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DStrand%26aufirst%3DJ.%26aulast%3DVarasteh%26aufirst%3DZ.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DK.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26atitle%3D%255B99mTc%2528CO%25293%255D%252B-%2528HE%25293-ZIGF1R%253A4551%252C%2520a%2520new%2520affibody%2520conjugate%2520for%2520visualization%2520of%2520insulin-like%2520growth%2520factor-1%2520receptor%2520expression%2520in%2520malignant%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26spage%3D439%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1224</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1224-1232&author=S.+J.+Hosseinimehrauthor=V.+Tolmachevauthor=A.+Orlova&title=Liver+uptake+of+radiolabeled+targeting+proteins+and+peptides%3A+considerations+for+targeting+peptide+conjugate+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DLiver%2520uptake%2520of%2520radiolabeled%2520targeting%2520proteins%2520and%2520peptides%253A%2520considerations%2520for%2520targeting%2520peptide%2520conjugate%2520design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D1224%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekblad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson-Karlström, A.</span><span> </span><span class="NLM_article-title">Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of <sup>99m</sup>Tc-Labeled anti-HER2 Affibody Molecules</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2568</span><span class="NLM_x">–</span> <span class="NLM_lpage">2576</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc800244b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVemtbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2568-2576&author=T.+Tranauthor=T.+Ekbladauthor=A.+Orlovaauthor=C.+Widstr%C3%B6mauthor=J.+Feldwischauthor=A.+Wennborgauthor=L.+Abrahms%C3%A9nauthor=V.+Tolmachevauthor=A.+Eriksson-Karlstr%C3%B6m&title=Effects+of+Lysine-Containing+Mercaptoacetyl-Based+Chelators+on+the+Biodistribution+of+99mTc-Labeled+anti-HER2+Affibody+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of 99mTc-Labeled Anti-HER2 Affibody Molecules</span></div><div class="casAuthors">Tran, Thuy A.; Ekblad, Torun; Orlova, Anna; Sandstrom, Mattias; Feldwisch, Joachim; Wennborg, Anders; Abrahmsen, Lars; Tolmachev, Vladimir; Eriksson Karlstrom, Amelie</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2568-2576</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of polar (mercaptoacetyl-triseryl) and neg. charged (mercaptoacetyl-triglumatyl) chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody mols. were previously investigated.  With glycine, serine, and glutamate, we demonstrated that substitution with a single amino acid in the chelator can significantly influence the biodistribution properties and the excretion pathways.  Here, we have taken this investigation further, by analyzing the effects of introduction of a pos. amino acid residue on the in vivo properties of the 99mTc-labeled Affibody mol.  The Affibody mols. with mercaptoacetyl-seryl-lysyl-seryl (maSKS) and mercaptoacetyl-trilysyl (maKKK) extensions were produced by peptide synthesis and labeled with 99mTc in alk. conditions.  A comparative biodistribution was performed in normal mice to evaluate the excretion pathway.  A shift toward renal excretion was obtained when serine was substituted with lysine in the chelating sequence.  The radioactivity in the gastrointestinal tract was reduced 3-fold for the 99mTc-maSKS-ZHER2:342 and 99mTc-maKKK-ZHER2:342 in comparison with the 99mTc-maSSS- ZHER2:342 conjugate 4 h post injection (p.i.).  The radioactivity in the liver was elevated when a triple substitution of pos. charged lysine was used.  The tumor targeting properties of 99mTc-maSKS-ZHER2:342 were further investigated in SKOV-3 xenografts.  The tumor uptake of 99mTc-maSKS-ZHER2:342 was 17 ± 7% IA/g 4 h p.i.  Tumor xenografts were well-visualized by gamma scintigraphy.  In conclusion, the substitution with one single lysine in the chelator results in better tumor imaging properties of the Affibody mol. ZHER2:342 and is favorable for imaging of tumors and metastases in the abdominal area.  Multiple lysine residues in the chelator are, however, undesirable due to elevated uptake both in the liver and kidneys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDmpWErMOST7Vg90H21EOLACvtfcHk0likee8R4H7kSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVemtbzJ&md5=70763ccd2238b97a4da5e25338429709</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbc800244b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800244b%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%26aulast%3DEkblad%26aufirst%3DT.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DEriksson-Karlstr%25C3%25B6m%26aufirst%3DA.%26atitle%3DEffects%2520of%2520Lysine-Containing%2520Mercaptoacetyl-Based%2520Chelators%2520on%2520the%2520Biodistribution%2520of%252099mTc-Labeled%2520anti-HER2%2520Affibody%2520Molecules%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D2568%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rusckowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hnatowich, D. J.</span><span> </span><span class="NLM_article-title">A comparison in monkeys of <sup>(99m)</sup>Tc labeled to a peptide by 4 methods</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1870-1877&author=M.+Rusckowskiauthor=T.+Quauthor=S.+Guptaauthor=A.+Leyauthor=D.+J.+Hnatowich&title=A+comparison+in+monkeys+of+%2899m%29Tc+labeled+to+a+peptide+by+4+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusckowski%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DT.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DLey%26aufirst%3DA.%26aulast%3DHnatowich%26aufirst%3DD.%2BJ.%26atitle%3DA%2520comparison%2520in%2520monkeys%2520of%2520%252899m%2529Tc%2520labeled%2520to%2520a%2520peptide%2520by%25204%2520methods%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D1870%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=953-960&author=V.+Tolmachevauthor=T.+A.+Tranauthor=D.+Rosikauthor=A.+Sj%C3%B6bergauthor=L.+Abrahms%C3%A9nauthor=A.+Orlova&title=Tumor+targeting+using+affibody+molecules%3A+interplay+of+affinity%2C+target+expression+level%2C+and+binding+site+composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DTran%26aufirst%3DT.%2BA.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DTumor%2520targeting%2520using%2520affibody%2520molecules%253A%2520interplay%2520of%2520affinity%252C%2520target%2520expression%2520level%252C%2520and%2520binding%2520site%2520composition%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampmeier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavare, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmullen, G. E.</span><span> </span><span class="NLM_article-title">Blower, P. Novel His-tag Sequence for Highly Efficient Site-Specific Radiolabelling of Proteins with [<sup>99mTc</sup>(CO)<sub>3</sub>]<sup>+</sup> and [<sup>186/188</sup>Re(CO)<sub>3</sub>]<sup>+</sup></span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=S216&issue=Suppl2&author=J.+D.+Williamsauthor=M.+Cooperauthor=F.+Kampmeierauthor=R.+Tavareauthor=G.+E.+Gmullen&title=Blower%2C+P.+Novel+His-tag+Sequence+for+Highly+Efficient+Site-Specific+Radiolabelling+of+Proteins+with+%5B99mTc%28CO%293%5D%2B+and+%5B186%2F188Re%28CO%293%5D%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DKampmeier%26aufirst%3DF.%26aulast%3DTavare%26aufirst%3DR.%26aulast%3DGmullen%26aufirst%3DG.%2BE.%26atitle%3DBlower%252C%2520P.%2520Novel%2520His-tag%2520Sequence%2520for%2520Highly%2520Efficient%2520Site-Specific%2520Radiolabelling%2520of%2520Proteins%2520with%2520%255B99mTc%2528CO%25293%255D%252B%2520and%2520%255B186%252F188Re%2528CO%25293%255D%252B%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol%2520Imaging%26date%3D2012%26volume%3D39%26issue%3DSuppl2%26spage%3DS216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span> </span><span class="NLM_article-title">Protein scaffold-based molecular probes for cancer molecular imaging</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=1037-1047&author=Z.+Miaoauthor=J.+Leviauthor=Z.+Cheng&title=Protein+scaffold-based+molecular+probes+for+cancer+molecular+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DLevi%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DZ.%26atitle%3DProtein%2520scaffold-based%2520molecular%2520probes%2520for%2520cancer%2520molecular%2520imaging%26jtitle%3DAmino%2520Acids%26date%3D2011%26volume%3D41%26spage%3D1037%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Nelson, D. L.; Cox, M. M.</span> <span class="citation_source-book">Lehninger Principles of Biochemistry</span>, <span class="NLM_edition">5th</span> ed.; <span class="NLM_publisher-name">W. H. Freeman and Company</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+L.+Nelson&author=M.+M.+Cox&title=Lehninger+Principles+of+Biochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26btitle%3DLehninger%2520Principles%2520of%2520Biochemistry%26pub%3DW.%2520H.%2520Freeman%2520and%2520Company%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jennifer D. Williams, Florian Kampmeier, Adam Badar, Kevin Howland, Margaret S. Cooper, Gregory E. D. Mullen, <span class="NLM_string-name hlFld-ContribAuthor">Philip J. Blower</span>. </span><span class="cited-content_cbyCitation_article-title">Optimal His-Tag Design for Efficient [99mTc(CO)3]+ and [188Re(CO)3]+ Labeling of Proteins for Molecular Imaging and Radionuclide Therapy by Analysis of Peptide Arrays. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (7)
                                     , 1242-1254. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00561" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00561%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DOptimal%252BHis-Tag%252BDesign%252Bfor%252BEfficient%252B%25255B99mTc%252528CO%2525293%25255D%25252B%252Band%252B%25255B188Re%252528CO%2525293%25255D%25252B%252BLabeling%252Bof%252BProteins%252Bfor%252BMolecular%252BImaging%252Band%252BRadionuclide%252BTherapy%252Bby%252BAnalysis%252Bof%252BPeptide%252BArrays%26aulast%3DWilliams%26aufirst%3DJennifer%2BD.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10102020%26date%3D15112020%26date%3D26112020%26volume%3D32%26issue%3D7%26spage%3D1242%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ling Qiu, Xi Li, Gaochao Lv, Yann Seimbille, Ke Li, Ying Peng, Qingzhu Liu, Minhao Xie, <span class="NLM_string-name hlFld-ContribAuthor">Jianguo Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Radiofluorinated Smart Probes for Noninvasive PET Imaging of Legumain Activity in Living Subjects. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2020,</strong> <em>92 </em>
                                    (17)
                                     , 11627-11634. <a href="https://doi.org/10.1021/acs.analchem.0c01253" title="DOI URL">https://doi.org/10.1021/acs.analchem.0c01253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.0c01253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.0c01253%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DRadiofluorinated%252BSmart%252BProbes%252Bfor%252BNoninvasive%252BPET%252BImaging%252Bof%252BLegumain%252BActivity%252Bin%252BLiving%252BSubjects%26aulast%3DQiu%26aufirst%3DLing%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D22032020%26date%3D28072020%26date%3D12082020%26date%3D28072020%26volume%3D92%26issue%3D17%26spage%3D11627%26epage%3D11634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sergey Deyev, Anzhelika Vorobyeva, Alexey Schulga, Galina Proshkina, Rezan Güler, John Löfblom, Bogdan Mitran, Javad Garousi, Mohamed Altai, Jos Buijs, Vladimir Chernov, Anna Orlova, <span class="NLM_string-name hlFld-ContribAuthor">Vladimir Tolmachev</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (3)
                                     , 995-1008. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00922" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00922%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DComparative%252BEvaluation%252Bof%252BTwo%252BDARPin%252BVariants%25253A%252BEffect%252Bof%252BAffinity%25252C%252BSize%25252C%252Band%252BLabel%252Bon%252BTumor%252BTargeting%252BProperties%26aulast%3DDeyev%26aufirst%3DSergey%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D31082018%26date%3D04012019%26date%3D21112018%26date%3D08022019%26date%3D04012019%26volume%3D16%26issue%3D3%26spage%3D995%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marine  Goux</span>, <span class="hlFld-ContribAuthor ">Guillaume  Becker</span>, <span class="hlFld-ContribAuthor ">Harmony  Gorré</span>, <span class="hlFld-ContribAuthor ">Sylvestre  Dammicco</span>, <span class="hlFld-ContribAuthor ">Ariane  Desselle</span>, <span class="hlFld-ContribAuthor ">Dominique  Egrise</span>, <span class="hlFld-ContribAuthor ">Natacha  Leroi</span>, <span class="hlFld-ContribAuthor ">François  Lallemand</span>, <span class="hlFld-ContribAuthor ">Mohamed Ali  Bahri</span>, <span class="hlFld-ContribAuthor ">Gilles  Doumont</span>, <span class="hlFld-ContribAuthor ">Alain  Plenevaux</span>, <span class="hlFld-ContribAuthor ">Mathieu  Cinier</span>, and <span class="hlFld-ContribAuthor ">André  Luxen</span>  . </span><span class="cited-content_cbyCitation_article-title">Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2017,</strong> <em>28 </em>
                                    (9)
                                     , 2361-2371. <a href="https://doi.org/10.1021/acs.bioconjchem.7b00374" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.7b00374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.7b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.7b00374%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DNanofitin%252Bas%252Ba%252BNew%252BMolecular-Imaging%252BAgent%252Bfor%252Bthe%252BDiagnosis%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BOver-Expressing%252BTumors%26aulast%3DGoux%26aufirst%3DMarine%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29062017%26date%3D17082017%26date%3D12092017%26date%3D20092017%26date%3D21082017%26volume%3D28%26issue%3D9%26spage%3D2361%26epage%3D2371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javad  Garousi</span>, <span class="hlFld-ContribAuthor ">Sarah  Lindbo</span>, <span class="hlFld-ContribAuthor ">Hadis  Honarvar</span>, <span class="hlFld-ContribAuthor ">Justin  Velletta</span>, <span class="hlFld-ContribAuthor ">Bogdan  Mitran</span>, <span class="hlFld-ContribAuthor ">Mohamed  Altai</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, and <span class="hlFld-ContribAuthor ">Sophia  Hober</span>  . </span><span class="cited-content_cbyCitation_article-title">Influence of the N-Terminal Composition on Targeting Properties of Radiometal-Labeled Anti-HER2 Scaffold Protein ADAPT6. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (11)
                                     , 2678-2688. <a href="https://doi.org/10.1021/acs.bioconjchem.6b00465" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.6b00465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.6b00465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.6b00465%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DInfluence%252Bof%252Bthe%252BN-Terminal%252BComposition%252Bon%252BTargeting%252BProperties%252Bof%252BRadiometal-Labeled%252BAnti-HER2%252BScaffold%252BProtein%252BADAPT6%26aulast%3DGarousi%26aufirst%3DJavad%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22082016%26date%3D12102016%26date%3D27102016%26date%3D16112016%26date%3D14102016%26volume%3D27%26issue%3D11%26spage%3D2678%26epage%3D2688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristina  Westerlund</span>, <span class="hlFld-ContribAuthor ">Hadis  Honarvar</span>, <span class="hlFld-ContribAuthor ">Emily  Norrström</span>, <span class="hlFld-ContribAuthor ">Joanna  Strand</span>, <span class="hlFld-ContribAuthor ">Bogdan  Mitran</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Amelie  Eriksson Karlström</span>, and <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>  . </span><span class="cited-content_cbyCitation_article-title">Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2016,</strong> <em>13 </em>
                                    (5)
                                     , 1668-1678. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b00089" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b00089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b00089%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DIncreasing%252Bthe%252BNet%252BNegative%252BCharge%252Bby%252BReplacement%252Bof%252BDOTA%252BChelator%252Bwith%252BDOTAGA%252BImproves%252Bthe%252BBiodistribution%252Bof%252BRadiolabeled%252BSecond-Generation%252BSynthetic%252BAffibody%252BMolecules%26aulast%3DWesterlund%26aufirst%3DKristina%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D31012016%26date%3D23032016%26date%3D21032016%26date%3D06042016%26date%3D02052016%26date%3D23032016%26volume%3D13%26issue%3D5%26spage%3D1668%26epage%3D1678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah  Lindbo</span>, <span class="hlFld-ContribAuthor ">Javad  Garousi</span>, <span class="hlFld-ContribAuthor ">Mikael  Åstrand</span>, <span class="hlFld-ContribAuthor ">Hadis  Honarvar</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Sophia  Hober</span>, and <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>  . </span><span class="cited-content_cbyCitation_article-title">Influence of Histidine-Containing Tags on the Biodistribution of ADAPT Scaffold Proteins. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2016,</strong> <em>27 </em>
                                    (3)
                                     , 716-726. <a href="https://doi.org/10.1021/acs.bioconjchem.5b00677" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.5b00677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.5b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.5b00677%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DInfluence%252Bof%252BHistidine-Containing%252BTags%252Bon%252Bthe%252BBiodistribution%252Bof%252BADAPT%252BScaffold%252BProteins%26aulast%3DLindbo%26aufirst%3DSarah%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D2016%26date%3D18122015%26date%3D15012016%26date%3D29012016%26date%3D16032016%26date%3D19012016%26volume%3D27%26issue%3D3%26spage%3D716%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dora Mugoli  Chigoho</span>, <span class="hlFld-ContribAuthor ">Jessica  Bridoux</span>, <span class="hlFld-ContribAuthor ">Sophie  Hernot</span>. </span><span class="cited-content_cbyCitation_article-title">Reducing the renal retention of low- to moderate-molecular-weight radiopharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>63 </em>, 219-228. <a href="https://doi.org/10.1016/j.cbpa.2021.06.008" title="DOI URL">https://doi.org/10.1016/j.cbpa.2021.06.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2021.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2021.06.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DReducing%252Bthe%252Brenal%252Bretention%252Bof%252Blow-%252Bto%252Bmoderate-molecular-weight%252Bradiopharmaceuticals%26aulast%3DChigoho%26aufirst%3DDora%2BMugoli%26date%3D2021%26volume%3D63%26spage%3D219%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Estel  Collado Camps</span>, <span class="hlFld-ContribAuthor ">Sanne A. M.  van Lith</span>, <span class="hlFld-ContribAuthor ">Cathelijne  Frielink</span>, <span class="hlFld-ContribAuthor ">Jordi  Lankhof</span>, <span class="hlFld-ContribAuthor ">Ingrid  Dijkgraaf</span>, <span class="hlFld-ContribAuthor ">Martin  Gotthardt</span>, <span class="hlFld-ContribAuthor ">Roland  Brock</span>. </span><span class="cited-content_cbyCitation_article-title">CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (7)
                                     , 602. <a href="https://doi.org/10.3390/ph14070602" title="DOI URL">https://doi.org/10.3390/ph14070602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14070602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14070602%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DCPPs%252Bto%252Bthe%252BTest%25253A%252BEffects%252Bon%252BBinding%25252C%252BUptake%252Band%252BBiodistribution%252Bof%252Ba%252BTumor%252BTargeting%252BNanobody%26aulast%3DCollado%2BCamps%26aufirst%3DEstel%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D7%26spage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Oroujeni</span>, <span class="hlFld-ContribAuthor ">Sara S.  Rinne</span>, <span class="hlFld-ContribAuthor ">Anzhelika  Vorobyeva</span>, <span class="hlFld-ContribAuthor ">Annika  Loftenius</span>, <span class="hlFld-ContribAuthor ">Joachim  Feldwisch</span>, <span class="hlFld-ContribAuthor ">Per  Jonasson</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chernov</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Fredrik Y.  Frejd</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (5)
                                     , 2770. <a href="https://doi.org/10.3390/ijms22052770" title="DOI URL">https://doi.org/10.3390/ijms22052770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22052770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22052770%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPreclinical%252BEvaluation%252Bof%252B99mTc-ZHER2%25253A41071%25252C%252Ba%252BSecond-Generation%252BAffibody-Based%252BHER2-Visualizing%252BImaging%252BProbe%252Bwith%252Ba%252BLow%252BRenal%252BUptake%26aulast%3DOroujeni%26aufirst%3DMaryam%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D5%26spage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger  Alberto</span>. </span><span class="cited-content_cbyCitation_article-title">Organometallic Chemistry of Drugs Based on Technetium and Rhenium. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820206-7.00029-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-820206-7.00029-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820206-7.00029-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820206-7.00029-9%26sid%3Dliteratum%253Aachs%26atitle%3DOrganometallic%252BChemistry%252Bof%252BDrugs%252BBased%252Bon%252BTechnetium%252Band%252BRhenium%26aulast%3DAlberto%26aufirst%3DRoger%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia Baguña  Torres</span>, <span class="hlFld-ContribAuthor ">Michael  Mosley</span>, <span class="hlFld-ContribAuthor ">Sofia  Koustoulidou</span>, <span class="hlFld-ContribAuthor ">Samantha  Hopkins</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>, <span class="hlFld-ContribAuthor ">Masuo  Kondoh</span>, <span class="hlFld-ContribAuthor ">Keisuke  Tachibana</span>, <span class="hlFld-ContribAuthor ">Veerle  Kersemans</span>, <span class="hlFld-ContribAuthor ">Bart  Cornelissen</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabeled cCPE Peptides for SPECT Imaging of Claudin-4 Overexpression in Pancreatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2020,</strong> <em>61 </em>
                                    (12)
                                     , 1756-1763. <a href="https://doi.org/10.2967/jnumed.120.243113" title="DOI URL">https://doi.org/10.2967/jnumed.120.243113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.120.243113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.120.243113%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DRadiolabeled%252BcCPE%252BPeptides%252Bfor%252BSPECT%252BImaging%252Bof%252BClaudin-4%252BOverexpression%252Bin%252BPancreatic%252BCancer%26aulast%3DTorres%26aufirst%3DJulia%2BBagu%25C3%25B1a%26date%3D2020%26date%3D2020%26volume%3D61%26issue%3D12%26spage%3D1756%26epage%3D1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javad  Garousi</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Fredrik Y.  Frejd</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-020-00094-w" title="DOI URL">https://doi.org/10.1186/s41181-020-00094-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-020-00094-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-020-00094-w%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DImaging%252Busing%252Bradiolabelled%252Btargeted%252Bproteins%25253A%252Bradioimmunodetection%252Band%252Bbeyond%26aulast%3DGarousi%26aufirst%3DJavad%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian  Brandl</span>, <span class="hlFld-ContribAuthor ">Sarah  Busslinger</span>, <span class="hlFld-ContribAuthor ">Uwe  Zangemeister-Wittke</span>, <span class="hlFld-ContribAuthor ">Andreas  Plückthun</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing the anti-tumor efficacy of protein-drug conjugates by engineering the molecular size and half-life. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2020,</strong> <em>327 </em>, 186-197. <a href="https://doi.org/10.1016/j.jconrel.2020.08.004" title="DOI URL">https://doi.org/10.1016/j.jconrel.2020.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2020.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2020.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DOptimizing%252Bthe%252Banti-tumor%252Befficacy%252Bof%252Bprotein-drug%252Bconjugates%252Bby%252Bengineering%252Bthe%252Bmolecular%252Bsize%252Band%252Bhalf-life%26aulast%3DBrandl%26aufirst%3DFabian%26date%3D2020%26volume%3D327%26spage%3D186%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger  Alberto</span>. </span><span class="cited-content_cbyCitation_article-title">The “Carbonyl Story” and Beyond; Experiences, Lessons and Implications. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 2743-2749. <a href="https://doi.org/10.1002/cbic.202000387" title="DOI URL">https://doi.org/10.1002/cbic.202000387</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000387%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DThe%252B%2525E2%252580%25259CCarbonyl%252BStory%2525E2%252580%25259D%252Band%252BBeyond%25253B%252BExperiences%25252C%252BLessons%252Band%252BImplications%26aulast%3DAlberto%26aufirst%3DRoger%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D2743%26epage%3D2749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shijie  Wang</span>, <span class="hlFld-ContribAuthor ">Dingyao  Gao</span>, <span class="hlFld-ContribAuthor ">Ke  Li</span>, <span class="hlFld-ContribAuthor ">Siqin  Ye</span>, <span class="hlFld-ContribAuthor ">Qingzhu  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Peng</span>, <span class="hlFld-ContribAuthor ">Gaochao  Lv</span>, <span class="hlFld-ContribAuthor ">Ling  Qiu</span>, <span class="hlFld-ContribAuthor ">Jianguo  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Radiopharmacological evaluation of a caspase-3 responsive probe with optimized pharmacokinetics for PET imaging of tumor apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (18)
                                     , 3512-3521. <a href="https://doi.org/10.1039/D0OB00690D" title="DOI URL">https://doi.org/10.1039/D0OB00690D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00690D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00690D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRadiopharmacological%252Bevaluation%252Bof%252Ba%252Bcaspase-3%252Bresponsive%252Bprobe%252Bwith%252Boptimized%252Bpharmacokinetics%252Bfor%252BPET%252Bimaging%252Bof%252Btumor%252Bapoptosis%26aulast%3DWang%26aufirst%3DShijie%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D18%26spage%3D3512%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hèctor  López-Laguna</span>, <span class="hlFld-ContribAuthor ">Rafael  Cubarsi</span>, <span class="hlFld-ContribAuthor ">Ugutz  Unzueta</span>, <span class="hlFld-ContribAuthor ">Ramón  Mangues</span>, <span class="hlFld-ContribAuthor ">Esther  Vázquez</span>, <span class="hlFld-ContribAuthor ">Antonio  Villaverde</span>. </span><span class="cited-content_cbyCitation_article-title">Endosomal escape of protein nanoparticles engineered through humanized histidine-rich peptides. </span><span class="cited-content_cbyCitation_journal-name">Science China Materials</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 644-653. <a href="https://doi.org/10.1007/s40843-019-1231-y" title="DOI URL">https://doi.org/10.1007/s40843-019-1231-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40843-019-1231-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40843-019-1231-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520China%2520Materials%26atitle%3DEndosomal%252Bescape%252Bof%252Bprotein%252Bnanoparticles%252Bengineered%252Bthrough%252Bhumanized%252Bhistidine-rich%252Bpeptides%26aulast%3DL%25C3%25B3pez-Laguna%26aufirst%3DH%25C3%25A8ctor%26date%3D2020%26date%3D2019%26volume%3D63%26issue%3D4%26spage%3D644%26epage%3D653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sergey M.  Deyev</span>, <span class="hlFld-ContribAuthor ">Anzhelika  Vorobyeva</span>, <span class="hlFld-ContribAuthor ">Alexey  Schulga</span>, <span class="hlFld-ContribAuthor ">Ayman  Abouzayed</span>, <span class="hlFld-ContribAuthor ">Tyran  Günther</span>, <span class="hlFld-ContribAuthor ">Javad  Garousi</span>, <span class="hlFld-ContribAuthor ">Elena  Konovalova</span>, <span class="hlFld-ContribAuthor ">Haozhong  Ding</span>, <span class="hlFld-ContribAuthor ">Torbjörn  Gräslund</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>145 </em>, 216-225. <a href="https://doi.org/10.1016/j.ijbiomac.2019.12.147" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2019.12.147</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2019.12.147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2019.12.147%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DEffect%252Bof%252Ba%252Bradiolabel%252Bbiochemical%252Bnature%252Bon%252Btumor-targeting%252Bproperties%252Bof%252BEpCAM-binding%252Bengineered%252Bscaffold%252Bprotein%252BDARPin%252BEc1%26aulast%3DDeyev%26aufirst%3DSergey%2BM.%26date%3D2020%26volume%3D145%26spage%3D216%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte  Rivas</span>, <span class="hlFld-ContribAuthor ">Jessica A.  Jackson</span>, <span class="hlFld-ContribAuthor ">Ingebjørg N.  Hungnes</span>, <span class="hlFld-ContribAuthor ">Michelle T.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Radioactive Metals in Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-08-102688-5.00010-6" title="DOI URL">https://doi.org/10.1016/B978-0-08-102688-5.00010-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102688-5.00010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102688-5.00010-6%26sid%3Dliteratum%253Aachs%26atitle%3DRadioactive%252BMetals%252Bin%252BImaging%252Band%252BTherapy%26aulast%3DRivas%26aufirst%3DCharlotte%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anzhelika  Vorobyeva</span>, <span class="hlFld-ContribAuthor ">Alexey  Schulga</span>, <span class="hlFld-ContribAuthor ">Elena  Konovalova</span>, <span class="hlFld-ContribAuthor ">Rezan  Güler</span>, <span class="hlFld-ContribAuthor ">John  Löfblom</span>, <span class="hlFld-ContribAuthor ">Mattias  Sandström</span>, <span class="hlFld-ContribAuthor ">Javad  Garousi</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chernov</span>, <span class="hlFld-ContribAuthor ">Olga  Bragina</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Sergey M.  Deyev</span>. </span><span class="cited-content_cbyCitation_article-title">Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-45795-8" title="DOI URL">https://doi.org/10.1038/s41598-019-45795-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-45795-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-45795-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DOptimal%252Bcomposition%252Band%252Bposition%252Bof%252Bhistidine-containing%252Btags%252Bimproves%252Bbiodistribution%252Bof%252B99mTc-labeled%252BDARPin%252BG3%26aulast%3DVorobyeva%26aufirst%3DAnzhelika%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaetano  De Tommaso</span>, <span class="hlFld-ContribAuthor ">Gaetano  Malgieri</span>, <span class="hlFld-ContribAuthor ">Lucia  De Rosa</span>, <span class="hlFld-ContribAuthor ">Roberto  Fattorusso</span>, <span class="hlFld-ContribAuthor ">Gianluca  D'Abrosca</span>, <span class="hlFld-ContribAuthor ">Alessandra  Romanelli</span>, <span class="hlFld-ContribAuthor ">Mauro  Iuliano</span>, <span class="hlFld-ContribAuthor ">Luca Domenico  D'Andrea</span>, <span class="hlFld-ContribAuthor ">Carla  Isernia</span>. </span><span class="cited-content_cbyCitation_article-title">Coordination of a bis-histidine-oligopeptide to Re(
              i
              ) and Ga(
              iii
              ) in aqueous solution. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2019,</strong> <em>48 </em>
                                    (40)
                                     , 15184-15191. <a href="https://doi.org/10.1039/C9DT02406A" title="DOI URL">https://doi.org/10.1039/C9DT02406A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT02406A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT02406A%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DCoordination%252Bof%252Ba%252Bbis-histidine-oligopeptide%252Bto%252BRe%252528%252Bi%252B%252529%252Band%252BGa%252528%252Biii%252B%252529%252Bin%252Baqueous%252Bsolution%26aulast%3DDe%2BTommaso%26aufirst%3DGaetano%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D40%26spage%3D15184%26epage%3D15191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shibo  Qi</span>, <span class="hlFld-ContribAuthor ">Susan  Hoppmann</span>, <span class="hlFld-ContribAuthor ">Yingding  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2019,</strong> <em>21 </em>
                                    (5)
                                     , 907-916. <a href="https://doi.org/10.1007/s11307-018-01310-5" title="DOI URL">https://doi.org/10.1007/s11307-018-01310-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-018-01310-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-018-01310-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DPET%252BImaging%252Bof%252BHER2-Positive%252BTumors%252Bwith%252BCu-64-Labeled%252BAffibody%252BMolecules%26aulast%3DQi%26aufirst%3DShibo%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D5%26spage%3D907%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mauricio  Morais</span>, <span class="hlFld-ContribAuthor ">Michelle T.  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2018,</strong> <em>30 </em>, 91-104. <a href="https://doi.org/10.1016/j.ddtec.2018.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2018.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2018.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2018.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DSite-specific%252Bchelator-antibody%252Bconjugation%252Bfor%252BPET%252Band%252BSPECT%252Bimaging%252Bwith%252Bradiometals%26aulast%3DMorais%26aufirst%3DMauricio%26date%3D2018%26volume%3D30%26spage%3D91%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank-Jan  Warnders</span>, <span class="hlFld-ContribAuthor ">Marjolijn N.  Lub-de Hooge</span>, <span class="hlFld-ContribAuthor ">Elisabeth G. E.  de Vries</span>, <span class="hlFld-ContribAuthor ">Jos G. W.  Kosterink</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 1837-1873. <a href="https://doi.org/10.1002/med.21498" title="DOI URL">https://doi.org/10.1002/med.21498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21498%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DInfluence%252Bof%252Bprotein%252Bproperties%252Band%252Bprotein%252Bmodification%252Bon%252Bbiodistribution%252Band%252Btumor%252Buptake%252Bof%252Banticancer%252Bantibodies%25252C%252Bantibody%252Bderivatives%25252C%252Band%252Bnon-Ig%252Bscaffolds%26aulast%3DWarnders%26aufirst%3DFrank-Jan%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D1837%26epage%3D1873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger  Alberto</span>. </span><span class="cited-content_cbyCitation_article-title">From oxo to carbonyl and arene complexes; A journey through technetium chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2018,</strong> <em>869 </em>, 264-269. <a href="https://doi.org/10.1016/j.jorganchem.2018.01.013" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2018.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2018.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2018.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DFrom%252Boxo%252Bto%252Bcarbonyl%252Band%252Barene%252Bcomplexes%25253B%252BA%252Bjourney%252Bthrough%252Btechnetium%252Bchemistry%26aulast%3DAlberto%26aufirst%3DRoger%26date%3D2018%26volume%3D869%26spage%3D264%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anzhelika  Vorobyeva</span>, <span class="hlFld-ContribAuthor ">Olga  Bragina</span>, <span class="hlFld-ContribAuthor ">Mohamed  Altai</span>, <span class="hlFld-ContribAuthor ">Bogdan  Mitran</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Alexey  Shulga</span>, <span class="hlFld-ContribAuthor ">Galina  Proshkina</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chernov</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Sergey  Deyev</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors. </span><span class="cited-content_cbyCitation_journal-name">Contrast Media & Molecular Imaging</span><span> <strong>2018,</strong> <em>2018 </em>, 1-11. <a href="https://doi.org/10.1155/2018/6930425" title="DOI URL">https://doi.org/10.1155/2018/6930425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/6930425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F6930425%26sid%3Dliteratum%253Aachs%26jtitle%3DContrast%2520Media%2520%2526%2520Molecular%2520Imaging%26atitle%3DComparative%252BEvaluation%252Bof%252BRadioiodine%252Band%252BTechnetium-Labeled%252BDARPin%252B9_29%252Bfor%252BRadionuclide%252BMolecular%252BImaging%252Bof%252BHER2%252BExpression%252Bin%252BMalignant%252BTumors%26aulast%3DVorobyeva%26aufirst%3DAnzhelika%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javad  Garousi</span>, <span class="hlFld-ContribAuthor ">Sarah  Lindbo</span>, <span class="hlFld-ContribAuthor ">Bogdan  Mitran</span>, <span class="hlFld-ContribAuthor ">Jos  Buijs</span>, <span class="hlFld-ContribAuthor ">Anzhelika  Vorobyeva</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Sophia  Hober</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-15366-w" title="DOI URL">https://doi.org/10.1038/s41598-017-15366-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-15366-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-15366-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DComparative%252Bevaluation%252Bof%252Btumor%252Btargeting%252Busing%252Bthe%252Banti-HER2%252BADAPT%252Bscaffold%252Bprotein%252Blabeled%252Bat%252Bthe%252BC-terminus%252Bwith%252Bindium-111%252Bor%252Btechnetium-99m%26aulast%3DGarousi%26aufirst%3DJavad%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Rosestedt</span>, <span class="hlFld-ContribAuthor ">Ken G.  Andersson</span>, <span class="hlFld-ContribAuthor ">Bogdan  Mitran</span>, <span class="hlFld-ContribAuthor ">Sara S.  Rinne</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">John  Löfblom</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Stefan  Ståhl</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of a radiocobalt-labelled affibody molecule for imaging of human epidermal growth factor receptor 3 expression. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Oncology</span><span> <strong>2017,</strong> <em>51 </em>
                                    (6)
                                     , 1765-1774. <a href="https://doi.org/10.3892/ijo.2017.4152" title="DOI URL">https://doi.org/10.3892/ijo.2017.4152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijo.2017.4152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijo.2017.4152%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Oncology%26atitle%3DEvaluation%252Bof%252Ba%252Bradiocobalt-labelled%252Baffibody%252Bmolecule%252Bfor%252Bimaging%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252B3%252Bexpression%26aulast%3DRosestedt%26aufirst%3DMaria%26date%3D2017%26date%3D2017%26volume%3D51%26issue%3D6%26spage%3D1765%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Ståhl</span>, <span class="hlFld-ContribAuthor ">Torbjörn  Gräslund</span>, <span class="hlFld-ContribAuthor ">Amelie  Eriksson Karlström</span>, <span class="hlFld-ContribAuthor ">Fredrik Y.  Frejd</span>, <span class="hlFld-ContribAuthor ">Per-Åke  Nygren</span>, <span class="hlFld-ContribAuthor ">John  Löfblom</span>. </span><span class="cited-content_cbyCitation_article-title">Affibody Molecules in Biotechnological and Medical Applications. </span><span class="cited-content_cbyCitation_journal-name">Trends in Biotechnology</span><span> <strong>2017,</strong> <em>35 </em>
                                    (8)
                                     , 691-712. <a href="https://doi.org/10.1016/j.tibtech.2017.04.007" title="DOI URL">https://doi.org/10.1016/j.tibtech.2017.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tibtech.2017.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tibtech.2017.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Biotechnology%26atitle%3DAffibody%252BMolecules%252Bin%252BBiotechnological%252Band%252BMedical%252BApplications%26aulast%3DSt%25C3%25A5hl%26aufirst%3DStefan%26date%3D2017%26volume%3D35%26issue%3D8%26spage%3D691%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fredrik Y  Frejd</span>, <span class="hlFld-ContribAuthor ">Kyu-Tae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Affibody molecules as engineered protein drugs. </span><span class="cited-content_cbyCitation_journal-name">Experimental & Molecular Medicine</span><span> <strong>2017,</strong> <em>49 </em>
                                    (3)
                                     , e306-e306. <a href="https://doi.org/10.1038/emm.2017.35" title="DOI URL">https://doi.org/10.1038/emm.2017.35</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/emm.2017.35&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Femm.2017.35%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520%2526%2520Molecular%2520Medicine%26atitle%3DAffibody%252Bmolecules%252Bas%252Bengineered%252Bprotein%252Bdrugs%26aulast%3DFrejd%26aufirst%3DFredrik%2BY%26date%3D2017%26date%3D2017%26volume%3D49%26issue%3D3%26spage%3De306%26epage%3De306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Frigerio</span>, <span class="hlFld-ContribAuthor ">Gerben  Franssen</span>, <span class="hlFld-ContribAuthor ">Elena  Luison</span>, <span class="hlFld-ContribAuthor ">Alessandro  Satta</span>, <span class="hlFld-ContribAuthor ">Ettore  Seregni</span>, <span class="hlFld-ContribAuthor ">Marco  Colombatti</span>, <span class="hlFld-ContribAuthor ">Giulio  Fracasso</span>, <span class="hlFld-ContribAuthor ">Riccardo  Valdagni</span>, <span class="hlFld-ContribAuthor ">Delia  Mezzanzanica</span>, <span class="hlFld-ContribAuthor ">Otto  Boerman</span>, <span class="hlFld-ContribAuthor ">Silvana  Canevari</span>, <span class="hlFld-ContribAuthor ">Mariangela  Figini</span>. </span><span class="cited-content_cbyCitation_article-title">Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 10919-10930. <a href="https://doi.org/10.18632/oncotarget.14229" title="DOI URL">https://doi.org/10.18632/oncotarget.14229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.14229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.14229%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DFull%252Bpreclinical%252Bvalidation%252Bof%252Bthe%252B123I-labeled%252Banti-PSMA%252Bantibody%252Bfragment%252BScFvD2B%252Bfor%252Bprostate%252Bcancer%252Bimaging%26aulast%3DFrigerio%26aufirst%3DBarbara%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D7%26spage%3D10919%26epage%3D10930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamideh  Sabahnoo</span>, <span class="hlFld-ContribAuthor ">Zohreh  Noaparast</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Abedi</span>, <span class="hlFld-ContribAuthor ">Seyed Jalal  Hosseinimehr</span>. </span><span class="cited-content_cbyCitation_article-title">New small 99mTc-labeled peptides for HER2 receptor imaging. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 1012-1024. <a href="https://doi.org/10.1016/j.ejmech.2016.11.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252Bsmall%252B99mTc-labeled%252Bpeptides%252Bfor%252BHER2%252Breceptor%252Bimaging%26aulast%3DSabahnoo%26aufirst%3DHamideh%26date%3D2017%26volume%3D127%26spage%3D1012%26epage%3D1024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaetano  De Tommaso</span>, <span class="hlFld-ContribAuthor ">Veronica  Celentano</span>, <span class="hlFld-ContribAuthor ">Gaetano  Malgieri</span>, <span class="hlFld-ContribAuthor ">Roberto  Fattorusso</span>, <span class="hlFld-ContribAuthor ">Alessandra  Romanelli</span>, <span class="hlFld-ContribAuthor ">Luca Domenico  D'Andrea</span>, <span class="hlFld-ContribAuthor ">Mauro  Iuliano</span>, <span class="hlFld-ContribAuthor ">Carla  Isernia</span>. </span><span class="cited-content_cbyCitation_article-title">fac
              -[Re(H
              2
              O)
              3
              (CO)
              3
              ]
              +
              Complexed with Histidine and Imidazole in Aqueous Solution: Speciation, Affinity and Binding Features. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2016,</strong> <em>1 </em>
                                    (13)
                                     , 3739-3744. <a href="https://doi.org/10.1002/slct.201600817" title="DOI URL">https://doi.org/10.1002/slct.201600817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201600817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201600817%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3Dfac%252B-%25255BRe%252528H%252B2%252BO%252529%252B3%252B%252528CO%252529%252B3%252B%25255D%252B%25252B%252BComplexed%252Bwith%252BHistidine%252Band%252BImidazole%252Bin%252BAqueous%252BSolution%25253A%252BSpeciation%25252C%252BAffinity%252Band%252BBinding%252BFeatures%26aulast%3DDe%25E2%2580%2585Tommaso%26aufirst%3DGaetano%26date%3D2016%26date%3D2016%26volume%3D1%26issue%3D13%26spage%3D3739%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed Mohammad  Abedi</span>, <span class="hlFld-ContribAuthor ">Alireza  Mardanshahi</span>, <span class="hlFld-ContribAuthor ">Roza  Shahhosseini</span>, <span class="hlFld-ContribAuthor ">Seyed Jalal  Hosseinimehr</span>. </span><span class="cited-content_cbyCitation_article-title">Nuclear medicine for imaging of epithelial ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Future Oncology</span><span> <strong>2016,</strong> <em>12 </em>
                                    (9)
                                     , 1165-1177. <a href="https://doi.org/10.2217/fon.16.19" title="DOI URL">https://doi.org/10.2217/fon.16.19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fon.16.19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffon.16.19%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Oncology%26atitle%3DNuclear%252Bmedicine%252Bfor%252Bimaging%252Bof%252Bepithelial%252Bovarian%252Bcancer%26aulast%3DAbedi%26aufirst%3DSeyed%2BMohammad%26date%3D2016%26volume%3D12%26issue%3D9%26spage%3D1165%26epage%3D1177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.N.  McCracken</span>, <span class="hlFld-ContribAuthor ">R.  Tavaré</span>, <span class="hlFld-ContribAuthor ">O.N.  Witte</span>, <span class="hlFld-ContribAuthor ">A.M.  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in PET Detection of the Antitumor T Cell Response. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 187-231. <a href="https://doi.org/10.1016/bs.ai.2016.02.004" title="DOI URL">https://doi.org/10.1016/bs.ai.2016.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.ai.2016.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.ai.2016.02.004%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252BPET%252BDetection%252Bof%252Bthe%252BAntitumor%252BT%252BCell%252BResponse%26aulast%3DMcCracken%26aufirst%3DM.N.%26date%3D2016%26spage%3D187%26epage%3D231%26pub%3DElsevier%26date%3D2016%26volume%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Goldstein</span>, <span class="hlFld-ContribAuthor ">Jane  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Maria  Livanos</span>, <span class="hlFld-ContribAuthor ">Julius  Leyton</span>, <span class="hlFld-ContribAuthor ">Kim  Vigor</span>, <span class="hlFld-ContribAuthor ">Gaurav  Bhavsar</span>, <span class="hlFld-ContribAuthor ">Gabriela  Nagy-Davidescu</span>, <span class="hlFld-ContribAuthor ">Mohammed  Rashid</span>, <span class="hlFld-ContribAuthor ">Enrique  Miranda</span>, <span class="hlFld-ContribAuthor ">Jenny  Yeung</span>, <span class="hlFld-ContribAuthor ">Berend  Tolner</span>, <span class="hlFld-ContribAuthor ">Andreas  Plückthun</span>, <span class="hlFld-ContribAuthor ">Stephen  Mather</span>, <span class="hlFld-ContribAuthor ">Tim  Meyer</span>, <span class="hlFld-ContribAuthor ">Kerry  Chester</span>. </span><span class="cited-content_cbyCitation_article-title">Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2015,</strong> <em>42 </em>
                                    (2)
                                     , 288-301. <a href="https://doi.org/10.1007/s00259-014-2940-2" title="DOI URL">https://doi.org/10.1007/s00259-014-2940-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-014-2940-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-014-2940-2%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DDevelopment%252Bof%252Bthe%252Bdesigned%252Bankyrin%252Brepeat%252Bprotein%252B%252528DARPin%252529%252BG3%252Bfor%252BHER2%252Bmolecular%252Bimaging%26aulast%3DGoldstein%26aufirst%3DRobert%26date%3D2015%26date%3D2014%26volume%3D42%26issue%3D2%26spage%3D288%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bogdan  Mitran</span>, <span class="hlFld-ContribAuthor ">Mohamed  Altai</span>, <span class="hlFld-ContribAuthor ">Camilla  Hofström</span>, <span class="hlFld-ContribAuthor ">Hadis  Honarvar</span>, <span class="hlFld-ContribAuthor ">Mattias  Sandström</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Torbjörn  Gräslund</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2015,</strong> <em>47 </em>
                                    (2)
                                     , 303-315. <a href="https://doi.org/10.1007/s00726-014-1859-z" title="DOI URL">https://doi.org/10.1007/s00726-014-1859-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-014-1859-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-014-1859-z%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DEvaluation%252Bof%252B99mTc-ZIGF1R%25253A4551-GGGC%252Baffibody%252Bmolecule%25252C%252Ba%252Bnew%252Bprobe%252Bfor%252Bimaging%252Bof%252Binsulin-like%252Bgrowth%252Bfactor%252Btype%252B1%252Breceptor%252Bexpression%26aulast%3DMitran%26aufirst%3DBogdan%26date%3D2015%26date%3D2014%26volume%3D47%26issue%3D2%26spage%3D303%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip J.  Blower</span>. </span><span class="cited-content_cbyCitation_article-title">A nuclear chocolate box: the periodic table of nuclear medicine. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2015,</strong> <em>44 </em>
                                    (11)
                                     , 4819-4844. <a href="https://doi.org/10.1039/C4DT02846E" title="DOI URL">https://doi.org/10.1039/C4DT02846E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4DT02846E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4DT02846E%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DA%252Bnuclear%252Bchocolate%252Bbox%25253A%252Bthe%252Bperiodic%252Btable%252Bof%252Bnuclear%252Bmedicine%26aulast%3DBlower%26aufirst%3DPhilip%2BJ.%26date%3D2015%26date%3D2015%26volume%3D44%26issue%3D11%26spage%3D4819%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica R.  Newton-Northup</span>, <span class="hlFld-ContribAuthor ">Marie T.  Dickerson</span>, <span class="hlFld-ContribAuthor ">Senthil R.  Kumar</span>, <span class="hlFld-ContribAuthor ">George P.  Smith</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Quinn</span>, <span class="hlFld-ContribAuthor ">Susan L.  Deutscher</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Bacteriophage Peptide Display to Tailor Pharmacokinetics of Biological Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2014,</strong> <em>16 </em>
                                    (6)
                                     , 854-864. <a href="https://doi.org/10.1007/s11307-014-0762-z" title="DOI URL">https://doi.org/10.1007/s11307-014-0762-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-014-0762-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-014-0762-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DIn%252BVivo%252BBacteriophage%252BPeptide%252BDisplay%252Bto%252BTailor%252BPharmacokinetics%252Bof%252BBiological%252BNanoparticles%26aulast%3DNewton-Northup%26aufirst%3DJessica%2BR.%26date%3D2014%26date%3D2014%26volume%3D16%26issue%3D6%26spage%3D854%26epage%3D864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Tavare</span>, <span class="hlFld-ContribAuthor ">W. H.  Wu</span>, <span class="hlFld-ContribAuthor ">K. A.  Zettlitz</span>, <span class="hlFld-ContribAuthor ">F. B.  Salazar</span>, <span class="hlFld-ContribAuthor ">K. E.  McCabe</span>, <span class="hlFld-ContribAuthor ">J. D.  Marks</span>, <span class="hlFld-ContribAuthor ">A. M.  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific 64Cu-DOTA conjugation. </span><span class="cited-content_cbyCitation_journal-name">Protein Engineering Design and Selection</span><span> <strong>2014,</strong> <em>27 </em>
                                    (10)
                                     , 317-324. <a href="https://doi.org/10.1093/protein/gzu030" title="DOI URL">https://doi.org/10.1093/protein/gzu030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/protein/gzu030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fprotein%2Fgzu030%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Engineering%2520Design%2520and%2520Selection%26atitle%3DEnhanced%252BimmunoPET%252Bof%252BALCAM-positive%252Bcolorectal%252Bcarcinoma%252Busing%252Bsite-specific%252B64Cu-DOTA%252Bconjugation%26aulast%3DTavare%26aufirst%3DR.%26date%3D2014%26date%3D2014%26volume%3D27%26issue%3D10%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Magdalena  Malm</span>, <span class="hlFld-ContribAuthor ">Maria  Rosestedt</span>, <span class="hlFld-ContribAuthor ">Zohreh  Varasteh</span>, <span class="hlFld-ContribAuthor ">Ken  Andersson</span>, <span class="hlFld-ContribAuthor ">Ram Kumar  Selvaraju</span>, <span class="hlFld-ContribAuthor ">Mohamed  Altai</span>, <span class="hlFld-ContribAuthor ">Hadis  Honarvar</span>, <span class="hlFld-ContribAuthor ">Joanna  Strand</span>, <span class="hlFld-ContribAuthor ">Stefan  Ståhl</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, <span class="hlFld-ContribAuthor ">John  Löfblom</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2014,</strong> <em>41 </em>
                                    (7)
                                     , 1450-1459. <a href="https://doi.org/10.1007/s00259-014-2733-7" title="DOI URL">https://doi.org/10.1007/s00259-014-2733-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-014-2733-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-014-2733-7%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DImaging%252Bof%252BHER3-expressing%252Bxenografts%252Bin%252Bmice%252Busing%252Ba%252B99mTc%252528CO%2525293-HEHEHE-ZHER3%25253A08699%252Baffibody%252Bmolecule%26aulast%3DOrlova%26aufirst%3DAnna%26date%3D2014%26date%3D2014%26volume%3D41%26issue%3D7%26spage%3D1450%26epage%3D1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian  Trousil</span>, <span class="hlFld-ContribAuthor ">Susan  Hoppmann</span>, <span class="hlFld-ContribAuthor ">Quang-Dé  Nguyen</span>, <span class="hlFld-ContribAuthor ">Maciej  Kaliszczak</span>, <span class="hlFld-ContribAuthor ">Giampaolo  Tomasi</span>, <span class="hlFld-ContribAuthor ">Peter  Iveson</span>, <span class="hlFld-ContribAuthor ">Duncan  Hiscock</span>, <span class="hlFld-ContribAuthor ">Eric O.  Aboagye</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography Imaging with
              18
              F-Labeled Z
              
                HER2:2891
              
              Affibody for Detection of HER2 Expression and Pharmacodynamic Response to HER2-Modulating Therapies. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2014,</strong> <em>20 </em>
                                    (6)
                                     , 1632-1643. <a href="https://doi.org/10.1158/1078-0432.CCR-13-2421" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-13-2421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-13-2421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-13-2421%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DPositron%252BEmission%252BTomography%252BImaging%252Bwith%252B18%252BF-Labeled%252BZ%252BHER2%25253A2891%252BAffibody%252Bfor%252BDetection%252Bof%252BHER2%252BExpression%252Band%252BPharmacodynamic%252BResponse%252Bto%252BHER2-Modulating%252BTherapies%26aulast%3DTrousil%26aufirst%3DSebastian%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D6%26spage%3D1632%26epage%3D1643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Strand</span>, <span class="hlFld-ContribAuthor ">Hadis  Honarvar</span>, <span class="hlFld-ContribAuthor ">Anna  Perols</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Ram Kumar  Selvaraju</span>, <span class="hlFld-ContribAuthor ">Amelie Eriksson  Karlström</span>, <span class="hlFld-ContribAuthor ">Vladimir  Tolmachev</span>, . </span><span class="cited-content_cbyCitation_article-title">Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , e70028. <a href="https://doi.org/10.1371/journal.pone.0070028" title="DOI URL">https://doi.org/10.1371/journal.pone.0070028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0070028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0070028%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DInfluence%252Bof%252BMacrocyclic%252BChelators%252Bon%252Bthe%252BTargeting%252BProperties%252Bof%252B68Ga-Labeled%252BSynthetic%252BAffibody%252BMolecules%25253A%252BComparison%252Bwith%252B111In-Labeled%252BCounterparts%26aulast%3DStrand%26aufirst%3DJoanna%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3De70028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Proposed structure of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled histidine-containing tags and calculated biochemical properties of the free peptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Analytical RP-HPLC analysis of the (HX)<sub>3</sub>-Z<sub>HER2:342</sub> variants. The <i>x</i>-axis corresponds to retention time after injection, and the <i>y</i>-axis corresponds to the absorbance measured at 220 nm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Influence of position and composition of the (HX)<sub>3</sub>-tag on uptake of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules in liver, spleen, and gastrointestinal tract at 4 h after injection. (A) (HX)<sub>3</sub>-tags placed in the N-terminus. (B). (HX)<sub>3</sub>-tags placed in the C-terminus. The radioactivity of different organs is expressed as % ID/g and presented as an average value from four animals ± standard deviation. * Data for intestines with content are presented as % of injected radioactivity per whole sample.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/medium/jm-2013-00218y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Influence of position and composition of the (HX)<sub>3</sub>-tags on radiactivity concentration of [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules in blood, lung, and muscle at 4 pi. The concentration of radioactivity in different organs is expressed as % ID/g and presented as an average value from four animals ± standard deviation. (B) Correlation between release of radioactivity from [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-labeled affibody molecules during histidine challenge and radioactivity concentration in blood at 4 h pi.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-12/jm400218y/production/images/large/jm-2013-00218y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400218y&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sharma, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyagi, T.</span><span> </span><span class="NLM_article-title">Receptor tyrosine kinase inhibitors as potent weapons in war against cancers</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2174%2F138161209787582219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19275641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=758-776&author=P.+S.+Sharmaauthor=R.+Sharmaauthor=T.+Tyagi&title=Receptor+tyrosine+kinase+inhibitors+as+potent+weapons+in+war+against+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor tyrosine kinase inhibitors as potent weapons in war against cancers</span></div><div class="casAuthors">Sharma, P. Sapra; Sharma, R.; Tyagi, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">758-776</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Receptor Tyrosine Kinases class I (RTK class I, EGF receptor family) constitute a family of transmembrane proteins involved in various aspects of cell growth and survival and have been implicated in the initiation and progression of several types of human malignancies.  Activation of EGFR may be because of overexpression, mutations resulting in constitutive activation, or autocrine expression of ligand.  In contrast, activation of HER2 occurs mainly by overexpression, which leads to spontaneous homodimerization and activation of downstream signaling events in a ligand-independent manner.  EGFR and HER2 have now been validated as a clin. relevant target, and several different types of agents inhibiting these receptors are currently in development.  The EGFR inhibitors Erlotinib, Gefitinib, and Cetuximab have undergone extensive clin. testing and have established clin. activity in non small cell lung cancer (NSCLS) and other types of solid tumors.  Several of the other erbB inhibitors are also undergoing advanced clin. testing, either alone or in combination with other agents.  This review reports various inhibitors, natural, small mols. and monoclonal antibodies, along with their reported activities for various members of erbB family.  It will highlight the potential for the development of novel anti-cancer mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4DFJZs8wJd7Vg90H21EOLACvtfcHk0lgf6z4ERO5CwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSnsrY%253D&md5=792b79efb1a5276505912df047108451</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F138161209787582219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161209787582219%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DP.%2BS.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DTyagi%26aufirst%3DT.%26atitle%3DReceptor%2520tyrosine%2520kinase%2520inhibitors%2520as%2520potent%2520weapons%2520in%2520war%2520against%2520cancers%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2009%26volume%3D15%26spage%3D758%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone-Elander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Current approaches to the use of radiolabeled tyrosine kinase-targeting drugs for patient stratification and treatment response monitoring: prospects and pitfalls</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1016%2FS1470-2045%2810%2970088-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20667780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1ertLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=992-1000&author=V.+Tolmachevauthor=S.+Stone-Elanderauthor=A.+Orlova&title=Current+approaches+to+the+use+of+radiolabeled+tyrosine+kinase-targeting+drugs+for+patient+stratification+and+treatment+response+monitoring%3A+prospects+and+pitfalls"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls</span></div><div class="casAuthors">Tolmachev, Vladimir; Stone-Elander, Sharon; Orlova, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">992-1000</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Summary: Transmembrane receptor tyrosine kinases (RTKs) are overexpressed in many malignancies.  RTK signalling triggers cell proliferation, suppression of apoptosis, increased motility, and recruitment of neovasculature.  Overexpressed RTKs are the mol. targets for an increasing no. of anticancer drugs.  Monoclonal antibodies block the ligands or their binding sites and prevent receptor dimerization, thereby hindering RTK signalling.  The antibody-dependent cellular cytotoxicity can boost the therapeutic effect.  Small-mol. tyrosine kinase inhibitors (TKIs) hamper downstream RTK signalling by targeting the intracellular kinase domain.  These drugs have significantly increased survival in several patient groups.  Improved patient stratification and therapy monitoring might further enhance the efficacy of anti-RTK therapy.  Radionuclide-based mol. imaging can provide methods for localizing and estg. the expression of RTKs.  It can potentially identify patients who have tumors that overexpress RTK and would, therefore, most likely benefit from a targeted treatment.  Monitoring changes in RTK expression during therapy could help avoid overtreatment and undertreatment.  Radionuclide-based methods are less invasive and less sensitive to expression heterogeneity than more conventional sampling methods.  The biochem. information is also obtained in an anatomical context.  The development of radiolabeled anti-RTK drugs and their analogs is the subject of intensive preclin. and translational research.  In this review, we present current approaches to developing imaging probes for in-vivo RTK visualization and discuss their advantages and disadvantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6aQHJNbdTIrVg90H21EOLACvtfcHk0lgf6z4ERO5CwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1ertLjI&md5=3f89bb6d613f9681a75bd8f7d09b577c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2810%2970088-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252810%252970088-7%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DStone-Elander%26aufirst%3DS.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DCurrent%2520approaches%2520to%2520the%2520use%2520of%2520radiolabeled%2520tyrosine%2520kinase-targeting%2520drugs%2520for%2520patient%2520stratification%2520and%2520treatment%2520response%2520monitoring%253A%2520prospects%2520and%2520pitfalls%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D992%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Löfblom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frejd, F. Y.</span><span> </span><span class="NLM_article-title">Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">584</span><span class="NLM_x">, </span> <span class="NLM_fpage">2670</span><span class="NLM_x">–</span> <span class="NLM_lpage">2680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=584&publication_year=2010&pages=2670-2680&author=J.+L%C3%B6fblomauthor=J.+Feldwischauthor=V.+Tolmachevauthor=J.+Carlssonauthor=S.+St%C3%A5hlauthor=F.+Y.+Frejd&title=Affibody+molecules%3A+engineered+proteins+for+therapeutic%2C+diagnostic+and+biotechnological+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6fblom%26aufirst%3DJ.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DFrejd%26aufirst%3DF.%2BY.%26atitle%3DAffibody%2520molecules%253A%2520engineered%2520proteins%2520for%2520therapeutic%252C%2520diagnostic%2520and%2520biotechnological%2520applications%26jtitle%3DFEBS%2520Lett.%26date%3D2010%26volume%3D584%26spage%3D2670%26epage%3D2680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höiden-Guthenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, F. Y.</span><span> </span><span class="NLM_article-title">Tumor imaging using a picomolar affinity HER2 binding affibody molecule</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">4339</span><span class="NLM_x">–</span> <span class="NLM_lpage">4348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=4339-4348&author=A.+Orlovaauthor=M.+Magnussonauthor=T.+L.+Erikssonauthor=M.+Nilssonauthor=B.+Larssonauthor=I.+H%C3%B6iden-Guthenbergauthor=C.+Widstr%C3%B6mauthor=J.+Carlssonauthor=V.+Tolmachevauthor=S.+St%C3%A5hlauthor=F.+Y.+Nilsson&title=Tumor+imaging+using+a+picomolar+affinity+HER2+binding+affibody+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DMagnusson%26aufirst%3DM.%26aulast%3DEriksson%26aufirst%3DT.%2BL.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DB.%26aulast%3DH%25C3%25B6iden-Guthenberg%26aufirst%3DI.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DF.%2BY.%26atitle%3DTumor%2520imaging%2520using%2520a%2520picomolar%2520affinity%2520HER2%2520binding%2520affibody%2520molecule%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D4339%26epage%3D4348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Imaging of EGFR expression in murine xenografts using site-specifically labeled anti-EGFR <sup>111</sup>In-DOTA-Z<sub>EGFR:2377</sub> affibody molecule: aspect of the injected tracer amount</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs00259-009-1283-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19838701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A280%3ADC%252BC3c7gs1Ckug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=613-622&author=V.+Tolmachevauthor=D.+Rosikauthor=H.+W%C3%A5llbergauthor=A.+Sj%C3%B6bergauthor=M.+Sandstr%C3%B6mauthor=M.+Hanssonauthor=A.+Wennborgauthor=A.+Orlova&title=Imaging+of+EGFR+expression+in+murine+xenografts+using+site-specifically+labeled+anti-EGFR+111In-DOTA-ZEGFR%3A2377+affibody+molecule%3A+aspect+of+the+injected+tracer+amount"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount</span></div><div class="casAuthors">Tolmachev Vladimir; Rosik Daniel; Wallberg Helena; Sjoberg Anna; Sandstrom Mattias; Hansson Monika; Wennborg Anders; Orlova Anna</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">613-22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Overexpression of epidermal growth factor receptor (EGFR) is a prognostic and predictive biomarker in a number of malignant tumours.  Radionuclide molecular imaging of EGFR expression in cancer could influence patient management.  However, EGFR expression in normal tissues might complicate in vivo imaging.  The aim of this study was to evaluate if optimization of the injected protein dose might improve imaging of EGFR expression in tumours using a novel EGFR-targeting protein, the DOTA-Z(EGFR:2377) Affibody molecule.  METHODS:  An anti-EGFR Affibody molecule, Z(EGFR:2377), was labelled with (111)In via the DOTA chelator site-specifically conjugated to a C-terminal cysteine.  The affinity of DOTA-Z(EGFR:2377) for murine and human EGFR was measured by surface plasmon resonance.  The cellular processing of (111)In-DOTA-Z(EGFR:2377) was evaluated in vitro.  The biodistribution of radiolabelled Affibody molecules injected in a broad range of injected Affibody protein doses was evaluated in mice bearing EGFR-expressing A431 xenografts.  RESULTS:  Site-specific coupling of DOTA provided a uniform conjugate possessing equal affinity for human and murine EGFR.  The internalization of (111)In-DOTA-Z(EGFR:2377) by A431 cells was slow.  In vivo, the conjugate accumulated specifically in xenografts and in EGFR-expressing tissues.  The curve representing the dependence of tumour uptake on the injected Affibody protein dose was bell-shaped.  The highest specific radioactivity (lowest injected protein dose) provided a suboptimal tumour-to-blood ratio.  The results of the biodistribution study were confirmed by gamma-camera imaging.  CONCLUSION:  The (111)In-DOTA-Z(EGFR:2377) Affibody molecule is a promising tracer for radionuclide molecular imaging of EGFR expression in malignant tumours.  Careful optimization of protein dose is required for high-contrast imaging of EGFR expression in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8Py3uNN3EoIqdXsLcGTEUfW6udTcc2eZU0nOJ5h-7Pbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7gs1Ckug%253D%253D&md5=1598caa865162de28b30667d495eb103</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00259-009-1283-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-009-1283-x%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DHansson%26aufirst%3DM.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DImaging%2520of%2520EGFR%2520expression%2520in%2520murine%2520xenografts%2520using%2520site-specifically%2520labeled%2520anti-EGFR%2520111In-DOTA-ZEGFR%253A2377%2520affibody%2520molecule%253A%2520aspect%2520of%2520the%2520injected%2520tracer%2520amount%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2010%26volume%3D37%26spage%3D613%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kronqvist, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göstring, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunneriusson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höiden-Guthenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedda, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frejd, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löfblom, J.</span><span> </span><span class="NLM_article-title">Combining phage and staphylococcal surface display for generation of ErbB3-specific affibody molecules</span> <span class="citation_source-journal">Protein Eng., Des. Sel.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1093%2Fprotein%2Fgzq118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=21177282" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=385-396&author=N.+Kronqvistauthor=M.+Malmauthor=L.+G%C3%B6stringauthor=E.+Gunneriussonauthor=M.+Nilssonauthor=I.+H%C3%B6iden-Guthenbergauthor=L.+Geddaauthor=F.+Y.+Frejdauthor=S.+St%C3%A5hlauthor=J.+L%C3%B6fblom&title=Combining+phage+and+staphylococcal+surface+display+for+generation+of+ErbB3-specific+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzq118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzq118%26sid%3Dliteratum%253Aachs%26aulast%3DKronqvist%26aufirst%3DN.%26aulast%3DMalm%26aufirst%3DM.%26aulast%3DG%25C3%25B6string%26aufirst%3DL.%26aulast%3DGunneriusson%26aufirst%3DE.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DH%25C3%25B6iden-Guthenberg%26aufirst%3DI.%26aulast%3DGedda%26aufirst%3DL.%26aulast%3DFrejd%26aufirst%3DF.%2BY.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DL%25C3%25B6fblom%26aufirst%3DJ.%26atitle%3DCombining%2520phage%2520and%2520staphylococcal%2520surface%2520display%2520for%2520generation%2520of%2520ErbB3-specific%2520affibody%2520molecules%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2010%26volume%3D24%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lindborg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höiden-Guthenberg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunneriusson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Hage, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herne, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietras, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frejd, F. Y.</span><span> </span><span class="NLM_article-title">Engineered high-affinity affibody molecules targeting platelet-derived growth factor receptor beta in vivo</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">407</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">315</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1016%2Fj.jmb.2011.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=21277312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFWqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=407&publication_year=2011&pages=298-315&author=M.+Lindborgauthor=E.+Cortezauthor=I.+H%C3%B6iden-Guthenbergauthor=E.+Gunneriussonauthor=E.+von+Hageauthor=F.+Syudauthor=M.+Morrisonauthor=L.+Abrahms%C3%A9nauthor=N.+Herneauthor=K.+Pietrasauthor=F.+Y.+Frejd&title=Engineered+high-affinity+affibody+molecules+targeting+platelet-derived+growth+factor+receptor+beta+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Engineered High-Affinity Affibody Molecules Targeting Platelet-Derived Growth Factor Receptor β In Vivo</span></div><div class="casAuthors">Lindborg, M.; Cortez, E.; Hoeiden-Guthenberg, I.; Gunneriusson, E.; von Hage, E.; Syud, F.; Morrison, M.; Abrahmsen, L.; Herne, N.; Pietras, K.; Frejd, F. Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">407</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">298-315</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Platelet-derived growth factor receptor (PDGFR) β is a marker of stromal pericytes and fibroblasts and represents an interesting target for both diagnosis and therapy of solid tumors.  A receptor-specific imaging agent would be a useful tool for further understanding the prognostic role of this receptor in vivo.  Affibody mols. constitute a class of very small binding proteins that are highly suited for in vivo imaging applications and that can be selected to specifically recognize a desired target protein.  Here we describe the isolation of PDGFRβ-specific Affibody mols. with subnanomolar affinity.  First-generation Affibody mols. were generated from a large naive library using phage display selection.  Subsequently, sequences from binders having a desired selectivity profile and competing with the natural ligand for binding were used in the design of an affinity maturation library, which was created using a single partially randomized oligonucleotide.  From this second-generation library, Affibody mols. with a 10-fold improvement in affinity (K d = 0.4-0.5 nM) for human PDGFRβ and a 4-fold improvement in affinity (K d = 6-7 nM) for murine PDGFRβ were isolated and characterized.  Complete reversible folding after heating to 90 °C, as demonstrated by CD anal., supports tolerance to labeling conditions for mol. imaging.  The binders were highly specific, as verified by dot blot showing staining reactivity only with human and murine PDGFRβ, but not with human PDGFRα, or a panel of control proteins including 16 abundant human serum proteins.  The final binder recognized the native conformation of PDGFRβ expressed in murine NIH-3T3 fibroblasts and human AU565 cells, and inhibited ligand-induced receptor phosphorylation in PDGFRβ-transfected porcine aortic endothelial cells.  The PDGFRβ-specific Affibody mol. also accumulated around tumoral blood vessels in a model of spontaneous insulinoma, confirming a potential for in vivo targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0zHAlJQGtlLVg90H21EOLACvtfcHk0lgB_qP52VmjXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFWqsbs%253D&md5=0d3f996fc70a3fe5373c5233a8203570</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DLindborg%26aufirst%3DM.%26aulast%3DCortez%26aufirst%3DE.%26aulast%3DH%25C3%25B6iden-Guthenberg%26aufirst%3DI.%26aulast%3DGunneriusson%26aufirst%3DE.%26aulast%3Dvon%2BHage%26aufirst%3DE.%26aulast%3DSyud%26aufirst%3DF.%26aulast%3DMorrison%26aufirst%3DM.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DHerne%26aufirst%3DN.%26aulast%3DPietras%26aufirst%3DK.%26aulast%3DFrejd%26aufirst%3DF.%2BY.%26atitle%3DEngineered%2520high-affinity%2520affibody%2520molecules%2520targeting%2520platelet-derived%2520growth%2520factor%2520receptor%2520beta%2520in%2520vivo%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D407%26spage%3D298%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Imaging of insulin-like growth factor type 1 receptor in prostate cancer xenografts using the affibody molecule <sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub></span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=90-97&author=V.+Tolmachevauthor=J.+Malmbergauthor=C.+Hofstr%C3%B6mauthor=L.+Abrahms%C3%A9nauthor=T.+Bergmanauthor=A.+Sj%C3%B6bergauthor=M.+Sandstr%C3%B6mauthor=T.+Gr%C3%A4slundauthor=A.+Orlova&title=Imaging+of+insulin-like+growth+factor+type+1+receptor+in+prostate+cancer+xenografts+using+the+affibody+molecule+111In-DOTA-ZIGF1R%3A4551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DMalmberg%26aufirst%3DJ.%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DBergman%26aufirst%3DT.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DImaging%2520of%2520insulin-like%2520growth%2520factor%2520type%25201%2520receptor%2520in%2520prostate%2520cancer%2520xenografts%2520using%2520the%2520affibody%2520molecule%2520111In-DOTA-ZIGF1R%253A4551%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D90%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Radionuclide molecular imaging using affibody molecules</span> <span class="citation_source-journal">Curr. Pharm. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2174%2F138920110792246609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20497119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CmsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=581-589&author=S.+Ahlgrenauthor=V.+Tolmachev&title=Radionuclide+molecular+imaging+using+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Radionuclide molecular imaging using affibody molecules</span></div><div class="casAuthors">Ahlgren, Sara; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Biotechnology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">CPBUBP</span>;
        ISSN:<span class="NLM_cas:issn">1389-2010</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The current way to increase efficacy of cancer therapy is the use of mol. recognition of aberrantly expressed gene products for selective treatment.  However, only a fraction of the patients have tumors with a particular mol. target.  Radionuclide imaging of mol. targets might help to stratify patient for cancer treatment.  Affibody mols. are scaffold proteins, which can be selected for high affinity recognition of proteinaceous mol. targets.  The capacity to re-fold under physiol. conditions allows labeling of Affibody mols. in a broad range of pH and temps. with preserved binding properties.  Peptide synthesis or introduction of a unique cysteine enables site-specific labeling of Affibody mols., resulting in uniform conjugates with well-defined pharmacol. characteristics.  The small size (7 kDa) of Affibody mols. provides rapid extravasation, rapid tumor penetration, and rapid clearance of unbound tracer from healthy organs and tissues.  In combination with sub-nanomolar affinity, this results in high contrast in vivo imaging a few hours after injection.  Excellent targeting has been demonstrated in pre-clin. studies with HER2-targeting Affibody mols. labeled with 99mTc and 111In for single photon computed tomog. (SPECT), and 18F, 64Cu, 124I and 68Ga for positron emission tomog. (PET).  Pilot clin. data confirm the high potential of Affibody mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMCx5xwZc2J7Vg90H21EOLACvtfcHk0liDmlFQrspJMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CmsrjI&md5=f5f1d1fd75658e31aa5d3af6a03f9c62</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F138920110792246609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920110792246609%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DRadionuclide%2520molecular%2520imaging%2520using%2520affibody%2520molecules%26jtitle%3DCurr.%2520Pharm.%2520Biotechnol.%26date%3D2010%26volume%3D11%26spage%3D581%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Baum, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuchardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span> </span><span class="NLM_article-title">Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic <sup>111</sup>In- or <sup>68</sup>Ga-labeled affibody molecules</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2967%2Fjnumed.109.073239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20484419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A280%3ADC%252BC3czmt1WnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=892-897&author=R.+P.+Baumauthor=V.+Prasadauthor=D.+M%C3%BCllerauthor=C.+Schuchardtauthor=A.+Orlovaauthor=A.+Wennborgauthor=V.+Tolmachevauthor=J.+Feldwisch&title=Molecular+imaging+of+HER2-expressing+malignant+tumors+in+breast+cancer+patients+using+synthetic+111In-+or+68Ga-labeled+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules</span></div><div class="casAuthors">Baum Richard P; Prasad Vikas; Muller Dirk; Schuchardt Christiane; Orlova Anna; Wennborg Anders; Tolmachev Vladimir; Feldwisch Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">892-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  The clinical utility of a human epidermal growth factor receptor 2 (HER2)-targeting Affibody molecule for detection and characterization of HER2-positive lesions was investigated in patients with recurrent metastatic breast cancer.  METHODS:  Three patients received (111)In- or (68)Ga-labeled DOTA(0)-Z(HER2:342-pep2) (ABY-002). gamma-Camera, SPECT, or PET/CT images were compared with earlier (18)F-FDG PET/CT results.  RESULTS:  Administration of radiolabeled ABY-002 was well tolerated.  Blood kinetics of radiolabeled ABY-002 showed a first half-life of 4-14 min, second half-life of 1-4 h, and third half-life of 12-18 h.  Radiolabeled ABY-002 detected 9 of 11 (18)F-FDG-positive metastases as early as 2-3 h after injection.  CONCLUSION:  Molecular imaging using (111)In- or (68)Ga-labeled ABY-002 has the potential to localize metastatic lesions in vivo, adds qualitative information not available today by conventional imaging techniques, and may allow the HER2 status to be determined for metastases not amenable to biopsy.  To our knowledge, this is the first report on clinical imaging data obtained with a non-immunoglobulin-based scaffold protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxq6EVK_8-BFvAgqb2vdc5fW6udTcc2ea6cQHKcEvRnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmt1WnsA%253D%253D&md5=4f67732329c856be99195fdd1c71ca05</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.109.073239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.109.073239%26sid%3Dliteratum%253Aachs%26aulast%3DBaum%26aufirst%3DR.%2BP.%26aulast%3DPrasad%26aufirst%3DV.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%26aulast%3DSchuchardt%26aufirst%3DC.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DFeldwisch%26aufirst%3DJ.%26atitle%3DMolecular%2520imaging%2520of%2520HER2-expressing%2520malignant%2520tumors%2520in%2520breast%2520cancer%2520patients%2520using%2520synthetic%2520111In-%2520or%252068Ga-labeled%2520affibody%2520molecules%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D892%26epage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sandberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garske, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sörensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindman, H.</span><span> </span><span class="NLM_article-title">First clinical observations of HER2 specific [<sup>111</sup>In]ABY-025 metastatic detection capability in females with metastatic breast cancer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl1</span><span class="NLM_x">) </span> <span class="NLM_fpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=220&issue=Suppl1&author=D.+Sandbergauthor=A.+Wennborgauthor=F.+Feldwischauthor=V.+Tolmachevauthor=J.+Carlssonauthor=U.+Garskeauthor=J.+S%C3%B6rensenauthor=H.+Lindman&title=First+clinical+observations+of+HER2+specific+%5B111In%5DABY-025+metastatic+detection+capability+in+females+with+metastatic+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandberg%26aufirst%3DD.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DFeldwisch%26aufirst%3DF.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DGarske%26aufirst%3DU.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DJ.%26aulast%3DLindman%26aufirst%3DH.%26atitle%3DFirst%2520clinical%2520observations%2520of%2520HER2%2520specific%2520%255B111In%255DABY-025%2520metastatic%2520detection%2520capability%2520in%2520females%2520with%2520metastatic%2520breast%2520cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26issue%3DSuppl1%26spage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Influence of labeling methods on biodistribution and imaging properties of radiolabelled peptides for visualization of molecular therapeutic targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2636</span><span class="NLM_x">–</span> <span class="NLM_lpage">2655</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2174%2F092986710791859397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=20491631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2636-2655&author=V.+Tolmachevauthor=A.+Orlova&title=Influence+of+labeling+methods+on+biodistribution+and+imaging+properties+of+radiolabelled+peptides+for+visualization+of+molecular+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of labelling methods on biodistribution and imaging properties of radiolabelled peptides for visualisation of molecular therapeutic targets</span></div><div class="casAuthors">Tolmachev, V.; Orlova, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2636-2655</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Progress in genomics and proteomics provides clin. oncol. with new anti-cancer drugs, which target selectively aberrantly expressed membrane proteins and assocd. signaling pathways in malignant cells.  Mol. targeting also enables specific delivery of cytotoxic substances to tumors sparing healthy tissues.  Improved selectivity of the treatment reduces side effects and widens the therapeutic window.  However, only a part of the patients might benefit from such treatment due to inter- and intrapatient heterogeneity of therapeutic target expression.  This makes it necessary to identify patients, who may benefit from targeting therapy.  Radiolabeled peptides can provide selective and sensitive detection of mol. therapeutic targets in both primary tumors and metastases in a single non-invasive procedure, making personalized treatment possible.  The choice of detection method (single photon emission tomog. or positron emission tomog.), radionuclide for labeling and labeling chem. can appreciably influence the imaging property of a tracer.  The labeling method might affect the binding affinity, the cellular processing and retention of a radionuclide, the biodistribution of a targeting peptide, and excretion pathways of a non-bound tracer and radiocatabolites.  This influences the sensitivity and specificity of the imaging.  This influence is exemplified by three classes of tumor-targeting peptides: somatostatin analogs, bombesin analogs and Affibody mols.  The review suggests approaches for selection of an optimal labeling chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5k8-43_isN7Vg90H21EOLACvtfcHk0liXL0WJnZBQnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nE&md5=da62e94476aef0b9ac9fae5cfc8c3d69</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F092986710791859397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859397%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DInfluence%2520of%2520labeling%2520methods%2520on%2520biodistribution%2520and%2520imaging%2520properties%2520of%2520radiolabelled%2520peptides%2520for%2520visualization%2520of%2520molecular%2520therapeutic%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2636%26epage%3D2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Núñez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erwin, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachowiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madewell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macapinlac, H. A.</span><span> </span><span class="NLM_article-title">Acquisition parameters for oncologic imaging with a new SPECT/multislice CT scanner</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs11307-009-0266-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=110-138&author=R.+N%C3%BA%C3%B1ezauthor=W.+D.+Erwinauthor=R.+E.+Wendtauthor=A.+Stachowiakauthor=M.+Marauthor=D.+Stevensauthor=J.+E.+Madewellauthor=H.+W.+Yeungauthor=H.+A.+Macapinlac&title=Acquisition+parameters+for+oncologic+imaging+with+a+new+SPECT%2Fmultislice+CT+scanner"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs11307-009-0266-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-009-0266-4%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25BA%25C3%25B1ez%26aufirst%3DR.%26aulast%3DErwin%26aufirst%3DW.%2BD.%26aulast%3DWendt%26aufirst%3DR.%2BE.%26aulast%3DStachowiak%26aufirst%3DA.%26aulast%3DMar%26aufirst%3DM.%26aulast%3DStevens%26aufirst%3DD.%26aulast%3DMadewell%26aufirst%3DJ.%2BE.%26aulast%3DYeung%26aufirst%3DH.%2BW.%26aulast%3DMacapinlac%26aufirst%3DH.%2BA.%26atitle%3DAcquisition%2520parameters%2520for%2520oncologic%2520imaging%2520with%2520a%2520new%2520SPECT%252Fmultislice%2520CT%2520scanner%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2010%26volume%3D2%26spage%3D110%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">512</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2006&pages=512-519&author=A.+Orlovaauthor=F.+Y.+Nilssonauthor=M.+Wikmanauthor=C.+Widstr%C3%B6mauthor=S.+St%C3%A5hlauthor=J.+Carlssonauthor=V.+Tolmachev&title=Comparative+in+vivo+evaluation+of+technetium+and+iodine+labels+on+an+anti-HER2+affibody+for+single-photon+imaging+of+HER2+expression+in+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DF.%2BY.%26aulast%3DWikman%26aufirst%3DM.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DComparative%2520in%2520vivo%2520evaluation%2520of%2520technetium%2520and%2520iodine%2520labels%2520on%2520an%2520anti-HER2%2520affibody%2520for%2520single-photon%2520imaging%2520of%2520HER2%2520expression%2520in%2520tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D47%26spage%3D512%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tran, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of a HER2-specific affibody molecule for molecular imaging</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1873</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs00259-009-1176-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19504093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSlu7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=1864-1873&author=T.+A.+Tranauthor=D.+Rosikauthor=L.+Abrahms%C3%A9nauthor=M.+Sandstr%C3%B6mauthor=A.+Sj%C3%B6bergauthor=H.+W%C3%A5llbergauthor=S.+Ahlgrenauthor=A.+Orlovaauthor=V.+Tolmachev&title=Design%2C+synthesis+and+biological+evaluation+of+a+HER2-specific+affibody+molecule+for+molecular+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imaging</span></div><div class="casAuthors">Tran, Thuy A.; Rosik, Daniel; Abrahmsen, Lars; Sandstroem, Mattias; Sjoeberg, Anna; Wallberg, Helena; Ahlgren, Sara; Orlova, Anna; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1864-1873</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose. The purpose of this study was to design and evaluate a novel platform for labeling of Affibody mols., enabling both recombinant and synthetic prodn. and site-specific labeling with 99mTc or trivalent radiometals.  Methods. The HER2-specific Affibody mol. PEP05352 was made by peptide synthesis.  The chelator sequence SECG (serine-glutamic acid-cysteine-glycine) was anchored on the C-terminal to allow 99mTc labeling.  The cysteine can alternatively serve as a conjugation site of the chelator DOTA for indium labeling.  The resulting 99mTc- and 111In-labeled Affibody mols. were evaluated both in vitro and in vivo.  Results. Both conjugates retained their capacity to bind to HER2 receptors in vitro and in vivo.  The tumor to blood ratio in LS174T xenografts was 30 at 4 h post-injection for both conjugates.  Biodistribution data showed that the 99mTc-labeled Affibody mol. had a fourfold lower kidney accumulation compared with the 111In-labeled Affibody mol. while the accumulation in other organs was similar.  Gamma camera imaging of the conjugates could clearly visualize the tumors 4 h after injection.  Conclusion. Incorporation of the C-terminal SECG sequence in Affibody mols. provides a general multifunctional platform for site-specific labeling with different nuclides (technetium, indium, gallium, cobalt or yttrium) and for a flexible prodn. (chem. synthesis or recombinant).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzFLblUMuT1bVg90H21EOLACvtfcHk0li6_ZW5NBVAcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSlu7zJ&md5=1e422a4037468bb6fe505a6afdec92bb</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00259-009-1176-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-009-1176-z%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%2BA.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520HER2-specific%2520affibody%2520molecule%2520for%2520molecular%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2009%26volume%3D36%26spage%3D1864%26epage%3D1873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Molecular design and optimization of <sup>99m</sup>Tc-labeled recombinant affibody molecules improves their biodistribution and imaging properties</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=461-469&author=H.+W%C3%A5llbergauthor=A.+Orlovaauthor=M.+Altaiauthor=S.+J.+Hosseinimehrauthor=C.+Widstr%C3%B6mauthor=J.+Malmbergauthor=S.+St%C3%A5hlauthor=V.+Tolmachev&title=Molecular+design+and+optimization+of+99mTc-labeled+recombinant+affibody+molecules+improves+their+biodistribution+and+imaging+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DAltai%26aufirst%3DM.%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DMalmberg%26aufirst%3DJ.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DMolecular%2520design%2520and%2520optimization%2520of%252099mTc-labeled%2520recombinant%2520affibody%2520molecules%2520improves%2520their%2520biodistribution%2520and%2520imaging%2520properties%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D461%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Altai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosestedt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ståhl, S.</span><span> </span><span class="NLM_article-title">Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of <sup>99m</sup>Tc-labeled recombinant affibody molecules</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1975</span><span class="NLM_x">–</span> <span class="NLM_lpage">1985</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=1975-1985&author=M.+Altaiauthor=H.+W%C3%A5llbergauthor=A.+Orlovaauthor=M.+Rosestedtauthor=S.+J.+Hosseinimehrauthor=V.+Tolmachevauthor=S.+St%C3%A5hl&title=Order+of+amino+acids+in+C-terminal+cysteine-containing+peptide-based+chelators+influences+cellular+processing+and+biodistribution+of+99mTc-labeled+recombinant+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAltai%26aufirst%3DM.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DRosestedt%26aufirst%3DM.%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DSt%25C3%25A5hl%26aufirst%3DS.%26atitle%3DOrder%2520of%2520amino%2520acids%2520in%2520C-terminal%2520cysteine-containing%2520peptide-based%2520chelators%2520influences%2520cellular%2520processing%2520and%2520biodistribution%2520of%252099mTc-labeled%2520recombinant%2520affibody%2520molecules%26jtitle%3DAmino%2520Acids%26date%3D2012%26volume%3D42%26spage%3D1975%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Waibel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willuda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnern, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stichelberger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abram, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plücthun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1038%2F12890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=10471933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADyaK1MXlslOmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=897-901&author=R.+Waibelauthor=R.+Albertoauthor=J.+Willudaauthor=R.+Finnernauthor=R.+Schibliauthor=A.+Stichelbergerauthor=A.+Egliauthor=U.+Abramauthor=J.+P.+Machauthor=A.+Pl%C3%BCcthunauthor=P.+A.+Schubiger&title=Stable+one-step+technetium-99m+labeling+of+His-tagged+recombinant+proteins+with+a+novel+Tc%28I%29-carbonyl+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex</span></div><div class="casAuthors">Waibel, Robert; Alberto, Roger; Willuda, Jorg; Finnern, Ricarda; Schibli, Roger; Stichelberger, Albert; Egli, Andre; Abram, Ulrich; Mach, Jean-Pierre; Pluckthun, Andreas; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">897-901</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We have developed a technetium labeling technol. based on a new organometallic chem., which involves simple mixing of the novel reagent, a 99mTc(I)-carbonyl compd., with a His-tagged recombinant protein.  This method obviates the labeling of unpaired engineered cysteines, which frequently create problems in large-scale expression and storage of disulfide-contg. proteins.  In this study, we labeled antibody single-chain Fv fragments to high specific activities (90 mCi/mg), and the label was very stable to serum and all other challenges tested.  The pharmacokinetic characteristics were indistinguishable from iodinated scFv fragments, and thus scFV fragments labeled by the new method will be suitable for biodistribution studies.  This novel labeling method should be applicable not only to diagnostic imaging with 99mTc, but also to radioimmunotherapy approaches with 186/188Re, and its use can be easily extended to almost any recombinant protein or synthetic peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtsBx_xGvq-bVg90H21EOLACvtfcHk0li6_ZW5NBVAcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslOmtLs%253D&md5=40e325f0dfd4bfab5d5cc4da00e4a6e0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F12890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12890%26sid%3Dliteratum%253Aachs%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DAlberto%26aufirst%3DR.%26aulast%3DWilluda%26aufirst%3DJ.%26aulast%3DFinnern%26aufirst%3DR.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DStichelberger%26aufirst%3DA.%26aulast%3DEgli%26aufirst%3DA.%26aulast%3DAbram%26aufirst%3DU.%26aulast%3DMach%26aufirst%3DJ.%2BP.%26aulast%3DPl%25C3%25BCcthun%26aufirst%3DA.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DStable%2520one-step%2520technetium-99m%2520labeling%2520of%2520His-tagged%2520recombinant%2520proteins%2520with%2520a%2520novel%2520Tc%2528I%2529-carbonyl%2520complex%26jtitle%3DNature%2520Biotechnol.%26date%3D1999%26volume%3D17%26spage%3D897%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Novak-Hofer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waibel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schibli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chester, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubiger, P. A.</span><span> </span><span class="NLM_article-title">Radiometal labeling of antibodies and antibody fragments for imaging and therapy</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=14970515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Kksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2004&pages=481-494&author=I.+Novak-Hoferauthor=R.+Waibelauthor=K.+Zimmermannauthor=R.+Schibliauthor=J.+Gr%C3%BCnbergauthor=K.+A.+Chesterauthor=A.+Murrayauthor=B.+K.+Loauthor=A.+C.+Perkinsauthor=P.+A.+Schubiger&title=Radiometal+labeling+of+antibodies+and+antibody+fragments+for+imaging+and+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Radiometal labeling of antibodies and antibody fragments for imaging and therapy</span></div><div class="casAuthors">Novak-Hofer, Ilse; Waibel, Robert; Zimmermann, Kurt; Schibli, Roger; Gruenberg, Juergen; Chester, Kerry A.; Murray, Andrea; Lo, Benny K. C.; Perkins, Alan C.; Schubiger, P. August</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">Antibody Engineering</span>),
    <span class="NLM_cas:pages">481-494</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Monoclonal antibodies are highly selective agents for delivering radiation to tumors for in vivo imaging and for therapy.  The labeling of antibodies with 3 metallic nuclides is described, which include 67Cu for both imaging and therapy, 99mTc for imaging, and 188/186Re for therapy.  The protocols also include methods for the evaluation of the radiochem. purity and immunoreactivity of 67Cu-labeled antibodies.  In addn., protocols for labeling the His-tagged single chain Fv MFE-23, an anti-CEA-antibody fragment, with 99mTc-tricarbonyl and with the 188Re nuclide are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkV0ioZ_jyTLVg90H21EOLACvtfcHk0li2smrKgcx7vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Kksg%253D%253D&md5=78f08c9038593179a3e86d621dd4f688</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovak-Hofer%26aufirst%3DI.%26aulast%3DWaibel%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DK.%26aulast%3DSchibli%26aufirst%3DR.%26aulast%3DGr%25C3%25BCnberg%26aufirst%3DJ.%26aulast%3DChester%26aufirst%3DK.%2BA.%26aulast%3DMurray%26aufirst%3DA.%26aulast%3DLo%26aufirst%3DB.%2BK.%26aulast%3DPerkins%26aufirst%3DA.%2BC.%26aulast%3DSchubiger%26aufirst%3DP.%2BA.%26atitle%3DRadiometal%2520labeling%2520of%2520antibodies%2520and%2520antibody%2520fragments%2520for%2520imaging%2520and%2520therapy%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2004%26volume%3D248%26spage%3D481%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span> </span><span class="NLM_article-title">HEHEHE-tagged affibody molecules may be purified by IMAC, are conveniently labeled with [<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup> and show improved biodistribution</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc1002357" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlalurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2013-2022&author=V.+Tolmachevauthor=C.+Hofstr%C3%B6mauthor=J.+Malmbergauthor=S.+Ahlgrenauthor=S.+J.+Hosseinimehrauthor=M.+Sandstr%C3%B6mauthor=L.+Abrahms%C3%A9nauthor=A.+Orlovaauthor=T.+Gr%C3%A4slund&title=HEHEHE-tagged+affibody+molecules+may+be+purified+by+IMAC%2C+are+conveniently+labeled+with+%5B99mTc%28CO%293%5D%2B+and+show+improved+biodistribution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation</span></div><div class="casAuthors">Tolmachev, Vladimir; Hofstrom, Camilla; Malmberg, Jennie; Ahlgren, Sara; Hosseinimehr, Seyed Jalal; Sandstrom, Mattias; Abrahmsen, Lars; Orlova, Anna; Graeslund, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2013-2022</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Affibody mols. are a class of small (ca. 7 kDa) robust scaffold proteins suitable for radionuclide mol. imaging of therapeutic targets in vivo.  A hexahistidine tag at the N-terminus streamlines development of new imaging probes by enabling facile purifn. using immobilized metal ion affinity chromatog. (IMAC), as well as convenient [99mTc(CO)3]+-labeling.  However, previous studies in mice have demonstrated that Affibody mols. labeled by this method yield higher liver accumulation of radioactivity, compared to the same tracer lacking the hexahistidine tag and labeled by an alternative method.  Two variants of the HER2-binding Affibody mol. ZHER2:342 were made in an attempt to create a tagged tracer that could be purified by immobilized metal affinity chromatog., yet would not result in anomalous hepatic radioactivity accumulation following labeling with [99mTc(CO)3]+.  In one construct, the hexahistidine tag was moved to the C-terminus.  In the other construct, every second histidine residue in the hexahistidine tag was replaced by the more hydrophilic glutamate, resulting in a HEHEHE-tag.  Both variants, denoted ZHER2:342-H6 and (HE)3-ZHER2:342, resp., could be efficiently purified using IMAC and stably labeled with [99mTc(CO)3]+ and were subsequently compared with the parental H6-ZHER2:342 having an N-terminal hexahistidine tag.  All three variants were demonstrated to specifically bind to HER2-expressing cells in vitro.  The hepatic accumulation of radioactivity in a murine model was 2-fold lower with [99mTc(CO)3]+-ZHER2:342-H6 compared to [99mTc(CO)3]+-H6-ZHER2:342, and more than 10-fold lower with [99mTc(CO)3]+-(HE)3-ZHER2:342.  These differences translated into appreciably superior tumor-to-liver ratio for [99mTc(CO)3]+-(HE)3-ZHER2:342 compared to the alternative conjugates.  This information might be useful for development of other scaffold-based mol. imaging probes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5PQtrJnBobVg90H21EOLACvtfcHk0li2smrKgcx7vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlalurrP&md5=80bdf638f387fe164822be26bc475c04</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fbc1002357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc1002357%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DMalmberg%26aufirst%3DJ.%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26atitle%3DHEHEHE-tagged%2520affibody%2520molecules%2520may%2520be%2520purified%2520by%2520IMAC%252C%2520are%2520conveniently%2520labeled%2520with%2520%255B99mTc%2528CO%25293%255D%252B%2520and%2520show%2520improved%2520biodistribution%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D2013%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hopp, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, K. R.</span><span> </span><span class="NLM_article-title">Prediction of protein antigenic determinants from amino acid sequence</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">3824</span><span class="NLM_x">–</span> <span class="NLM_lpage">3828</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1982&pages=3824-3828&author=T.+P.+Hoppauthor=K.+R.+Woods&title=Prediction+of+protein+antigenic+determinants+from+amino+acid+sequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHopp%26aufirst%3DT.%2BP.%26aulast%3DWoods%26aufirst%3DK.%2BR.%26atitle%3DPrediction%2520of%2520protein%2520antigenic%2520determinants%2520from%2520amino%2520acid%2520sequence%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1982%26volume%3D78%26spage%3D3824%26epage%3D3828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kyte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doolittle, R. F.</span><span> </span><span class="NLM_article-title">A simple method for displaying the hydropathic character of a protein</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1016%2F0022-2836%2882%2990515-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=7108955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADyaL38Xks1yjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=1982&pages=105-132&author=J.+Kyteauthor=R.+F.+Doolittle&title=A+simple+method+for+displaying+the+hydropathic+character+of+a+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A simple method for displaying the hydropathic character of a protein</span></div><div class="casAuthors">Kyte, Jack; Doolittle, Russell F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-32</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">A computer program that progressively evaluates the hydrophilicity and hydrophobicity of a protein along its amino acid sequence was devised.  A hydropathy scale takes into consideration the hydrophilic and hydrophobic properties of each of the 20 amino acid side chains.  Correlation was demonstrated between the plotted values and known structures detd. by crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPRHRl8WYl97Vg90H21EOLACvtfcHk0li2smrKgcx7vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xks1yjtro%253D&md5=ee67eb115939dfe56b2b2cae2c32dbd3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2882%2990515-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252882%252990515-0%26sid%3Dliteratum%253Aachs%26aulast%3DKyte%26aufirst%3DJ.%26aulast%3DDoolittle%26aufirst%3DR.%2BF.%26atitle%3DA%2520simple%2520method%2520for%2520displaying%2520the%2520hydropathic%2520character%2520of%2520a%2520protein%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1982%26volume%3D157%26spage%3D105%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baastrup, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fant, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody molecules</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc700307y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXntV2g" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=235-243&author=S.+Ahlgrenauthor=A.+Orlovaauthor=D.+Rosikauthor=M.+Sandstr%C3%B6mauthor=A.+Sj%C3%B6bergauthor=B.+Baastrupauthor=O.+Widmarkauthor=G.+Fantauthor=J.+Feldwischauthor=V.+Tolmachev&title=Evaluation+of+maleimide+derivative+of+DOTA+for+site-specific+labeling+of+recombinant+affibody+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules</span></div><div class="casAuthors">Ahlgren, Sara; Orlova, Anna; Rosik, Daniel; Sandstroem, Mattias; Sjoeberg, Anna; Baastrup, Barbro; Widmark, Olof; Fant, Gunilla; Feldwisch, Joachim; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-243</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Affibody mols. are a new class of small (7 kDa) scaffold affinity proteins, which demonstrate promising properties as agents for in vivo radionuclide targeting.  The Affibody scaffold is cysteine-free and therefore independent of disulfide bonds.  Thus, a single thiol group can be engineered into the protein by introduction of one cysteine.  Coupling of thiol-reactive bifunctional chelators can enable site-specific labeling of recombinantly produced Affibody mols.  In this study, the use of 1,4,7,10-tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide (MMA-DOTA) for 111In-labeling of anti-HER2 Affibody mols. His6-ZHER2:342-Cys and ZHER2:2395-Cys has been evaluated.  The introduction of a cysteine residue did not affect the affinity of the proteins, which was 29 pM for His6-ZHER2:342-Cys and 27 pM for ZHER2:2395-Cys, comparable with 22 pM for the parental ZHER2:342.  MMA-DOTA was conjugated to DTT-reduced Affibody mols. with a coupling efficiency of 93% using a 1:1 molar ratio of chelator to protein.  The conjugates were labeled with 111In to a specific radioactivity of up to 7 GBq/mmol, with preserved binding for the target HER2.  In vivo, the non-His-tagged variant 111In-[MMA-DOTA-Cys61]-ZHER2:2395-Cys demonstrated appreciably lower liver uptake than its His-tag-contg. counterpart.  In mice bearing HER2-expressing LS174T xenografts, 111In-[MMA-DOTA-Cys61]-ZHER2:2395-Cys showed specific and rapid tumor localization, and rapid clearance from blood and nonspecific compartments, leading to a tumor-to-blood-ratio of 18 ± 8 already 1 h p.i.  Four hours p.i., the tumor-to-blood ratio was 138 ± 8.  Xenografts were clearly visualized already 1 h p.i.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd4OnqYTv9HbVg90H21EOLACvtfcHk0lhuSaAaLZvFpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXntV2g&md5=38967dbf371fa3e9e7766ace799a0137</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbc700307y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc700307y%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DBaastrup%26aufirst%3DB.%26aulast%3DWidmark%26aufirst%3DO.%26aulast%3DFant%26aufirst%3DG.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DEvaluation%2520of%2520maleimide%2520derivative%2520of%2520DOTA%2520for%2520site-specific%2520labeling%2520of%2520recombinant%2520affibody%2520molecules%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D235%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ahlgren, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wållberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjertman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndorff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinkelborg, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyr, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Targeting of HER2-expressing tumors with a site-specifically <sup>99m</sup>Tc-labeled recombinant affibody molecule, Z<sub>HER2:2395</sub>, with C-terminally engineered cysteine</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">789</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.2967%2Fjnumed.108.056929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=19372467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtV2hsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=781-789&author=S.+Ahlgrenauthor=H.+W%C3%A5llbergauthor=T.+A.+Tranauthor=C.+Widstr%C3%B6mauthor=M.+Hjertmanauthor=L.+Abrahms%C3%A9nauthor=D.+Berndorffauthor=L.+M.+Dinkelborgauthor=J.+E.+Cyrauthor=J.+Feldwischauthor=A.+Orlovaauthor=V.+Tolmachev&title=Targeting+of+HER2-expressing+tumors+with+a+site-specifically+99mTc-labeled+recombinant+affibody+molecule%2C+ZHER2%3A2395%2C+with+C-terminally+engineered+cysteine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine</span></div><div class="casAuthors">Ahlgren, Sara; Waallberg, Helena; Tran, Thuy A.; Widstroem, Charles; Hjertman, Magnus; Abrahmsen, Lars; Berndorff, Dietmar; Dinkelborg, Ludger M.; Cyr, John E.; Feldwisch, Joachim; Orlova, Anna; Tolmachev, Vladimir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-789</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The detection of human epidermal growth factor receptor type 2 (HER2) expression in malignant tumors provides important information influencing patient management.  Redionuclide in vivo imaging of HER2 may permit the detection of HER2 in both primary tumors and metastases by a single noninvasive procedure.  Small (7 kDa) high-affinity anti-HER2 Affibody mols. may be suitable tracers for SPECT visualization of HER2-expressing tumors.  The use of generator-produced 99mTc as a label would facilitate the prompt translation of anti-HER2 Affibody mols. into use in clinics.  Methods: A C-terminal cysteine was introduced into the Affibody mol. ZHER2:342 to enable site-specific labeling with 99mTc.  Two recombinant variants, His6-ZHER2:342-Cys (dissocn. const. [KD], 29 pM) and ZHER2:2395-Cys, lacking a His tag (KD, 27 pM), were labeled with 99mTc in yields exceeding 90%.  The binding specificity and the cellular processing of Affibody mols. were studied in vitro.  Biodistribution and γ-camera imaging studies were performed in mice bearing HER2-expressing xenografts.  Results: 99mTc-His6-ZHER2:342-Cys was capable of targeting HER2-expressing SKOV-3 xenografts in SCID mice, but the liver radioactivity up-take was high.  A series of comparative biodistribution expts. indicated that the presence of the His tag caused elevated accumulation in the liver.  99mTc-ZHER2:2395-Cys, not contg. a His tag, showed low uptake in the liver and high and specific uptake in HER2-expressing xenografts.  Four hours after injection, the radioactivity uptake values (percentage of injected activity per g of tissue [%IA/g]) were 6.9 ± 2.5 (mean ± SD) %IA/g in LS174T xenografts (moderate level of HER2 expression) and 15 ± 3 %IA/g in SKOV-3 xenografts (high level of HER2 expression).  The corresponding tumor-to-blood ratios were 88 ± 24 and 121 ± 24, resp.  Both LS174T and SKOV-3 xenografts were clearly visualized with a clin. γ-camera 1 h after injection of 99mTc-ZHER2:2395-Cys.  Conclusion: The Affibody mol. 99mTc-ZHER2:2395-Cys is a promising tracer for SPECT visualization of HER2-expressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorXZQm1LQ8YbVg90H21EOLACvtfcHk0lhuSaAaLZvFpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtV2hsrw%253D&md5=f9d6f7c050b96835736797cd8cfe5e05</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.056929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.056929%26sid%3Dliteratum%253Aachs%26aulast%3DAhlgren%26aufirst%3DS.%26aulast%3DW%25C3%25A5llberg%26aufirst%3DH.%26aulast%3DTran%26aufirst%3DT.%2BA.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DHjertman%26aufirst%3DM.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DBerndorff%26aufirst%3DD.%26aulast%3DDinkelborg%26aufirst%3DL.%2BM.%26aulast%3DCyr%26aufirst%3DJ.%2BE.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DTargeting%2520of%2520HER2-expressing%2520tumors%2520with%2520a%2520site-specifically%252099mTc-labeled%2520recombinant%2520affibody%2520molecule%252C%2520ZHER2%253A2395%252C%2520with%2520C-terminally%2520engineered%2520cysteine%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D781%26epage%3D789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangsell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span> </span><span class="NLM_article-title">Use of a HEHEHE purification tag instead of a hexa-histidine tag improves biodistribution of affibody molecules site-specifically labeled with <sup>(99m)</sup>Tc, <sup>(111)</sup>In, and <sup>(125)</sup>I</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3817</span><span class="NLM_x">–</span> <span class="NLM_lpage">3826</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200065e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3817-3826&author=C.+Hofstr%C3%B6mauthor=A.+Orlovaauthor=M.+Altaiauthor=F.+Wangsellauthor=T.+Gr%C3%A4slundauthor=V.+Tolmachev&title=Use+of+a+HEHEHE+purification+tag+instead+of+a+hexa-histidine+tag+improves+biodistribution+of+affibody+molecules+site-specifically+labeled+with+%2899m%29Tc%2C+%28111%29In%2C+and+%28125%29I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm200065e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200065e%26sid%3Dliteratum%253Aachs%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DAltai%26aufirst%3DM.%26aulast%3DWangsell%26aufirst%3DF.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26aulast%3DTolmachev%26aufirst%3DV.%26atitle%3DUse%2520of%2520a%2520HEHEHE%2520purification%2520tag%2520instead%2520of%2520a%2520hexa-histidine%2520tag%2520improves%2520biodistribution%2520of%2520affibody%2520molecules%2520site-specifically%2520labeled%2520with%2520%252899m%2529Tc%252C%2520%2528111%2529In%252C%2520and%2520%2528125%2529I%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3817%26epage%3D3826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varasteh, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gräslund, T.</span><span> </span><span class="NLM_article-title">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>IGF1R:4551</sub>, a new affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm400218y&amp;key=10.1007%2Fs00259-012-2284-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm400218y&amp;key=23179942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BC3sXit1yhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=439-449&author=A.+Orlovaauthor=C.+Hofstr%C3%B6mauthor=J.+Strandauthor=Z.+Varastehauthor=M.+Sandstr%C3%B6mauthor=K.+Anderssonauthor=V.+Tolmachevauthor=T.+Gr%C3%A4slund&title=%5B99mTc%28CO%293%5D%2B-%28HE%293-ZIGF1R%3A4551%2C+a+new+affibody+conjugate+for+visualization+of+insulin-like+growth+factor-1+receptor+expression+in+malignant+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours</span></div><div class="casAuthors">Orlova, Anna; Hofstroem, Camilla; Strand, Joanna; Varasteh, Zohreh; Sandstrom, Mattias; Andersson, Karl; Tolmachev, Vladimir; Graeslund, Torbjoern</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">439-449</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose Radionuclide imaging of insulin-like growth factor type 1 receptor (IGF-1R) expression in tumors might be used for selection of patients who would benefit from IGF-1R-targeted therapy.  We have previously shown the feasibility of IGF-1R imaging using the Affibody mol. 111In-DOTA-His6-ZIGF1R:4551.  The use of 99mTc instead of 111In should improve sensitivity and resoln. of imaging, and reduce the dose burden to patients.  We hypothesized that inclusion of a HEHEHE tag instead of a His6 tag in ZIGF1R:4551 would permit its convenient purifn. using IMAC, enable labeling with [99mTc(CO)3]+, and improve its biodistribution.  Methods ZIGF1R:4551 was expressed with a HEHEHE tag in the N terminus.  The resulting (HE)3-ZIGF1R:4551 construct was labeled with [99mTc(CO)3]+.  Targeting of IGF-1R-expressing cells using [99mTc(CO)3]+-(HE)3-ZIGF1R:4551 was evaluated in vitro and in vivo.  Results (HE)3-ZIGF1R:4551 was stably labeled with 99mTc with preserved specific binding to IGF-1R-expressing DU-145 prostate cancer cells in vitro.  In mice, [99mTc(CO)3]+-(HE)3-ZIGF1R:4551 accumulated in IGF-1R-expressing organs (pancreas, stomach, lung and salivary gland). [99mTc(CO)3]+-(HE)3-ZIGF1R:4551 demonstrated 3.6-fold lower accumulation in the liver and spleen than 111In-DOTA-ZIGF1R:4551.  In NMRI nu/nu mice with DU-145 prostate cancer xenografts, the tumor uptake was 1.32 ± 0.11 %ID/g and the tumor-to-blood ratio was 4.4 ± 0.3 at 8 h after injection.  The xenografts were visualized using a gamma camera 6 h after injection.  Conclusion 99mTc(CO)3]+-(HE)3-ZIGF1R:4551 is a promising candidate for visualization of IGF-1R expression in malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbX-7pDUPZRrVg90H21EOLACvtfcHk0lhF4vs5ND2Dkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXit1yhurs%253D&md5=b3564a0e6253d030f0338c8c403f19b0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2284-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2284-8%26sid%3Dliteratum%253Aachs%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DHofstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DStrand%26aufirst%3DJ.%26aulast%3DVarasteh%26aufirst%3DZ.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DK.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DGr%25C3%25A4slund%26aufirst%3DT.%26atitle%3D%255B99mTc%2528CO%25293%255D%252B-%2528HE%25293-ZIGF1R%253A4551%252C%2520a%2520new%2520affibody%2520conjugate%2520for%2520visualization%2520of%2520insulin-like%2520growth%2520factor-1%2520receptor%2520expression%2520in%2520malignant%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26spage%3D439%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hosseinimehr, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1224</span><span class="NLM_x">–</span> <span class="NLM_lpage">1232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1224-1232&author=S.+J.+Hosseinimehrauthor=V.+Tolmachevauthor=A.+Orlova&title=Liver+uptake+of+radiolabeled+targeting+proteins+and+peptides%3A+considerations+for+targeting+peptide+conjugate+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosseinimehr%26aufirst%3DS.%2BJ.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DLiver%2520uptake%2520of%2520radiolabeled%2520targeting%2520proteins%2520and%2520peptides%253A%2520considerations%2520for%2520targeting%2520peptide%2520conjugate%2520design%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2012%26volume%3D17%26spage%3D1224%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekblad, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widström, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldwisch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennborg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson-Karlström, A.</span><span> </span><span class="NLM_article-title">Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of <sup>99m</sup>Tc-Labeled anti-HER2 Affibody Molecules</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2568</span><span class="NLM_x">–</span> <span class="NLM_lpage">2576</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc800244b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400218y&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVemtbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2568-2576&author=T.+Tranauthor=T.+Ekbladauthor=A.+Orlovaauthor=C.+Widstr%C3%B6mauthor=J.+Feldwischauthor=A.+Wennborgauthor=L.+Abrahms%C3%A9nauthor=V.+Tolmachevauthor=A.+Eriksson-Karlstr%C3%B6m&title=Effects+of+Lysine-Containing+Mercaptoacetyl-Based+Chelators+on+the+Biodistribution+of+99mTc-Labeled+anti-HER2+Affibody+Molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of 99mTc-Labeled Anti-HER2 Affibody Molecules</span></div><div class="casAuthors">Tran, Thuy A.; Ekblad, Torun; Orlova, Anna; Sandstrom, Mattias; Feldwisch, Joachim; Wennborg, Anders; Abrahmsen, Lars; Tolmachev, Vladimir; Eriksson Karlstrom, Amelie</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2568-2576</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The effects of polar (mercaptoacetyl-triseryl) and neg. charged (mercaptoacetyl-triglumatyl) chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody mols. were previously investigated.  With glycine, serine, and glutamate, we demonstrated that substitution with a single amino acid in the chelator can significantly influence the biodistribution properties and the excretion pathways.  Here, we have taken this investigation further, by analyzing the effects of introduction of a pos. amino acid residue on the in vivo properties of the 99mTc-labeled Affibody mol.  The Affibody mols. with mercaptoacetyl-seryl-lysyl-seryl (maSKS) and mercaptoacetyl-trilysyl (maKKK) extensions were produced by peptide synthesis and labeled with 99mTc in alk. conditions.  A comparative biodistribution was performed in normal mice to evaluate the excretion pathway.  A shift toward renal excretion was obtained when serine was substituted with lysine in the chelating sequence.  The radioactivity in the gastrointestinal tract was reduced 3-fold for the 99mTc-maSKS-ZHER2:342 and 99mTc-maKKK-ZHER2:342 in comparison with the 99mTc-maSSS- ZHER2:342 conjugate 4 h post injection (p.i.).  The radioactivity in the liver was elevated when a triple substitution of pos. charged lysine was used.  The tumor targeting properties of 99mTc-maSKS-ZHER2:342 were further investigated in SKOV-3 xenografts.  The tumor uptake of 99mTc-maSKS-ZHER2:342 was 17 ± 7% IA/g 4 h p.i.  Tumor xenografts were well-visualized by gamma scintigraphy.  In conclusion, the substitution with one single lysine in the chelator results in better tumor imaging properties of the Affibody mol. ZHER2:342 and is favorable for imaging of tumors and metastases in the abdominal area.  Multiple lysine residues in the chelator are, however, undesirable due to elevated uptake both in the liver and kidneys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDmpWErMOST7Vg90H21EOLACvtfcHk0ljkqOQaXlLgyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVemtbzJ&md5=70763ccd2238b97a4da5e25338429709</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fbc800244b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc800244b%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.%26aulast%3DEkblad%26aufirst%3DT.%26aulast%3DOrlova%26aufirst%3DA.%26aulast%3DWidstr%25C3%25B6m%26aufirst%3DC.%26aulast%3DFeldwisch%26aufirst%3DJ.%26aulast%3DWennborg%26aufirst%3DA.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DEriksson-Karlstr%25C3%25B6m%26aufirst%3DA.%26atitle%3DEffects%2520of%2520Lysine-Containing%2520Mercaptoacetyl-Based%2520Chelators%2520on%2520the%2520Biodistribution%2520of%252099mTc-Labeled%2520anti-HER2%2520Affibody%2520Molecules%26jtitle%3DBioconjugate%2520Chem.%26date%3D2008%26volume%3D19%26spage%3D2568%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rusckowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hnatowich, D. J.</span><span> </span><span class="NLM_article-title">A comparison in monkeys of <sup>(99m)</sup>Tc labeled to a peptide by 4 methods</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1870</span><span class="NLM_x">–</span> <span class="NLM_lpage">1877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2001&pages=1870-1877&author=M.+Rusckowskiauthor=T.+Quauthor=S.+Guptaauthor=A.+Leyauthor=D.+J.+Hnatowich&title=A+comparison+in+monkeys+of+%2899m%29Tc+labeled+to+a+peptide+by+4+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusckowski%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DT.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DLey%26aufirst%3DA.%26aulast%3DHnatowich%26aufirst%3DD.%2BJ.%26atitle%3DA%2520comparison%2520in%2520monkeys%2520of%2520%252899m%2529Tc%2520labeled%2520to%2520a%2520peptide%2520by%25204%2520methods%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D42%26spage%3D1870%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tolmachev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjöberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahmsén, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orlova, A.</span><span> </span><span class="NLM_article-title">Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=953-960&author=V.+Tolmachevauthor=T.+A.+Tranauthor=D.+Rosikauthor=A.+Sj%C3%B6bergauthor=L.+Abrahms%C3%A9nauthor=A.+Orlova&title=Tumor+targeting+using+affibody+molecules%3A+interplay+of+affinity%2C+target+expression+level%2C+and+binding+site+composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DTran%26aufirst%3DT.%2BA.%26aulast%3DRosik%26aufirst%3DD.%26aulast%3DSj%25C3%25B6berg%26aufirst%3DA.%26aulast%3DAbrahms%25C3%25A9n%26aufirst%3DL.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DTumor%2520targeting%2520using%2520affibody%2520molecules%253A%2520interplay%2520of%2520affinity%252C%2520target%2520expression%2520level%252C%2520and%2520binding%2520site%2520composition%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Williams, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampmeier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavare, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmullen, G. E.</span><span> </span><span class="NLM_article-title">Blower, P. Novel His-tag Sequence for Highly Efficient Site-Specific Radiolabelling of Proteins with [<sup>99mTc</sup>(CO)<sub>3</sub>]<sup>+</sup> and [<sup>186/188</sup>Re(CO)<sub>3</sub>]<sup>+</sup></span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=S216&issue=Suppl2&author=J.+D.+Williamsauthor=M.+Cooperauthor=F.+Kampmeierauthor=R.+Tavareauthor=G.+E.+Gmullen&title=Blower%2C+P.+Novel+His-tag+Sequence+for+Highly+Efficient+Site-Specific+Radiolabelling+of+Proteins+with+%5B99mTc%28CO%293%5D%2B+and+%5B186%2F188Re%28CO%293%5D%2B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DJ.%2BD.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DKampmeier%26aufirst%3DF.%26aulast%3DTavare%26aufirst%3DR.%26aulast%3DGmullen%26aufirst%3DG.%2BE.%26atitle%3DBlower%252C%2520P.%2520Novel%2520His-tag%2520Sequence%2520for%2520Highly%2520Efficient%2520Site-Specific%2520Radiolabelling%2520of%2520Proteins%2520with%2520%255B99mTc%2528CO%25293%255D%252B%2520and%2520%255B186%252F188Re%2528CO%25293%255D%252B%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol%2520Imaging%26date%3D2012%26volume%3D39%26issue%3DSuppl2%26spage%3DS216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Z.</span><span> </span><span class="NLM_article-title">Protein scaffold-based molecular probes for cancer molecular imaging</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1047</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=1037-1047&author=Z.+Miaoauthor=J.+Leviauthor=Z.+Cheng&title=Protein+scaffold-based+molecular+probes+for+cancer+molecular+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DLevi%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DZ.%26atitle%3DProtein%2520scaffold-based%2520molecular%2520probes%2520for%2520cancer%2520molecular%2520imaging%26jtitle%3DAmino%2520Acids%26date%3D2011%26volume%3D41%26spage%3D1037%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Nelson, D. L.; Cox, M. M.</span> <span class="citation_source-book">Lehninger Principles of Biochemistry</span>, <span class="NLM_edition">5th</span> ed.; <span class="NLM_publisher-name">W. H. Freeman and Company</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.+L.+Nelson&author=M.+M.+Cox&title=Lehninger+Principles+of+Biochemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DD.%2BL.%26btitle%3DLehninger%2520Principles%2520of%2520Biochemistry%26pub%3DW.%2520H.%2520Freeman%2520and%2520Company%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400218y&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm400218y%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400218y" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                949KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798fd87488024ad","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
